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Abstract     
Multiplexed Mass Spectrometric Approaches for Protein 
Cross-Linking Analysis and Protein Functional Studies 
by 
Bo Wang 
Chair: Kristina I. Håkansson 
Mass spectrometry (MS) alone, or combined with chemical cross-linking and 
proteolysis, is a valuable method in protein characterization. However, detection of cross-
linked peptides remains challenging due to ion suppression and cross-linked peptide 
signals are difficult to differentiate from those of unmodified peptides.  In this thesis, 
efforts to design a novel chemical cross-linker with metal oxide enrichment potential or 
unique gas-phase fragmentation pattern are presented. A series of biological studies, 
including mapping of protein-peptide interactions in the transcriptional machinery and 
determination of enzyme function and functional differentiation in natural product 
biosynthesis, were also performed.  
Photo-cross-linking combined with multiplexed MS and biotin-avidin enrichment 
was employed to map binding sites between gene transcriptional activators and a co-
activator (mediator) with resolution up to one amino acid residue. Unprecedented C-C 
and C-S bond cleavages were observed in matrix-assisted laser desorption/ionization 
xxvi 
 
tandem time-of-flight collision induced dissociation (MALDI TOF/TOF CID) of photo-
cross-linked products. 
A novel phosphate-containing cross-linker was synthesized and demonstrated to 
have amine reactivity. The corresponding cross-linked product was selectively enriched 
by metal dioxides. Gas-phase fragmentation patterns of peptides linked with disulfide-
containing cross-linkers were examined in electron capture dissociation (ECD), electron 
detachment dissociation (EDD), negative ion CID, and MALDI TOF/TOF CID, to find 
an optimal gas-phase cleavage method for identification of such cross-linked peptides.  
Iodinated peptides were subjected to ECD and electron transfer dissociation (ETD), 
showing highly selective C-I bond cleavage. A proximate, either through bond or through 
space, positive charge appears to facilitate C-I bond cleavage. These results provide a 
guide to design novel gas-phase cleavable cross-linkers and an additional model for 
elucidating the ECD/ETD mechanism.  Quadrupole fractionation was also applied in this 
thesis to enhance detection in the 350-600 m/z region. 
Fourier transform ion cyclotron resonance (FT-ICR) MS and infrared multiphoton 
dissociation (IRMPD) were applied to characterize the function and functional 
differentiation of enzymes from natural product biosynthetic pathways.  GCN5-related N-
acetyltransferase and enoyl reductase (ER) involved in Curacin A (Cur) biosynthesis were 
shown to have the unprecedented functions of dual decarboxylation/thiol acetyl transfer 
and cyclopropanation, respectively. Catalytic efficiencies of Cur and Jamaicamide ERs 
and site-specific mutants of Cur halogenase were measured by IRMPD. The role of a 
sulfotransferase in decarboxylative chain termination in Cur biosynthesis was also 
elucidated.   
1 
 
Chapter 1                                                           
Introduction     
 
1.1 Chemical Cross-linking and Mass Spectrometry 
1.1.1 Mass Spectrometry for Protein Analysis   
With the development of modern proteomics came the realization that increasing 
the number of proteins isolated and characterized from cells or tissues is not sufficient to 
reveal the physiological complexity of living organisms, which involve specific higher 
order protein structure and networks of protein-protein interactions.  It has been estimated 
that there are 35,000 protein-protein interactions in Saccharomyces cerevisiae, i.e., 
roughly six interactions for each protein [1, 2].  For human beings, the number of protein 
interactions is estimated to be even higher: 150,000-650,000 interactions from 26,000-
38,000 protein-coding genes [3, 4].  After screening these possible interactions, ~6-25% 
have been confirmed or are under consideration, resulting in a number of ~38,000 [5].  
The vast numbers of protein-protein interactions in living organisms indicate that: 1) the 
functions of each protein rely not only on its sequence and higher order structure, but also 
on its interaction network which can be either transient or stable; and 2) a certain protein 
may be involved in more than one interaction network to modulate related biological 
functions.  Therefore, in order to fully understand a protein’s biological function, it is 
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necessary to characterize its higher order structure and its protein-protein interaction 
network.  In the latter case, the details of each interaction, including the identity, 
stoichiometry, interaction site, etc., should be determined.   
Various techniques have been applied to characterize protein-protein interactions 
and protein complexes.  Traditional approaches like X-ray crystallography [6-9], electron 
microscopy (EM) [10, 11], and nuclear magnetic resonance (NMR) [12-15] spectroscopy 
can characterize protein complexes with resolution up to the atomic level and therefore 
yield direct insight into protein-protein interactions.  However, these approaches are 
laborious and have low sensitivity.  Furthermore, highly purified protein complexes are 
required.  Also, although proteins as large as 110 kDa have been characterized by NMR 
[16], that technique typically has size limitations around 30-35 kDa [17, 18].   
The advent of mass spectrometry (MS) for biomolecular analysis by coupling to 
soft ionization sources, including electrospray ionization (ESI) [19] and matrix-assisted 
laser desorption/ionization (MALDI) [20, 21], has allowed progression towards 
characterization of multi-protein complexes.  Advantages of MS include its high 
sensitivity for probing the real-time status of a protein complex, low sample requirements 
(as low as attomoles for proteins [22]), and high sample throughput.  Meanwhile, high 
mass accuracy can be obtained from different mass analyzers, including 5-10 ppm for 
reflectron time of flight (TOF) [23], 1-5 ppm or sub-ppm for Fourier transform ion 
cyclotron resonance (FT-ICR) [23, 24], and less than 2 ppm for orbitrap [25].  
MS can sometimes characterize protein complexes directly [26, 27] by assuming 
that interactions within the complex can be maintained from the liquid phase (prior to 
sample ionization) to the gas phase (inside the mass spectrometer).  Typically, direct MS 
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analysis of protein complexes is conducted with ESI, which is the softest ionization for 
large non-volatile biomolecules, including proteins, carbohydrates, and oligonucleotides.  
ESI can generate multiply charged gaseous ions with little disturbance to the analyte 
structure.  Many successful experiments involving application of ESI MS to characterize 
protein complexes have been reported.  For example, MS can reveal protein-protein and 
protein-ligand interactions [28-30].  Application of tandem mass spectrometry (MS/MS) 
further allows binding sites to be localized [31, 32].  MS has been applied to reveal 
structures of protein complexes with mass up to MDa, including virus capsids [33, 34] 
and the intact ribosome [35].  
1.1.2 Combining Chemical Cross-linking with Mass Spectrometry for Protein 
Structural and Protein-protein Interaction Analysis 
Chemical cross-linking combined with MS is an emerging method for 
characterizing protein higher order structure and interactions.  Detection by MS provides 
several advantages, including: 1) relatively high tolerance for the presence of un-cross-
linked proteins/peptides in the sample; 2) the amount of sample required can be as low as 
femtomoles [36]; 3) no strict size limitation of cross-linked proteins, particularly when 
proteolysis is employed; 4) fast speed of analysis; 5) various approaches for identification 
and confirmation of cross-linked proteins/peptides, including accurate mass measurement 
and MS/MS analysis.   
One strategy for applying chemical cross-linking to proteins is to target the side 
chains of certain amino acid residues, including amines [37, 38], sulfhydryls [39], and 
carboxylic acids [40] with specific reactive groups on chemical cross-linkers.  Upon the 
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cross-linking reaction, targeted amino acid pairs are covalently linked by chemical cross-
linkers with cleavable [41] or un-cleavable spacer arms of various lengths.  Once the 
cross-linked products are identified, the proximity relationship of cross-linked residue 
pairs can be estimated.  Another approach relies on photo-chemically reactive groups, 
including aryl azides [42, 43], diazirines [44, 45], and benzophenones [46, 47], to 
generate covalent linkage of chemical groups in spacial vicinity.  A third method 
establishes covalent [48] or non-covalent [49] interaction between cross-linking reagents 
and specific chemical groups on amino acid side chains (e.g., amine groups of lysine).  In 
this approach, “linkage” between two amino acid residues is not applicable. 
Once cross-linking is accomplished, modified proteins can be analyzed by the so 
called top-down approach [50].  Another approach is to carry out proteolytic digestion 
and identify cross-linked proteolytic peptides by MS/MS, thereby providing a rough map 
of the protein structure and the interaction sites (when applicable).  For cross-linking 
reagents based on non-covalent interactions, ESI MS is typically applied to detect a 
protein mass shift and thereby obtain the number of reagents that are involved in 
interaction.  This approach is analogous to hydrogen/deuterium exchange but reveals the 
solvent accessibility of certain residue side chains rather than the protein backbone [49]. 
Efficient detection of cross-linked peptides, particularly for photo-cross-linking, 
still remains challenging due to: 1) the low yield and resulting ion suppression effect 
from an excess of non-cross-linked peptides (ion suppression can be reduced by selective 
enriching of cross-linked peptides (e.g. biotin-avidin affinity purification).  2) the 
formation (in some cases) of inter-, intra-, and dead-end products in the chemical cross-
linking reaction [51], which makes spectra more complex.  3) the difficulty to 
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differentiate cross-linked peptide signals from those of unmodified peptides, particularly 
in LC/MS/MS analysis.  Product ions from cross-linked peptides are either identical to 
their non-cross-linked counterparts, or bear a “mystery” mass shift (because the 
mass/identity of the other attached peptide is unknown prior to analysis).  Database 
searching exhaustively against all possible peptide pair combinations is a huge challenge 
for computation and storage space [52].  Several efforts have been made to overcome 
these challenges and these are discussed in sections 1.1.4 and 1.1.5 below. 
1.1.3 Reactive Groups of Chemical Cross-linkers 
As mentioned above, chemical cross-linkers rely on their reactive groups to form 
covalent bonds between two amino acid residues in a protein and thereby map protein 
structure and interfaces in protein-protein interactions.  Chemical cross-linkers can be 
classified as homobifunctional, i.e., targeting two identical residues (e.g., a lysine pair), 
heterobifunctional, i.e., comprising two different reactive groups targeting different 
residues, or trifunctional, i.e., including a third chemical group that can be used for, e.g., 
isolation of identification.  Some of the most widely used cross-linking reactions and the 
corresponding chemical cross-linkers are discussed below.  
1.1.3.1 Amine-reactive Groups 
Amine-reactive groups target free amine groups, including protein N-termini and 
the ε-amino group in Lys side chains.  The most widely used amine-reactive group is N-
hydroxysuccinimide (NHS) ester, which was introduced in the 1970s [37, 38].  The NHS 
group is hydrophobic and insoluble in aqueous buffers.  Therefore, organic solvent is 
required to carry out NHS reactions.  In order to extend the application of NHS, sulfate 
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(SO3) groups were introduced to produce a water-soluble analog, sulfo-NHS [53].  The 
reaction of NHS with primary amine group (-NH2) is shown in Scheme 1.  After the 
reaction, the NHS group is released and a stable amide bond is formed.  Although NHS 
mainly targets amine groups, it also reacts with hydroxyl groups of serine and tyrosine 
and such products have been confirmed by MS/MS analysis [54].  The pH value for the 
NHS reaction is critical for controlling the specificity.  For example, NHS reacts with N-
termini and tyrosine OH under acidic conditions (pH 6.0). but, in basic conditions (pH 




Scheme 1.1.  Reaction Scheme of NHS/sulfo-NHS ester with a primary amine (NHS: 
R=H; sulfo-NHS: R=SO3Na) 
 
1.1.3.2 Sulfhydryl-reactive Group     
Incorporation of a maleimide moiety into chemical cross-linkers targets sulfhydryl 
groups, i.e., Cys residues (with SH group on their side chain) in proteins or protein 
complexes.  As shown in Scheme 1.2, a sulfhydryl group can insert into the maleimide 
moiety by Michael addition.  The pH value is important for controlling the reaction 
between maleimide and an SH group, e.g., maleimide reacts specifically with SH group 
in the pH range 6.5 to 7.5 [39, 56] but demonstrates potential side reaction with NH2 
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group at basic conditions [57].  In addition, one should be aware of the limitation of 
sulfhydryl-reactive chemical cross-linkers because: 1) Cys is a rare amino acid with the 
lowest frequency [58]; 2) the formation of disulfide (S-S) bonds between Cys pairs 
blocks the reaction between maleimide and SH group.  If S-S bonds are reduced to 
release SH groups prior to the cross-linking reaction, the native conformation or 




Scheme 1.2.  Reaction Scheme of sulfhydryl with maleimide. 
 
1.1.3.3 Photo-reactive Groups 
Photo-reactive groups incorporated into chemical cross-linkers include aryl azide, 
diazirine, and benzophenone moieties.  Photo cross-linking reactions are catalyzed by UV 
irradiation at specified wavelengths.  In general, photo-reactive groups are incorporated 
into heterobifunctional cross-linkers with an additional amine- or sulfhydryl-reactive 
group [36].  
Studies of the photochemical properties of aryl azides started about 80 years ago 
[42].  Upon UV irradiation, aryl azide loses N2 and forms short-lived singlet nitrene [42], 
which can undergo insertion into adjacent C-H or C-N bonds [59] (Scheme 1.3).  Aryl 
azide has been the most commonly applied photo-cross-linking reagent [60] to 
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investigate protein-DNA [61], protein-RNA [62], and protein-protein interactions[63, 64].  
One major limitation of applying aryl azides in protein characterization is the 
wavelengths (<280nm) [36] for inducing photo-activation, which may cause photolytic 







Scheme 1.3.  Photo-reaction of aryl azide. 
 
Diazirines can be activated at wavelengths longer than 350 nm to induce photo 
cross-linking reaction based on carbene chemistry [65].  The mechanism is shown in 
Scheme 1.4.  It has been reported that activated diazirines may generate undesired diazo 
isomerization but the rearrangement can be avoided by introducing an CF3 group into the 




Scheme 1.4.  Photo-reaction of diazirine.  
 
Benzophone (BP) is activated at 365 nm to form a triplet intermediate, which 
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induces hydrogen abstraction from any C-H bond within the right proximity.  This 
process results in formation of a C-C bond between BP and the target molecule [46] 
(Scheme 1.5).  At this wavelength for photo-activation, protein damage can be effectively 
minimized.  Another favorable character of BP is its reversible photo-activation property: 
if the H abstraction process does not occur, BP can relax back to its ground state and be 
re-activated in the next round of irradiation [46].  BP-based photo cross-linkers have been 
widely used in the characterization of protein-protein interactions [67-71].  Specifically, 
p-benzoyl phenyl alanine (pBpa), which contains BP moiety, can be expressed as an 






Scheme 1.5.  Photo-reaction of benzophenone (adopted from reference [46]). 
1.1.3.4 Cross-linking through Non-covalent Interactions  
18-crown-6 ether (18C6) was reported to exhibit non-covalent interaction with 
lysine [74].  18C6 [49] and another analog, phenyl bis-crown (PBC) [75], were applied to 
structural determination of proteins, including cytochrome c, ubiquitin, and melittin.  By 
examining the number of adducts in different charge states of the protein, solvent 
accessibility of side chains is inferred.  Therefore, protein structural and conformational 
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changes can be monitored.  
1.1.4 Modifications of Chemical Cross-linkers 
In addition to the reactive groups, other chemical modifications can be introduced 
into chemical cross-linkers to facilitate detection of cross-linked products.  Some 
strategies are described below. 
1.1.4.1 Isotope-labeled Chemical Cross-linkers 
A chosen number of deuterium atoms can be selectively incorporated into 
chemical cross-linkers and isotopically labeled cross-linkers are then mixed with their 
unmodified counterparts (1:1 w/w) to react with proteins or protein complexes.  After the 
cross-linking reaction followed by proteolysis, cross-linked peptides demonstrate 
characteristic isotopic patterns (due to the existence of deuterium atoms), which will aid 
their identification [76-80].  
Oxygen atoms in chemical cross-linkers can also be substituted by 18O to yield di-
18O-labeled species [81].  After reacting proteins with a mixture of labeled and unlabeled 
cross-linker followed by proteolysis, two sets of mass spectral peaks from 
intermolecularly cross-linked peptides can be observed with a mass difference of 4 Da 
[81]. 
1.1.4.2 Thiol-cleavable Chemical Cross-linkers 
Thiol-cleavable cross-linkers (TCCs), such as 3,3´-dithiobis [sulfosuccinimidyl 
propionate] (DTSSP), were first synthesized in 1976 [38] and have been applied to map 
protein complex interfaces [41, 82, 83] as well as protein three-dimensional structure 
with low-resolution [84].  The strategy of identifying TCC products involves dividing the 
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product in half after the cross-linking reaction.  One half (fraction 1) is subjected to 
disulfide bond reduction followed by thiol group alkylation [85] in solution phase and the 
other half, fraction 2, is left untreated.  These two fractions are then subjected to 
proteolysis and peptide mapping by MS.  Comparison of mass spectral peaks reveals 
potential inter-molecularly cross-linked products as they are observed in fraction 2 but 
not in fraction 1.  Similarly, putative intra-molecularly cross-linked products demonstrate 
a +116 Da shift (due to reduction and alkylation) for fraction 1 compared to fraction 2.  
One drawback is that these manipulations prior to MS analysis increase sample 
consumption and operation time.  
1.1.4.3 Gas-phase Cleavable Chemical Cross-linkers 
Another way to differentiate cross-linked peptides from unmodified peptides is to 
design a cross-linker that is cleavable in the gas phase.  The basic idea is to incorporate a 
specific moiety, which is labile upon IR irradiation [80, 86], UV irradiation [87], or 
collisions with neutral gas [88-92].  During MS/MS analysis, precursor ions containing a 
gas-phase cleavable cross-linker produce characteristic product ions, e.g., so called 
“reporter ions” [88], which identify cross-linked products.  Gas-phase cleavable cross-
linkers demonstrate promising prospects because multiple rounds of MS analysis or 
comparison of complex spectra from different liquid-phase treatments (e.g., such as 
described for DTSSP cross-linkers) is not necessary.  Therefore, the time for sample 
preparation, the amount of sample, and time for analysis are reduced. 
1.1.4.4 Enrichable Chemical Cross-linkers 
To improve the detection of cross-linked products, trifunctional cross-linkers, 
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which contain two reactive groups and a biotin moiety, have been designed and applied in 
cross-linking research [70, 77, 93-95].  After the cross-linking reaction and proteolysis, 
cross-linked products can be selectively enriched by biotin-avidin affinity purification.  
However, incorporation of biotin into cross-linkers presents some problems: 1) Biotin 
must be sufficiently distant from the other two reactive groups to minimize interference.  
Therefore, a long chain, e.g., polyethylene glycol [96], is introduced to isolate the biotin 
group but this strategy makes the cross-linker bulky.  The length of the spacer arm 
normally exceeds the preferred range of 8-15 Å [36, 81], which may influence the 
acquisition of meaningful information on protein structure and interactions. 2) Strong 
detergents, including SDS and urea, are normally required to dissociate biotin-avidin 
interactions.  Such detergents are not compatible with MS analysis and removal of 
detergents may be challenging and cause sample loss.    
An alternative approach for enriching cross-linked products, termed click-enabled 
linker for interacting proteins (CLIP) [97] was recently reported.  The CLIP strategy 
involves a novel trifunctional cross-linker, which contains two reactive groups and one 
alkyne moiety.  Proteolysis is carried out after the cross-linking reaction and the resulting 
peptides, cross-linked and unmodified ones, are mixed with biotin-azide enrichment tag.  
Cross-linked peptides can then be retained by alkyne-azide reaction and purified by 
biotin-avidin affinity purification. 
1.1.4.5 Zero-length Chemical Cross-linkers 
If a chemical cross-linker does not have a spacer arm between two reactive groups, 
it is referred to as a zero-length (ZL) species.  One example of a ZL cross-linker is 1-
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ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC), which can couple 
carboxyl groups to primary amines with  [36, 98], or be used to synthesize the NHS 
group [99]. 
Protein footprinting techniques can also be classified as “zero-length” cross-
linking because the utilized reagents only target one specific group, including amines [48] 
(Lys, N-termini) or carboxyl groups (Asp, Glu, and C-termini) [100], i.e., following the 
reaction, only one residue is modified.  The corresponding products can be regarded as 
analogs of dead-end products [51].  By detecting these modified residues, the solvent 
accessible area of the target protein or protein complex can be deduced and that 
information translates into protein conformation or interface information. 
1.1.5 Other Methods to Facilitate the Detection of Cross-linked Products 
1.1.5.1 Separation Methods 
Cross-linked protein complexes can be separated from un-reacted species by gel 
electrophoresis if the mass difference between them is big enough.  Bands corresponding 
to cross-linked species can be identified by estimating the mass after cross-linking (e.g., 
the mass of protein A plus the mass of its binding partner, protein B) and excised for 
subsequent proteolysis and MS analysis [36].  In addition, the cross-linking yield can be 
estimated by examining the staining intensity of the corresponding gel bands. 
Gel separation is mainly applied for cross-linked protein complexes.  When cross-
linking reactions are carried out on one specific protein (e.g., for structural analysis) or 
the mass difference between a cross-linked complex and its interacting units is not 
sufficient, the bottom-up method (to characterize peptide fragments from proteolysis) can 
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be directly applied by combining enrichment, LC/MS, and LC/MS/MS methods.  To 
differentiate cross-linked peptides from unmodified peptides, either gas-phase cleavable 
cross-linkers that generate unique fragments, or computer programs with appropriate 
algorithms to identify cross-linked peptides can be used.    
1.1.5.2 Computer-aided Identification of Cross-linked Peptides 
Spectra obtained from LC/MS/MS analysis of proteolyzed cross-linked proteins 
or protein complexes are highly complex and vast in number.  For intermolecular and 
dead-end cross-linked peptides, MS/MS identification can be accomplished with certain 
programs, including “in silico-digestion” programs (e.g., “Peptide Mass” from 
www.Expasy.org) and MS/MS fragmentation prediction programs (e.g. “MS-Product” 
from http://prospector.ucsf.edu).  Any potential residues that undergo cross-linking to 
form intermolecularly cross-linked and dead-end products can be defined as modified 
residues with a specific mass shift caused by the cross-linking reaction.  Generation of 
such lists is easily automated.  
Detection of intermolecularly cross-linked peptides is much more difficult 
because the mass shift from inter-cross-linking is unknown prior to identification.  
Therefore, the strategies used for intramolecular and dead-end species are not applicable.  
Since 2000, a series of programs have been developed to aid the identification of 






Table 1.1 Computer Programs for Cross-linked Peptide Identification 
Program Name URL* Reference 
MS2Assign http://roswell.ca.sandia.gov/~mmyang [51] 
MS2PRO N/A [101] 
SearchXlinks http://www.searchxlinks.de/cgi-bin/home.pl [102] 
C-MS3D http://ms3d.org [103] 
xComb http://phenyx.proteomics.washingto.edu/CXDB/index.cgi [104]
* Obtained from the references and may have expired. 
 
In addition to the open-source programs mentioned above, in-house programs 
have been developed to facilitate identification of cross-linked peptides [52, 105]. 
 
1.2 Fourier Transform Ion Cyclotron Resonance Mass Spectrometry 
(FT-ICR MS) 
1.2.1 The Basic Theory of FT-ICR MS 
The concept of obtaining mass-to-charge ratios via the measurement of ion 
cyclotron frequencies was introduced in the early 1950s [106].  With the development of 
FT-NMR, the concept and technique of FT-ICR MS was conceived and first introduced in 
1974 by Comisarow and Marshall [107].  Since its inception, FT-ICR MS has become a 
powerful tool applied in numerous areas, including proteomics. 
Unlike other types of mass analyzers, including magnetic sector (ion deflection), 
TOF (time for ions to travel a certain distance), and quadrupole/ion trap (ion stability in 
DC and RF fields), the FT-ICR mass analyzer, provides measurement of ion motion in a 
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fixed magnetic field.  Once ions are generated from various ion sources, including ESI 
and MALDI, they are transferred into the ICR trapping cell (see Figure 1.1) in an ultra 
high vacuum environment (10-9 to 10-10 Torr) and a spatially uniform magnetic field (up 
to 21 Tesla) provided by cryogenic or turbomolecular pumps and superconducting coils, 
respectively.  Ion motion in the ICR trapping cell is governed by the Lorenz force given 
by equation 1a in which F, m, a, q, v, B stand for force, ion mass, acceleration, charge, 
velocity, and strength of magnetic field, respectively.  Specifically, the direction of the 
Lorenz force is perpendicular to the plane of v and B and pointing inward to the center of 
the ICR trapping cell.  If ions remain undisturbed, e.g. no collisions, their path is circular 
with a radius r, resulting in an outward directed centrifugal force Fc, with the magnitude 
shown in equation 2.  The centrifugal force balances the inward directed Lorenz force 
with the magnitude qvB (equation 1b).  The linear velocity divided by the cyclotron 
radius, v/r, in equation 2 can be substituted by the angular velocity, ω, to yield equation 3.  
Setting equation 1 equal to equation 3 and rearranging yields equation 4 in which ω is the 
ion cyclotron frequency. 
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Because B is constant, it is clear that ω is determined by only one variable: the 
charge-to-mass ratio (q/m).  In other words, q/m, and thus m/z (m in units of u and z for 
the number of elementary charges) can be determined with ultra high accuracy because ω 
can be measured with high accuracy [108].  Unlike other mass analyzers, initial ion 
kinetic energy does not influence the measurement because ω is independent of it.  In 
other words, ions with a certain m/z value will demonstrate exactly the same ω regardless 
of their kinetic energy although they will orbit at different radii.  
1.2.2 FT-ICR Instrumentation 
The previous section shows that measurement of ω in an ICR trapping cell 
provides highly accurate m/z values.  To achieve that goal, designs of FT-ICR MS 
instrumentation are very important.  Some related aspects are discussed below. 
First of all, when ions enter the ICR trapping cell, the magnetic field governs 
radial ion motion via the Lorenz force.  However, ion motion along the direction of the 
magnetic field is independent of the magnetic field strength and is not confined within the 
ICR trapping cell.  Therefore, trapping electrodes have to be installed at both ends of the 
ICR trapping cell to provide an axial harmonic electric field preventing ions from 
escaping axially.  By introducing this axial electric field, ions can be held in the ICR 
trapping cell oscillating between the two trapping electrodes and performing ion 
cyclotron motion in the radial direction.  In addition, the combination of the added 
electric field and the magnetic field will cause ions to undergo magnetron motion in 
which the center of cyclotron motion precesses around the ICR trapping cell.  The 
frequency of ion magnetron motion is far less than ω [108].  
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As ions enter the ICR trapping cell and are trapped, they demonstrate random 
cyclotron phases.  Ions with a certain m/z value may start their cyclotron motion at any 
point along a circle inside the ICR trapping cell, which prevents detection of ω by 
measuring induced current between detector plates because currents on one side of the 
cell would be balanced to zero by currents induced on the opposite side of the cell.  In 
addition, the initial cyclotron radius is much smaller than the ICR cell, precluding 
detection of induced currents.  To solve these problems, RF excitation is applied to 
excitation electrodes incorporated into the ICR trapping cell (see Fig. 1.1) to provide a 
spatially uniform electric field oscillating perpendicular to the direction of the magnetic 
field.  The radiofrequency of the excitation electric field can be controlled to match the 
cyclotron frequency of ions with a certain m/z value and thereby make those ions absorb 
energy, which expands their ion cyclotron radii, and synchronize their cyclotron motion 
coherently as an ion packet.  Consequently, if an observation point is set on the ICR 
trapping cell wall, ion packets will approach and leave that point in an alternating manner.  
Detection electrodes (Fig. 1.1), which are positioned at opposite sides of the ICR trapping 
cell wall, record the differential current from the orbiting ion packets.  This current is 
then amplified and digitized to generate a time-domain signal containing all ion 
frequencies (and hence m/z values) present in the ICR cell.  By applying fast Fourier 
transformation, the time-domain signal can be converted to a frequency domain spectrum, 
which can be converted to an m/z spectrum by using equation 4.  However, equation 4 
does not take into account higher order effects due to the presence of the axial electric 
field.  Thus, the modified equation 5 is typically used for frequency-to-m/z conversion in 
which vc is the observed cyclotron frequency [23].  It should be pointed out that 
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detectable image current between the two detection plates requires a certain number of 
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Ion excitation in the ICR trapping cell is not only required for detection but also 










Figure 1.1.  Schematic diagram of a typical ICR trapping cell, which includes trapping 
electrodes, detection electrodes, and excitation electrodes.  The direction of ion motion 
and the magnetic field are indicated with arrows. 
 
As mentioned above, the presence of the magnetic field in ICR MS is crucial for 
generating ion cyclotron motion.  However, a strong magnetic field gradient between the 
20 
 
ICR trapping cell and other parts of the FT-ICR MS instrument causes problems 
regarding transmission of ions into the ICR trapping cell.  This phenomenon is called the 
magnetic mirror effect [111].  If the ratio of ion axial to radial velocity along the path of 
motion to the ICR trapping cell is insufficient, ions may be radially ejected [111] or even 
reverse their direction [112].  Efforts have been made to prevent ions from leaving 
radially by applying quadrupole [113] or octopole [114] ion guides.  In an alternative 
approach, electrostatic lenses [115] are used to increase ion axial velocity through the 
magnetic field gradient and then retarding the ions before trapping.   
Most experiments described in this thesis were carried out with a 7T-ESI-
quadrupole-FT-ICR mass spectrometer, shown in Figure 1.2.  FT-ICR MS instruments are 
typically coupled with an ESI source, as first reported in 1989 [116] because: 1) ESI 
tends to provide multiply charged ions with m/z values typically below 2000 [112].  
Limiting m/z values is important because the performance of FT-ICR MS decreases as 
m/z values increase [108].  For example, as shown in equation 6 [117], the resolving 
power (R) of FT-ICR MS is proportional to ion cyclotron frequency and the duration (T) 
of detection.  Clearly, ions with lower m/z values (higher ω) give higher R.  In order to 






    (6) 
 
2) multiply charged ions are preferred in MS/MS analysis and specifically required in 
some FT-ICR MS/MS techniques, including electron capture dissociation (ECD) [118] in 
21 
 
positive ion mode and electron detachment dissociation (EDD) [119] in negative ion 
mode.  MALDI typically generates singly charged ions with much higher m/z values than 

























Figure 1.2.  Diagram of 7T FT-ICR mass spectrometer used in this work. 
 
Ions generated at atmospheric pressure by the ESI source are unavoidably 
experiencing collisions and repulsion between each other.  Therefore, a dual stage ion 
funnel, as shown in Fig. 1.2, is located after the ESI source to accept a wide spatial 
distribution of ions and focus them into the mass spectrometer by a combination of RF 
fields and a gradient DC potential [120-122].  Ions are then subjected to a first round of 
external ion accumulation in a hexapole.  A quadrupole mass filter is placed after this 
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hexapole to provide further ion focusing and precursor ion selection for MS/MS analysis.  
Mass-selective external ion accumulation is accomplished in a second hexapole (collision 
cell) located after the quadrupole.  Mass-selective external ion accumulation provides 
improved sensitivity and dynamic range of ESI FT-ICR MS [123].  The collision cell can 
also be used for collision induced dissociation (CID) by adjusting its DC offset.  Product 
ions are analyzed in the ICR trapping cell.  A series of high voltage ion transfer optics are 
utilized as described above, to allow ions to overcome the magnetic mirror effect and 
enter the ICR cell.  
Fig. 1.2 also shows two additional components: first, an indirectly heated 
dispenser cathode [124], which generates electrons for ion-electron reactions, including 
ECD, EDD, electron induced dissociation (EID) [125, 126], etc.;  second, a 10.6 µm CO2 
laser, which provides photons for infrared multiphoton dissociation (IRMPD) [127, 128]. 
In summary, FT-ICR MS provides the highest mass resolving power, defined as 
m/Δm50% (m is the mass of an ion and Δm50% is the peak width of that ion at half 
maximum peak height) of all mass analyzers.  Values of ~4×106 at m/z 1,000 [23] and 
8×106 for crude oil analysis [129] have been reported, and even 1.7×107 at m/z 1,087 by 
modifying the ICR trapping cell [130].    Purcell et al. reported the identification of more 
than 12,000 compounds from crude oil in a 400 Da mass window [131-133].  For 
biomolecules, FT-ICR MS can obtain unit protein resolution up to 142 kDa [134].  In 
addition, FT-ICR MS provides up to sub-ppm mass measurement accuracy for peptides 
[135] and better than 100-300 ppb in crude oil analysis [136].  Although ~200 charges are 
required to generate detectable image current in an ICR trapping cell (as mentioned 
above), those charges have to enter the cell if an external ion source is used.  
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Nevertheless, FT-ICR MS can still provide detection limits as low as ~6,000 molecules 
with external ion accumulation [123].  Also, single-molecule detection has been reported 
with up to 104 charges [137]. 
 
1.3 Tandem Mass Spectrometry (MS/MS) 
The term tandem mass spectrometry (MS/MS) indicates two-stages of MS 
analysis.  The first stage is to isolate precursor ions with specific m/z values for further 
analysis.  In the case of the FT-ICR MS instrument shown in Figure 1.2, isolation can be 
achieved by the external quadrupole, or in the ICR trapping cell by using correlated 
harmonic excitation fields [138].  The second MS stage is to apply various ion activation 
techniques to dissociate precursor ions and generate product ions.  Structural information 
of precursor ions can be deduced by analyzing these product ions.  Similarly, MS analysis 
in more than two stages (e.g., MS3, MS4, etc.) [139, 140] is performed by further isolating 
a specific product ion and subjecting it to further fragmentation.  In the work discussed in 
this thesis, utilized MS/MS techniques include CID, IRMPD, ECD, electron transfer 
dissociation (ETD) [141], and EDD.  These techniques are discussed in detail below. 
1.3.1 CID and IRMPD: Slow Heating Methods to Produce Fragmentation 
Although the manner of generating precursor ion excitation is different in CID 
and IRMPD, they are classified into one category because they yield similar 
fragmentation pathways and generate comparable product ions after activation.  
Gas-phase ion decomposition due to collisional activation was observed and 
explained in the beginning of the 20th century [142, 143].  The first set of CID spectra 
24 
 
were reported in the 1960s [144, 145].  Later on, McLafferty and co-workers [146] 
proposed that CID would be a powerful tool to characterize ion structure.  After nearly 
four decades of research and development, CID has become the most widely applied 
MS/MS technique, typically performed in the low-energy regime, i.e. at less than 100 eV.  
Generally, low-energy CID can be considered as a two-step process [147, 148].  In the 
first step, a precursor ion (An+/-) collides with target neutral gas, e.g., N2 or Ar, and 
obtains vibrational or electronic internal energy [147] by absorbing translational energy 
during the collision.  Precursor ions are continually excited by multiple collisions to yield 
An+/-*.  The interval of each collision is ~tens to hundreds of milliseconds [149].  Due to 
the relatively long time scale for excitation, low-energy CID is considered a slow-heating 
MS/MS method [150].  In the second step, internal energies distribute throughout the 
molecule and cause rupture of the most labile chemical bonds.  Formation of product ions 
in CID is a result of competition between multiple dissociation pathways [151] and the 
dissociation starts with the channels of lowest dissociation energy [147].   
The development of “soft” ionization techniques, including ESI and MALDI, 
allowed CID to be applied to large biomolecules.  Peptide fragmentation behavior in CID 
is influenced by the collision energy.  Low energy CID (1-100 eV) of peptide cations 
produces mainly b- and y-type product ions (Figure 1.3.) by “charge-directed 
fragmentation”[152], as further discussed below.  In high-energy CID (keV collision 
energy), v-, d-, and w-type ions (Figure 1.3.) are also generated via “charge-remote 
fragmentation” [153].  CID fragmentation behavior for deprotonated peptides is more 
complicated, demonstrating the same product ion types as in positive ion CID (e.g., b- 
and y-type ions) but also other ions resulting from various backbone cleavages and side 
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Figure 1.3.  Peptide product ion nomenclature in MS/MS.  Cleavage of Cα-C, C-N, and 
N-Cα backbone bonds yields a-/x-, b-/y-, and c-/z-type product ions, respectively.  Side 
chain losses (mainly in high-energy CID) produce d-, v-, and w-type ions. 
 
In IRMPD, precursor ions with IR chromophore(s) are irradiated with a low 
power CO2 laser (<100 W) and activated by absorbing photons.  Because the energy 
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transferred to precursor ions by each photon is only about 0.1 eV [155], relatively long 
duration of IR irradiation (ten to hundreds of milliseconds, or more) is needed for 
generating effective activation and dissociation, thus IRMPD is also a slow-heating 
technique.  Subsequently, activated precursor ions undergo internal energy redistribution 
and dissociations similar to those from CID.  Therefore, IRMPD and CID provide similar 
spectra in most cases.  One advantage of IRMPD over CID is the avoidance of the low 
mass cut-off limit in RF-based trapping instruments (e.g., ion trap) [155].  In addition, the 
amount of energy deposited into precursor ions can be adjusted more accurately than CID 
by varying laser power or irradiation time [155].  IRMPD can also provide higher 
fragmentation efficiency than CID for phosphate-containing molecules, including 
phosphopeptides [156, 157], products from a phosphate-containing cross-linker [86], and 
metabolites[158] due to the high gas-phase IR absorption of the phosphate group.  Thus, 
such species can be differentiated from non-phosphate-containing analytes at low 
irradiation power for which phosphate-containing species will show reduced abundances 
(due to dissociation) and other species will not.  Finally, IRMPD is preferred over in-cell 
CID in FT-ICR MS because introduction of collision gas, which decreases FT-ICR 
performance, is not required. 
Fragmentation of protonated peptides in CID and IRMPD can be rationalized by 
the “mobile proton model” [159-162].  According to this theory, protons are originally 
located at basic sites, including N-termini and side chains of basic residues (if available).  
Protons may also associate with the oxygen atom of the amide carbonyl group or the 
backbone amide nitrogen atom by solvation.  Following peptide activation from the 
energy imparted in CID or IRMPD, protons can migrate from their original locations to 
27 
 
backbone amide nitrogens.  Protons initially located at strongly basic residues, i.e. 
arginine, are restricted from migrating effectively and, thus, the presence of arginines 
equal to or in higher number than the number of protons alters fragmentation behavior 
[159].   
1.3.2 ECD, ETD, and EDD: Radical-driven Fragmentation Techniques 
ECD, ETD, and EDD are categorized together because they all rely on the 
generation of gas-phase radical ions to induce dissociation.  In addition, their peptide 
fragmentation patterns are completely different from those in CID and IRMPD.  
Therefore, radical-driven and slow-heating based dissociation methods yield 
complementary product ions.  Combining these two kinds of MS/MS approaches extends 
the amount of structural information that can be generated for biomolecules, including 
proteins, peptides, and carbohydrates. 
Since its inception [118], ECD has become a promising MS/MS technique.  In 
ECD (see Scheme 1.6), low energy electrons (<1 eV) are captured by multiply charged 
precursor cations, resulting in the formation of a radical charge reduced cation and 
subsequent N-Cα backbone bond cleavage generates even-electron c- and radical z-type 
product ions [118] (Figure 1.3).  
 
 1 eV








One of the most exciting characteristics of ECD is the retention of protein post-
translational modifications (PTMs) during backbone fragmentation.  As a result, ECD is 
extremely useful for localizing PTMs, including phosphorylation [163-169], 
glycosylation [170-174], and sulfation [175, 176], which are labile in the gas phase and 
thus preferentially lost in slow-heating MS/MS.  In addition, ECD provides preferential 
cleavage of disulfide (S-S) bonds [177], which demonstrate limited fragmentation in 
positive ion mode low-energy CID [178].  S-S bond rupture can also be achieved in 
several other MS/MS approaches, including negative mode CID [179] and IRMPD [180], 
EDD [180], and high-energy CID [92, 181, 182].  In some cases, ECD can retain and 
therefore characterize non-covalent interactions at protein-protein interfaces [31, 183].  
Because CID and ECD produce different product ion types (b-/y- and c-/z-type ions, 
respectively) they can be combined to provide complementary sequential and structural 
information of proteins and peptides, which is particularly useful for peptide de novo 
sequencing [184].  Limitations of ECD include the charge state (n) requirement (n≥2, 
otherwise not applicable) and its low fragmentation efficiency [185, 186].  
The exact mechanism of ECD is still under controversy.  At present, there are two 
main theories: the first one for peptide ECD [118, 177, 187, 188] involves electron 
capture at protonated sites, including the side chains of basic residues (Arg, Lys, and His) 
or the N-terminal primary amine group, to yield neutralization and formation of a 
hypervalent radical center with subsequent energy release.  A hot hydrogen atom (H•) is 
ejected and can attack an S-S bond (if present), or a backbone carbonyl group to form a 
labile aminoketyl intermediate.  This hydrogen migration is followed by preferential S-S 
bond cleavage or non-selective cleavage of adjacent N-Cα bonds, respectively.  In the 
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latter case, c- and z- type ions are generated (Figure 1.3).  The second theory, referred to 
as the “superbase mechanism” was proposed by Turecek’s [189] and Simons’ groups [190, 
191].  Here, S-S bonds or backbone carbonyl groups capture an electron directly into 
their antibonding orbitals, generating a highly basic site (superbase).  Protons are then 
abstracted from nearby locations to yield charge neutralization, and subsequent N-Cα 
bond cleavage.  In the superbase model, protons do not have to originate from protonated 
basic sites, thus, it can explain ECD of metal-adducted peptides, particularly because the 
acidity of Cα protons can be greatly increased in the presence of metals [189].  Simons 
and co-workers showed computationally that 90-99% of electrons are capture by 
positively charged sites but 1-10% are directly attached to either σ* (S-S bond) or π* 
(amide) orbitals assisted by Columbic stabilization from adjacent positively charged 
groups, rendering attachment exothermic [190, 191].  Further, electrons captured by 
positively charged groups can be released and transferred to S-S or N-Cα bonds [192].  
ETD is believed to be analogous to ECD by sharing a similar mechanism and 
generating c- and z-type product ions [141, 192, 193].  One favorable characteristic of 
ETD over ECD is its direct compatibility with radio-frequency based ion storage without  
needing a magnetic field to confine electrons [194].  Because the electron transfer process 
in ETD relies on electron donation from radical reagent anions, some factors that 
influence ECD and ETD dissociation, including cross sections for electron 
capture/transfer, recombination energies, and the time scales of the electron 
capture/transfer processes, can be different [195].  For example, precursor ions absorb all 
electron energy in ECD but, in ETD, energy is partitioned between analyte ions and the 
remaining neutral reagent [192].  In addition, it has been reported that doubly protonated 
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precursor ions yield less backbone fragmentation than their triply protonated counterparts 
in ECD [196].  In ETD, doubly protonated species generally generate limited 
fragmentation unless supplementary activation methods, including collisional activation 
and pre-IR irradiation, are applied [194, 195].   
EDD is an ion-electron based MS/MS approach for multiply charged anions.  As 
shown in Scheme 1.7, precursor anions are irradiated with electrons with much higher 
energy (>10 eV) than in ECD.  Upon irradiation, one electron is detached from precursor 
ions, leading to formation of charge reduced anions and subsequent dissociation.  For 
peptides, mainly the backbone Cα-C bond is cleaved to produce a- and x-type ions 
(Figure 1.3).  Because EDD operates in negative ion mode, it is an ideal approach for 
characterizing acidic biomolecules, including oligonucleotides [197-199] and 
oligosaccharides [200-202].  Similar to ECD, EDD retains PTMs, including 
phosphorylation [169] and sulfation [119].  
 
>10 eV
[M - nH]n- [M - nH](n - 1)-•* + 2e-
e‐ fragments
 
Scheme 1.7. EDD process. 
 
The mechanism of EDD has been studied by Simons’ and Zubarev’s groups [203, 
204].  Briefly, formation of multiply charged anions is the result of deprotonation at 
acidic residues (aspartic and glutamic acids with carboxyl side chain), C-termini, and 
backbone amide nitrogens.  In the latter case, electron ejection from the deprotonated site 
results in formation of a radical site on the nitrogen atom.  Experimental observation [119, 
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205] as well as computational analysis [203, 204] revealed that backbone N-centered 
radicals induces Cα-C cleavage to produce even-electron x-type and radical a-type 
product ions. 
 
1.4 Application of FT-ICR MS to Investigate Natural Product 
Biosynthetic Pathways 
1.4.1 Natural Product Biosynthesis by NRPS and PKS Catalysis 
Non-ribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs) are 
two enzyme families that catalyze the biosynthesis of a vast number of natural products 
with tremendous structural diversity.  In addition, many natural products from 
PKS/NRPS biosynthesis demonstrate pharmacological potential, including 
antitumor[206], antimicrobial, and immunosuppressant [207, 208] properties.  Some 

















Figure 1.4.  Structure and biological functions of some natural products derived from 
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NRPS and PKS biosynthesis. 
 
During NRPS and PKS catalysis, substrates are covalently linked to a serine 
residue of a carrier protein through a phosphopantetheine (PPant) arm (chemical structure 
is shown in Chapter 7), which is introduced by a phosphopantetheinyl transferase [209, 
210].  Substrates in NRPS/PKS catalysis are subjected to various chemical reactions (e.g., 
dehydration and decarboxylation) and undergo chain elongation to form intermediates of 
increasing length.  These intermediates are transferred to downstream carrier domains for 
the next step of chain elongation and processing. Eventually, the natural product is 
released.  
1.4.2 The Role of FT-ICR MS in Investigating NRPS and PKS Biosynthesis 
The first application of FT-ICR MS to investigate the proteins of an NRPS 
biosynthetic pathway was reported in 1999 [211].  In that work, a proteolytic peptide with 
PPant moiety was detected by FT-ICR MS without HPLC purification. 
In top-down analysis, the ultra high resolving power provided by FT-ICR MS can 
resolve isotopic peaks for a protein (e.g., carrier domains with loaded substrates or 
intermediates) in a specific charge state and, therefore, the correct charge state can be 
obtained from the m/z difference between isotopic peaks by a simple calculation [208].  
Knowledge of the charge state corresponding to a particular mass spectral peak allows the 
mass of that protein to be measured with high accuracy.  Based on this virtue of FT-ICR 
MS, NRPS/PKS catalytic reactions can be straightforwardly monitored by measuring the 
mass shift between carrier domain-loaded substrates and products and, thus, provide 
33 
 
insights into the function of specific catalytic domains.  For example, - 18 Da shift 
between substrate and product indicates a dehydration reaction.  We have successfully 
applied this strategy to interrogate NRPS/PKS catalysis as discussed in Chapter 7.   
Under certain conditions, MS/MS approaches provided by FT-ICR MS can 
simplify the analysis of NRPS/PKS reactions.  For example, application of IRMPD/CID 
has been shown to cleave the PPant arm of carrier domains [212].  Substrate conversion 
information (e.g., dehydration, decarboxylation, halogen addition) remains linked to the 
ejected low mass PPant ions and can be deduced from MS/MS.  Therefore, the complex 
isotopic distributions of intact proteins in top-down analysis can be avoided.  
 
1.5 Dissertation Overview 
The main objectives for this thesis are 1) to apply chemical cross-linking, MS, 
and MS/MS techniques for investigation of protein-protein interactions; 2) to investigate 
the optimal conditions and approach for cleaving disulfide-containing chemical cross-
linkers in the gas phase; 3) to study the MS/MS behavior of iodinated amino acid side 
chains for evaluating the prospective of designing a novel chemical cross-linker with a C-
I bond; 4) to design a novel chemical cross-linker with metal-dioxide enrichment 
potential; 5) to apply the mass-selective interface in FT-ICR MS for improving detection 
in the low m/z area; 6) to apply FT-ICR MS and IRMPD for characterization of enzyme 
function and functional differentiation. 
In Chapter 2, photo-cross-linking (BP-based), biotin-avidin affinity purification,   
and multiplexed mass spectrometric techniques, including ESI FT-ICR MS, MALDI MS, 
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low-energy CID, and high-energy MALDI TOF/TOF CID were combined to successfully 
map the binding sites between three gene transcriptional activators, including Gal4, Gcn4, 
and VP2, and the coactivator Med15.  In some cases, resolution up to a single amino acid 
residue could be obtained.  To our knowledge, this work includes the first report of BP-
based photo cross-linking for peptides up to 5 kDa and identity confirmation by MS/MS.  
It also reports for the first time specific C-S/S-C and C-C bond cleavage of BP cross-
linked products in MALDI TOF/TOF CID, thus presenting an additional tool for 
identification of such products. This work was a collaboration project with Professor 
Anna Mapp and has been published in Angewandte Chemie [71]. 
Chapter 3 presents efforts to find the optimal approach for dissociating disulfide-
containing chemical cross-linkers in the gas phase and thereby facilitate and expedite the 
identification of cross-linked peptides.  In this work, DTSSP, a commercial chemical 
cross-linker with a midpoint SS linkage, was reacted with model peptides as well as a 
protein (ubiquitin).  Among the cross-linked peptides obtained from these reactions, five 
intermolecularly cross-linked peptides (ICPs) were subjected to ECD, activated ion (AI) 
ECD, MALDI TOF/TOF CID, negative ion CID, and EDD.   The results demonstrate that 
ECD provides the most efficient S-S and C-S bond cleavage but, sometimes, IR pre-
irradiation is required.  Negative ion CID, which provides preferred S-S and C-S bond 
cleavages for peptides containing disulfide bonds, did not yield stable and consistent 
results in our work.  EDD resulted in S-S and C-S bond cleavages but with low efficiency.  
MALDI TOF/TOF CID showed C-S bond cleavage to form a 66 Da doublet, which can 
aid the identification of ICPs.  In addition, MALDI TOF/TOF CID does not require 
highly abundant precursor ions.  Based on these results, it appears that the combination of 
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ECD and MALDI TOF/TOF CID may be the best choice for maximizing S-S and C-S 
bond cleavage in ICPs. 
In Chapter 4, specific residues in peptides, including His and Tyr, were selectively 
iodinated.  Iodinated peptides were subjected to ECD and ETD in their triply- and doubly 
protonated as well as calcium-adducted forms.  For all iodinated peptides, carbon iodine 
(C-I) bond cleavage was observed in both ECD and ETD but with various efficiencies 
depending on the distance between the positive charge and the C-I bond, either through 
bond or through space: the closer the distance, the higher trend for efficient C-I bond 
cleavage in ECD/ETD.  C-I bonds were not cleaved in MALDI TOF/TOF CID.  These 
results provide new insights into the mechanism(s) of ECD and ETD for 
proteins/peptides.  In addition, selective C-I bond rupture in ECD offers interesting 
prospects for designing novel C-I bond containing cross-linkers with unique iodine 
ejection in ECD. 
Efforts to design a new phosphate-containing homobifunctional cross-linker are 
shown in Chapter 5.  Based on previous reports, zirconium dioxide (ZrO2) and titanium 
dioxide (TiO2) enrichment can specifically enhance the detection of phosphopeptides in 
MS [213].  After incubating the designed phosphate-containing cross-linker with 
substance P, one intramolecularly cross-linked product was observed, which confirmed 
the reactivity of the new cross-linker.  In addition, the cross-linked product, spiked into a 
proteolytic peptide mixture (trypsin digested apomyoglobin) could be selectively 
enriched by TiO2 and ZrO2 due to the presence of the phosphate group.  CID 




In Chapter 6, we utilized an external quadrupole to improve the detection of 
peptides in FT-ICR MS, particularly within the 350-600 m/z region.  Data show that 
application of quadrupole fractionation (QF) (i.e., use of consecutive 50 m/z isolation 
windows), increases peptide signals 2-11 fold compared to standard broadband mode 
detection.  The additional time required for QF was considered and compensated for.   
In Chapter 7, FT-ICR MS was successfully applied to characterize portions of the 
biosynthetic pathway of the natural products, curacin A (Cur) and jamaicamide (Jam).  
This work included elucidation of the functional differentiation of the highly similar Cur 
and Jam biosynthetic enzymes, and provided supporting information for enzyme 
functional determination based on crystal structures.  The function of a GCN5-related N-
acetyltransferase (GNAT) in the Cur pathway was characterized with FT-ICR MS and 
IRMPD, demonstrating the unprecedented function of transferring an acyl group to a free 
thiol group rather than the canonical amine group.     
The functions of putative dehydratases (ECH1) and decarboxylases (ECH2) from 
the Cur and Jam pathways were also revealed.  ECH1 and ECH2 from the Cur pathway 
generate a product with α,β C=C moiety whereas Jam ECH1 and ECH2 yield a β,γ C=C 
configuration.  Coupled with Cur halogenase (Hal), Cur ECH1 and ECH2, Cur 
enoylreductase (ER) was revealed to catalyze an unprecedented cyclopropanation 
reaction.  Meanwhile, Cur ER still retains the canonical function of reducing an α,β C=C 
bond.  The saturation function of Jam ER is redundant in the Jam biosynthetic pathway 
due to generation of β,γ C=C and vinyl chloride group by upstream enzymes (Hal, ECH1 
and ECH2).  By applying IRMPD, the catalytic efficiency of Cur ER cyclopropanation as 
well as Cur ER and Jam ER saturation were evaluated.  The results show that Cur ER 
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catalyzes cyclopropanation much faster, around 240-fold, than saturation.  Jam ER still 
shows highly efficient catalytic ability for the saturation reaction.  With a similar strategy, 
the function of  a series of site-specific Hal mutants was also evaluated.  Top-down FT-
ICR MS and IRMPD were also applied to characterize intermediates after 
sulfotransferase (ST) and thioesterase (TE) treatments for elucidating the chain 
termination mechanism in the Cur pathway.  The work in this Chapter is part of 
collaboration projects with Professors David Sherman and Janet Smith and has been 
published in Science, Nature, Journal of the American Chemical Society, and 
Proceedings of the National Academy of Sciences of the United States of America [214-
217].  A summary of all results in this thesis as well as prospects for future work are 
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Chapter 2  
Photo-cross-linking and Complementary Use of ESI and 
MALDI Mass Spectrometry to Map Interaction Sites between 
Transcriptional Activators and Mediator 15 
 
2.1 Introduction 
The process of eukaryotic gene expression, in which RNA is synthesized from a 
corresponding DNA template, is initiated by proteins termed transcriptional activators.  
Activators initially bind to specific DNA sequences upstream of the gene transcription 
starting site [1], then they recruit and assemble the transcriptional complex which 
includes RNA polymerase II (pol II) and associated general transcriptional factors.  In 
addition, activators aid pol II to bind correctly at specific sequences in DNA and attract 
pol II to the starting point of transcription.  The interaction between activators and pol II 
is indirect and relayed by an approximately 20 protein co-activator/mediator complex [2].  
Due to their central role in gene transcription, malfunctioning or mis-regulated activators 
can cause many human diseases, such as diabetes [3], Huntington’s disease [4], and 
cancers [5, 6].  Therefore, detailed understanding of the function and activation of 
activators, including mapping of the interaction/binding sites between activators and 
mediator, is desired.  Such understanding will also provide necessary information for 
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designing artificial activators aiming at transcription-based therapeutics.  Strong efforts 
have been made to reveal such binding interactions in detail [7-9].  However, the multiple 
binding areas shared by various activators [10, 11] make it difficult to localize specific 
binding sites for a particular activator, and the technical challenges of obtaining 
covalently cross-linked peptides in high yield makes the application of MS and MS/MS 
strategies for high resolution analysis challenging. 
Nevertheless, photo-cross-linking followed by proteolytic digestion and mass 
spectrometric characterization of the covalently linked products has proven valuable for 
characterizing protein-protein interactions [12-15].  p-Benzoyl phenyl alanine (pBpa) is 
an unnatural amino acid that can be incorporated in vivo into transcriptional activators.  
pBpa has a benzophone (BP) moiety that can be activated into a triplet state under 365 
nm irradiation and thereby abstract a hydrogen atom from any closely located C-H bond 
to form a C-C bond [16].  The 365 nm wavelength used in pBpa photo-cross-linking 
minimizes protein damage.  In addition, if H abstraction does not occur, pBpa can relax 
back to the ground state and be re-activated in the next round of irradiation [16].  This 
property is beneficial for reaction yield.  However, challenges still exist in applying this 
strategy: first, the acid-rich sequences of many transcriptional activators make positive 
ESI mode difficult due to their low ionization efficiency and labile nature [17, 18].  The 
hydrophilic nature of activators also diminishes ESI efficiency due to their reduced 
surface activity [19, 20].  Second, the photo-cross-linking efficacy of pBpa depends on 
the stability and proper accessibility of the interacting partners [16] thus the yield may be 
very low [21, 22].  Third, cross-linked products generally need to be separated from non-
cross-linked material prior to analysis.  However, as shown in Table 2.1., the mass 
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increment of our Med15 construct (Med15 1-416; 47 kDa) after cross-linking is less than 
4 kDa, rendering gel-based separation difficult.   
 




Gcn4 (105-134) TPMFEYENLEDNSKEWTSLFDNDIPVTTDDC 3770.5917
Gal4 (854-874) CGMFNTTTMDDVYNYFDDEDT 2712.0343
VP2 DFDLDMLGDFDLDMLGC 2036.8210
1:  Phe in sequence marked by bold and italic font was substituted by pBpa.               
2: Cys with underline is introduced to incorporate N-(6-(biotinamido)hexyl)-3'-(2'-
pyridyldithio)-propionamide (BHPDP).                                                                                                     
3: Mass of BHPDP is not included. 
 
In collaboration with Prof. Mapp’s group, in vitro cross-linking experiments with 
the activators VP2/Gcn4/Gal4 and the protein co-activator Med15 (residues 1-416) were 
performed.  In order to verify the photo-cross-linking yield, top-down analysis of cross-
linked product from a shorter Med15 fragment, 107-255 (average MW of 33,582) with 
Gcn4 was carried out (the binding activity with Gcn4 is similar for this construct as for 
Med15 1-416 [23]).  As shown in Figure 2.1, the major mass spectral peaks both with and 
without cross-linking correspond to unmodified Med15.  No detectable signals were 
observed for a cross-linked species.  Therefore, it can be concluded that the photo-cross-
linking yield was too low for direct analysis.  
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Efforts were made to overcome all these challenges.  First, a reversible 
biotinylation reagent ((N-(6-(biotinamido)hexyl)-3'-(2'-pyridyldithio)-propionamide, 
BHPDP) was used to incorporate a biotin moiety into activators (at a Cys residue, located 
either at the N- or C-terminus, as shown in Table 2.1).  As shown in Figure 2.2, BHPDP 
has a biotin moiety linked to an SH reactive group.  Once the Cys residue is biotinylated, 
cross-linked products can be selectively bound to neutravidin beads for enrichment.  The 
presence of a disulfide bond in BHPDP allows bound species to be released from the 
neutravidin by S-S reduction with dithiothreitol (DTT).  This strategy is beneficial 
because use of detergents, which are not compatible with subsequent MS analysis and 
difficult to remove, can be avoided.  Second, both MALDI and ESI (the latter was 
applied in both positive and negative ion modes) were utilized combined with 
corresponding MS/MS approaches.  Briefly, the cross-linking reaction was carried out 
and the product was subjected to trypsin digestion, then cross-linked peptides were 
selectively isolated via biotine-avidin affinity purification, identified by ESI FT-ICR MS 
and/or MALDI-MS, and confirmed by MS/MS approaches, including ESI low-energy 
CID and MALDI TOF/TOF high-energy CID.  MALDI and ESI have previously been 
shown to yield complementary information in proteomic analyses in that some proteins 






Figure 2.1. Partial ESI FT-ICR mass spectra from top-down analysis of unreacted Med15 
107-255 (top) and Med15 107-255 cross-linked with Gcn4 (bottom).  Charge states +28-
+31 of unmodified Med15 107-255 are observed in both cases.  The arrows 1-3 indicate 
m/z regions where the cross-linked product (Med15 and Gcn4) should be observed in its 



















Figure 2.2. Chemical structure of BHPDP. 
 
2.2 Experimental  
All experiments involving sample preparation, including Med15 expression, 
synthesis of Gal4, Gcn4, and VP2, and BHPDP conjugation, were accomplished by Dr. 
Majmudar [28].    
For ESI in both positive and negative ion mode, samples were analyzed with an 
actively shielded 7 Tesla quadrupole-Fourier transform ion cyclotron resonance mass 
spectrometer (APEX-Q, Bruker Daltonics, Billerica, MA). Target analytes in electrospray 
solution (1:1 CH3CN:H2O with 0.1% HCOOH for positive ion mode, and 1:1 CH3CN: 
H2O with 20 mM NH4HCO3 for negative ion mode) were directly infused into an ESI 
source (Apollo II, Bruker Daltonics) at a flow rate of 70 µL/h.  A counterflow of hot (240 
C) nitrogen gas was applied to assist desolvation of ESI droplets.  Multiply charged ions 
generated by ESI were externally accumulated in a hexapole and transferred into an 
infinity ICR cell [29] through a series of high-voltage optics for m/z analysis. For 
external CID, precursor ions were mass-selectively accumulated in the hexapole collision 
cell at collision voltages ranging from -18-24 V.  Argon was used as collision gas.  All 
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data were acquired with XMASS software (version 6.1, Bruker Daltonics) in broadband 
mode from m/z = 200 to 2000 with 512k data points and summed up to 50 scans.  Mass 
spectra were analyzed with MIDAS software [30].  
For MALDI analysis (performed at the Michigan Proteome Consortium), 5 µL of 
alpha-cyano-4-hydroxycinnaminic acid (5 mg/mL in 50% acetonitrile, 0.1% TFA, 2 mM 
ammonium citrate) were added to the avidin purified cross-linked tryptic peptides.  
Samples were taken to dryness and resuspended in 5 μL of 50% acetonitrile/0.1% TFA.  
0.5 μL of this solution was hand-spotted onto a 192-well MALDI target and allowed to 
dry under atmosphere.  MALDI mass spectra were acquired on an Applied Biosystems 
4800 Proteomics Analyzer (TOF/TOF) in reflector positive ion mode.  Peptide masses 
were acquired up to 8,000 Da.  Mass spectra were obtained with 2000 laser (Nd-YAG 
laser operating at 355 nm and 200 Hz) shots.  At least three trypsin autolysis peaks were 
used for internal calibration.  MS/MS spectra were also acquired in positive ion mode.  
MS/MS spectra were accumulated based on 6,000 laser shots, or until up to five peptide 
product ions were observed at a signal-to-noise ratio of 100.  Atmosphere, at a pressure of 
~6x10-7 Torr was used as collision gas with a collision energy of 2 keV. 
 
2.3 Results and Discussion 
2.3.1 Identified Binding Sites between Med15 and Gcn4/Gal4/VP2 
The identified binding sites of Gal4, Gcn4 and VP2 within Med15 (1-416) are 
shown in Figure 2.3.  These results show that all three activators share two binding sites: 
residues 74-78 and 207-217 in Med15.  Additionally, Gal4 and VP2 have one common 
60 
 
binding site: residues 160-174, and VP2 has three more unique binding sites; residues 79-
85, 222-231, and 345-348.  
 
 
Figure 2.3.  Binding sites identified in Med15 for Gal4, Gcn4 and VP2. 
 
The mass spectrometric mapping of binding sites between Med15 and the three 
activators Gal4, Gcn4, and VP2 relied on the complementary use of MALDI and ESI, 
which was particularly crucial for VP2 analysis.  As summarized in Table 2.2, all VP2 
cross-linked products, including Med15 345-348, 74-78, 79-85, 207-217, 222-231, and 
160-174, could only be detected and confirmed by MALDI MS and MS/MS.  More 
details are provided in Figure 2.4, in which signals of six potential VP2 cross-linked 
peptides can be clearly observed in MALDI (top panel) whereas only two potential VP2 
cross-linked products, 74-78 and 207-217, are observed in negative ESI MS (bottom 
panel).  No potential cross-linked products were detected in positive ESI MS (middle 
panel).  Interestingly, the utilized VP2 sequence contains 35% acidic residues (6 out of 17) 
and no basic residues (His, Arg, or Lys), which enhance MALDI response [26, 31].  












74‐78 79‐85 160‐174 207‐217 222‐231 345‐348
VP2          VP2 VP2 VP2 VP2 VP2




VP2-Med15 cross-linked products were detected only in negative ion mode for which 
MS/MS analysis is much more complex compared to positive ion mode [32].  For Gcn4 
(Figure 2.5), MALDI MS (top panel) provided detection of cross-linked products 
involving Med15 74-78 whereas positive ESI MS (insets of bottom panel) provided 
detection of Med15 207-217 cross-linked with Gcn4.  Finally, for Gal4 (Figure 2.6), 
MALDI MS (top panel) provided detection of two Gal4 cross-linked products: Med15 
74-78 and 207-217.  In addition to these two cross-linked products, the cross-linked 
peptide 160-174 was detected in positive ESI MS, as shown in the inset of the bottom 
panel in Figure 2.6. 
 






Figure 2.4. MALDI-TOF (top) and ESI FT-ICR MS (positive mode, middle; negative 
mode, bottom) analysis of VP2/Med15 cross-linked products.  Here, α represents the 
activator VP2, β1 corresponds to Med15 345-348, β2 to Med15 74-78, β3 to Med15 79-







































85, β4 to Med15 207-217, β5 to Med15 222-231, and β6 to Med15 160-174.  Cross-
linked products were verified by MS/MS. 
 
Figure 2.5. MALDI TOF (top) and ESI FT-ICR MS (positive ion mode, bottom) analysis 
of cross-linked products involving Gcn4 and Med15.  Here, α1 represents the activator 
α1β1
α2β1































tryptic peptide Gcn4 119-134; α2 represents Gcn4 105-134, β1 corresponds to Med15 74-
78, and β2 to Med15 207-217. 
 
Figure 2.6. MALDI-TOF (top) and ESI FT-ICR MS (positive ion mode, bottom) analysis 
αβ1
αβ3






























of cross-linked products involving Gal4 and Med15.  Following photo-cross-linking, 
samples were subjected to proteolysis and purification as described in the experimental 
section.  Here, α represents the activator Gal4, β1 corresponds to Med15 74-78, β2 to 
Med15 160-174, and β3 to Med15 207-217. 
 
It should be noted that MALDI and ESI MS can provide cross-linked product 
candidates but they need to be confirmed by MS/MS.  In this work, up to twenty 
candidates of Gal4, Gcn4, and VP2 cross-linked products with Med15 were observed but 
several could not be confirmed by MS/MS.  Thus, multiplexed MS/MS analyses are 
crucial to maximize the confirmation.  Low-energy CID and MALDI TOF/TOF high-
energy CID were both applied and yielded complementary information.  As shown in 
Table 2.2, some cross-linked candidates, including Gal4-Med15 160-174, Gal4-Med15 
207-217, and Gcn4-Med15 207-217, could only be confirmed by ESI MS/MS while 
others, including Gcn4-Med15 74-78 and all six VP2 cross-linked products, were only 
verified by MALDI TOF/TOF CID.   
MALDI TOF/TOF CID (Figure 2.7, top) of VP2-Med15 207-217 produced 14 
backbone product ions along both VP2 and Med15 207-217, thereby providing confident 
confirmation of this cross-linked product.  Peaks 1 and 2 in the MALDI TOF/TOF CID 
spectrum may be assigned as C-S and S-C bond cleavage in the Met side chain or pBpa 
moiety and are discussed in detail below.  Negative ion CID (Fig. 2.7, bottom), on the 
other hand, produced only uninformative neutral losses from the precursor ions, thus 
precluding confirmation of the cross-linked product.  An example for Gcn4 is shown in 
Figure 2.8.  Here, positive mode ESI CID provided localization of the cross-linking site 
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between Gcn4 and Med15 to Met213.  In addition, 12 backbone cleavages on Gcn4 and 
their neutral losses (shown in inset) provided confident identification of the cross-linked 
product.  MALDI TOF/TOF CID of the singly protonated form of the same cross-linked 
species (Fig. 2.8, bottom), on the other hand, showed very limited fragmentation.  In 
addition, observed low-abundance peaks are ill defined, particularly in the higher m/z 
area shown in the insets.  Thus, accurate m/z values could not be obtained.  An example 
for Gal4, the product Gal4-Med15 74-78 is shown in Figure 2.9.  Low-energy ESI CID 
provided 12 backbone cleavages whereas only five were observed in MALDI TOF/TOF 
CID.  However, it should be noticed that MALDI was necessary for confirmation of VP2-
Med15 cross-linked species.  Similarly, some cross-linked products were only detectable 
in ESI and were thus limited to low energy CID, as shown in Figure 2.10 for 




Figure 2.7. MALDI-TOF/TOF CID MS/MS (top) and ESI FT-ICR MS/MS (negative ion 
low-energy CID, bottom) of a potential cross-linked product: VP2:Med15 207-217.  
Peaks 1 and 2 can be assigned as C-S bond cleavages, assuming that cross-linking 
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fragmentation is observed but in negative ion mode ESI FT-ICR MS/MS, only neutral 
losses of water and ammonia were seen, precluding confident verification of this cross-
linked product with the latter technique (* = unidentified peaks).  Here, α represents VP2 





















































Figure 2.8.  ESI FT-ICR MS/MS (positive ion mode, top) and MALDI TOF/TOF high-
energy CID MS/MS (bottom) of the potential cross-linked product Gal4:Med15 207-217.  
A series of backbone cleavages was observed in ESI MS/MS and,based on the 
fragmentation along the Med15 207-217 peptide backbone, the pBpa cross-linking site 
can be localized to Met 213.  In MALDI TOF/TOF MS/MS, only a limited number of 
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Figure 2.9.  MALDI TOF-TOF CID MS/MS (top) and ESI FT-ICR MS/MS (positive ion 























































































= free tryptic peptide VAVMR; * = unidentified peak). 
 
 
Figure 2.10.  ESI FT-ICR MS/MS (positive ion mode) of the potential cross-linked 
product involving Gal4 and Med15(160-174). Several peaks were not identified, perhaps 
due to imperfect precursor ion isolation.  Here, α represents Gal4 and β corresponds to 
Med 15(160-174).  
 
MALDI and ESI MS analysis revealed binding sites between Gal4, Gcn4, and 
VP2 within a few amino acid residues in Med15.  In some cases, cross-linking could be 
localized to one single residue (e.g., Met213 in Med15).  It may be noted that most of the 




















all three activators, Med15 160-174 for VP2 and Gal4, and Med15 79-85, Med15 222-
231, and Med15 345-348 for VP2, contain Met or Arg residues.  It has been reported that 
methyl or methylene groups adjacent to heteroatoms on amino acid side chains are 
preferable for the pBpa photo-cross-linking reaction and the efficiency of forming photo-
cross-linked products relies on the existence of Arg or Met within the reactive region [13].  
For Med15 222-231, the C-terminal Arg is not likely involved in the cross-linking 
reaction because, if so, it would not result in proteolytic cleavage. 
Most of the Med15 activator binding sites that were identified and confirmed by 
ESI and MALDI MS and low- and high-energy CID are located within or close to several 
regions that were previously predicted to have affinity for activators.  For example, 
residues 74-78 and 79-85 are located within the 62-90 region, which is believed to 
comprise helix 3 of the Med15 KIX module and an activator binding region [33, 34].  
Med15 residues 160-174 and 207-217 are located close to the 143-156 and 196-204 
regions, which are homologous to the A and B-boxes of mammalian co-activators that 
demonstrate activator binding affinity[35].  
Further, in vivo functional assays were carried out (by Dr. Lum in Prof. Mapp’s 
group) to validate the binding sites found in vitro.  These results [28] demonstrated that 
truncation of Med15 (1-186) leads to reduction of activity for Gal4 and VP2.  Deletion of 
Med15 1-345, on the other hand, suppressed the activity of all activators.  These results 
are consistent with findings in this Chapter because, as shown in Figure 2.3, the binding 
sites of VP2 (residues 74-78, 79-85, 161-174, 207-217, and 222-231), Gal4 (74-78, 160-
174, and 207-217), and Gcn4 (74-78, 207-217) are distributed over both deleted regions.  
In addition, Med15 74-78 may be important for Gal4 activity but not for Gcn4 because 
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deletion of Med15 1-186 suppressed the activity of Gal4 only.  In other words, Med15 
207-217 may be the key binding site for Gcn4 activity.   
Two papers regarding interaction between Gcn4 and Med15 have been published 
recently.  Herbig et al. reported that no interaction was observed between Gcn4 and 
Med15 KIX domain (residues 6-90 [36].  This result is inconsistent with the findings in 
this Chapter but supportive of our discussion (see above) that cross-linked products 
detected between Med15 74-78 and Gcn4 may not represent behavior in vivo.  Binding 
sites revealed by that work include residues 158-238 and 277-368.  The former binding 
site covers Med15 207-217, which was revealed and validated in this Chapter.  In the 
second paper, the B-box in Med15 was believed to be crucial for functional interaction 
with Gcn4 [37].  In addition, the Med15 KIX domain was revealed to interact directly 
with Gcn4 as confirmed by NMR analysis [37].  However, this interaction may be 
redundant due to the random coil motif in the Gcn4 activation domain in solution, which 
may result in non-functional interactions [37].    
2.3.2 Gas-phase cleavage of Bpa photo-crosslinker in MALDI TOF/TOF CID 
Notably, abundant product ion peaks corresponding to gas-phase cleavage of the 
pBpa cross-linker were observed in MALDI TOF/TOF CID spectra.  The fragmentation 
occurred of either the C-S or S-C bond of a Met side chain cross-linked to pBpa (Figure 
2.7.), or of a C-C bond (Figure 2.9.) that formed from cross-linking of pBpa to Med15.  
In the former case, C-S/S-C bond cleavages in MALDI TOF/TOF CID may be explained 
by analogous C-S/S-C cleavage occurring for peptides with disulfide (SS) bond linkages 
[38].  The resulting 34 Da doublet occurring in MS/MS spectra (see top panel of Figure 
2.7 (peak 1 and 2)) may facilitate the identification of pBpa cross-linked products in 
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MALDI TOF/TOF CID.  For the latter case, C-C bond cleavage results in release of the 
two cross-linked peptides (yielding the tryptic peptide peak β in Figure 2.9).  Such unique 
fragmentation of pBpa has not been reported in previous sector high-energy CID of pBpa 
cross-linked peptides [13] and was also absent in our low-energy CID spectra.  This 
unique C-C bond cleavage may also provide a new approach to identify pBpa cross-
linked products in MALDI TOF/TOF CID.   
 
2.4 Summary 
In conclusion, the combination of photo-cross-linking and multiplexed mass 
spectrometry provided binding sites of the transcriptional activators, Gal4, Gcn4, and 
VP2, with the coactivator Med15 at high resolution.  In some cases, the binding site can 
be localized to a single amino acid residue.  To our knowledge, this work includes the 
first application of BP-based photo-cross-linking to yield products with MW up to 5 kDa 
that could be confirmed by MS and MS/MS.  Also, it is the first observation of unique C-
S/S-C and C-C bond cleavages in photo-cross-linked products from MALDI TOF/TOF 
CID.  This observation provides a useful tool for identifying BP-based photo-cross-linked 
products.  Complementary use of ESI and MALDI was necessary to maximize the 
detection of Med15 binding sites.  In addition, the combination of low- and high-energy 
CID provided complementary structural information and was crucial for screening cross-
linking product candidates and confirming them.  Detected binding sites for Gal4, Gcn4 
and VP2 are located at or close to evolutionary conserved regions, including the 
GACKIX, A and B box motifs, which contain activator binding sites.  The multiple 
binding sites of activators revealed in this work may provide clues for future screening of 
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small molecules that target activator binding sites and therefore have activatory/inhibitory 
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Chapter 3  
Gas-Phase Cleavage of Sulfur-Sulfur and Sulfur-Carbon 






Thiol-cleavable cross-linkers (TCCs) are utilized to map interfaces in protein 
complexes [1, 2] as well as to determine low resolution three-dimensional protein 
structures [3].  The conventional strategy for identifying tryptic peptides linked by TCCs 
involves splitting the sample in two.  One half of the sample is subjected to disulfide 
reduction, optionally followed by thiol group alkylation [4] and the other half is not.  
Comparison of mass spectra of the reduced and unreduced proteolyzed samples reveals 
potential inter-molecularly cross-linked peptides as they are observed in the unreduced 
sample but not in the reduced sample.  Similarly, putative intra-molecularly cross-linked 
products demonstrate a mass shift, e.g., +2 Da without alkylation and +57 Da with 
iodoacetamide alkylation, for the reduced sample.  Such sample manipulations prior to 
mass spectrometry (MS) analysis increase sample consumption and operation time.  
Efforts have been made to eliminate these shortcomings by performing S-S and C-S bond 
cleavage in the gas phase by applying tandem MS (MS/MS) techniques.  For example, 
79 
 
King et al. utilized high-energy CID on a MALDI TOF/TOF mass spectrometer to 
identify peptides cross-linked by 3,3’-dithiobis (sulfosuccinimidyl propionate) (DTSSP) 
[5].  In that work, doublet isotopic clusters separated by 66 Da as well as specific neutral 
losses allowed identification of dead-end, inter-, and intra-molecularly cross-linked 
peptide products.  However, high-energy CID may not be a suitable approach in all cases, 
for example it can cause loss of post-translational modifications (PTMs).  Also, high-
energy CID involves significant ion scattering, which can lower sensitivity.  Thus, 
systematic investigation of the fragmentation behavior of peptides linked by TCCs by 
alternative MS/MS techniques is of interest for elucidating the optimal approach of gas-
phase S-S and C-S bond cleavage in cross-linking applications.   
Several MS/MS fragmentation techniques have been shown to effectively cleave 
S-S and C-S bonds in peptides containing natural disulfide bonds. These techniques 
include high-energy CID [6], electron capture dissociation (ECD) [7], electron transfer 
dissociation (ETD) [8, 9], electron detachment dissociation (EDD) [10], 157 nm 
photodissociation [11], MALDI post-source decay [12], MALDI in-source decay (ISD) 
[13], and negative ion CID [14] and infrared multiphoton dissociation (IRMPD) [10]. 
Several hypotheses have been put forth to explain the preferential S-S and C-S bond 
cleavage occurring following various MS/MS activation approaches with a particular 
focus on radical-driven fragmentation.  For example, in the “hot hydrogen” model of 
ECD, electron-proton recombination is thought to occur and preferential S-S bond 
cleavage is considered a result of the high hydrogen atom affinity of the S-S bond [7].  
Other models invoke electron capture into the σ* orbital of the S-S bond, either directly 
through Coulomb stabilization, or via through bond electron transfer [15, 16]. McLuckey 
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and co-workers [8] argued that hydrogen transfer is unlikely to contribute to S-S bond 
cleavage in ETD because such cleavages increased when protons were replaced by fixed 
charges.  Disulfide bond cleavage in positive mode low-energy CID is charge state 
dependent [17]: as the charge state of insulin decreased from +5 to +1, the efficiency of 
S-S bond cleavage increased with exclusively such cleavage for the +1 charge state.   
Gas-phase S-S bond cleavage has also been investigated in MS/MS of metal-
adducted peptides.  Complexes of singly charged disulfide-containing peptides with 
sodium and magnesium were found to selectively lose H2S2, allowing identification of 
disulfide bonds [18].  Transitional metals have also been used to facilitate S-S bond 
rupture in sustained off-resonance irradiation (SORI) CID, which is ineffective for 
protonated disulfide-containing peptides [19].  Finally, based on the high affinity of 
gold(I) for sulfur [20], multiply charged S-S bond-containing peptides complexed with 
gold(I) were shown to undergo selective S-S cleavage in low-energy CID [21]. 
Activated ion ECD (AI-ECD) is a variant of ECD in which analytes are unfolded 
through heating either before or after electron irradiation.  This strategy can provide 
greatly enhanced sequence information compared to conventional ECD because product 
ion pairs that would otherwise be held together through noncovalent interactions are 
separated [22].  Infrared irradiation is considered to be the preferred approach of 
activation in AI-ECD due its easy implementation and the avoidance of pressure or 
temperature increases [23].  To our knowledge, comparison of ECD and AI-ECD for S-
S/C-S bond cleavage efficiency has not been reported. 
Here, we used the TCCs DTSSP (I) and dithiobis (succinimidyl propionate) (DSP) 
(II), to react with model peptides, including α-melanocyte-stimulating hormone (MSH) 
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and [Lys3]-bombesin (BN), and protein (ubiquitin, proteolyzed after the reaction) to 
generate a series of inter-molecularly cross-linked peptides (ICPs), referred to as type 2 
cross-linked products [24].  Type 1 (intramolecularly cross-linked) and type 2 products 
are both crucial for providing information on spatial constrains in a protein [24] but only 
type 2 products can reveal inter-protein interactions and demonstrate separated product 
ions following S-S/C-S bond cleavages in MS/MS analysis.  Fragmentation patterns of 
these ICPs following a variety of MS/MS activation approaches, including ECD, AI-ECD, 
negative ion CID, EDD, and MALDI TOF/TOF high-energy CID were carried out in a 
systematic manner with the aim to find the optimum strategy for gas-phase S-S/C-S bond 
cleavage in ICPs linked by TCCs.  Preferential cleavage of S-S or C-S bonds allows 












3.2 Experimental  
 
3.2.1 Reagents and Cross-linking Reactions.  
Model peptides MSH (Ac-SYSMEHFRWGKPV-NH2) and BN 
(pEQKLGNQWAVGHLM-NH2) were purchased from Sigma (St. Louis, MO) and used 
without further purification.  DTSSP and DSP were purchased from Pierce (Rockford, IL).  
For cross-linking reactions, 1 mM of MSH or BN were incubated in bicarbonate buffer 
(0.1 M, pH 8) with DSP at up to 1:2 peptide to cross-linker molar ratio for 35 minutes at 
room temperature.  The cross-linking reaction was then quenched by adding 1M 
ammonium bicarbonate to a 50 mM final concentration. Cross-linked products were 
desalted with C18 Ziptips (Millipore, Billerica, MA) and diluted with either 
49.95:49.95:0.1 CH3CN:H2O:CH3COOH or 49.875:49.875:0.25 MeOH:H2O:NH4OH for 
positive or negative ion mode MS analysis, respectively. Ubiquitin (Sigma, St. Louis, 
MO) was incubated with DTSSP at 1:100 protein to cross-linker molar ratio for 35 
minutes in 15 mM HEPES buffer (pH 7.6) at room temperature for 35-45 minutes.  After 
the cross-linking reaction, the protein was denatured by heating (100 ˚C) for 10 minutes 
followed by prompt placing on ice. The protein was then digested with trypsin or Glu-C 
(Promega, Madison, WI) at a 1:50 enzyme to protein ratio for 15-20 hours at 37 °C.  The 
digestion was quenched by adding formic acid to 0.1% final concentration (v/v).  The 
resulting peptides were desalted with C18 Ziptips and diluted with spray solvent as 
described above for either positive or negative ion mode MS analysis. 
3.2.2 Mass Spectrometry and Data Analysis 
All experiments involving ECD, AI-ECD, negative ion CID, and EDD were 
carried out with an actively shielded 7 Tesla Fourier transform ion cyclotron resonance 
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(Q-FT-ICR) mass spectrometer (Apex-Q, Bruker Daltonics, Billerica, MA). Target 
analytes were directly infused into an electrospray ionization (ESI) source (Apollo II, 
Bruker Daltonics) and electrosprayed in positive ion mode for ECD and AI-ECD 
experiments, and in negative ion mode for EDD and CID experiments at a flow rate of 70 
μL/h. A counterflow of hot (200-240 °C) nitrogen gas was applied to assist desolvation of 
ESI droplets.  Potential cross-linked products, which were determined by accurate mass, 
were selected for MS/MS experiments.  Precursor ions were accumulated in the first 
hexapole for 0.1 s, transferred through the mass-selective quadrupole (5-10 m/z isolation 
window), mass selectively accumulated in the second hexapole for up to 1-2 s, then ions 
were transferred through high-voltage ion optics, and captured in the ICR cell by 
dynamic trapping.  An indirectly heated hollow dispenser cathode was used to generate 
an electron beam for electron-based activation.  ECD was performed at a bias voltage of 
negative 0.2-0.8 V and an irradiation time of 50-80 ms.  For AI-ECD, all conditions were 
kept the same as in ECD except that isolated precursor ions were pre-irradiated for 20-
100 ms by 10.6 μm photons at 10 W laser power (25 W CO2 laser, Synrad, Mukilteo, 
WA).  Control experiments for each AI-ECD analysis, in which precursor ions were only 
irradiated by IR photons, were performed to ensure that pre-IR irradiation did not cause 
unexpected fragmentation.  Negative ion CID of mass-selected cross-linked products was 
performed in an external collision cell at a collision voltage of 16-25 V.  Argon was used 
as collision gas.  EDD was performed at a - 21 V bias voltage for 750-1200 ms.  All 
spectra were acquired with XMASS (version 6.1, Bruker Daltonics) using 512 K data 
points and summed over 10-66 scans.  Data processing was performed with the MIDAS 
analysis software [25].  For accurate mass determination, external calibration was 
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performed with ES tuning mix (Hewlett Packard, Waldbronn, Germany).  Internal 
calibration in EDD was performed by using the calculated masses of precursor and 
charge reduced ions.  These calibrations were based on a two-term frequency-to-m/z 
calibration equation [26].  For MALDI TOF/TOF analysis, 0.5 µL of alpha cyano-4-
hydroxycinnamic acid (CHCA) and 2,5-dihydroxybenzoic acid (DHB) mixture (each 10 
mg/mL in 50% acetonitrile, 0.1% TFA) was hand-spotted to 0.5 µL cross-linked peptides 
onto a 192-well MALDI target and allowed to dry under atmosphere.  MALDI mass 
spectra were acquired on an Applied Biosystems 4800 Proteomics Analyzer in reflector 
positive ion mode.  Peptide masses were acquired up to 4000 Da.  Mass spectra were 
obtained with 2000 laser (Nd-YAG laser operating at 355 nm and 200 Hz) shots.  MS/MS 
spectra were also acquired in positive ion mode.  Atmosphere, at a pressure of around 6 × 
10-7 torr was used as collision gas with a collision energy of 2 keV.  
3.2.3 Nomenclature for ICPs and their fragments in MS and MS/MS spectra  
Intermolecularly cross-linked TCC products of MSH and BN are termed MSH-
TCC and BN-TCC, respectively.  ICPs from ubiquitin proteolysis are referred to as 
αnTCCβn in which αn represents the peptide with the longest N-terminal stretch before the 
cross-linking site and βn represents the other peptide.  Here, the ICP pair corresponding to 
residues 35-51 (GIPPDQQRLIFAGKQLE) and 52-64 (DGRTLSDYNIQKE) is termed 
α1TCCβ1 and for the ICP pair 43-54 (LIFAGKQLEDGR) and 55-72 
(TLSDYNIQKESTLHLVLR) is termed α2TCCβ2.  
In cases where fragmentation occurs within either chain of the ICPs but does not 
involve a TCC moiety, the corresponding product ions are referred to in the standard 
peptide product ion nomenclature but with the subscript α or β (this nomenclature is not 
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applicable for MSH-TCC and BN-TCC due to their symmetric structures), e.g., c6β1’
+ 
(from β1 of α1TCCβ1).  When fragmentation occurs at a peptide backbone bond with 
retention of a TCC moiety as well as another intact cross-linked peptide, the 
corresponding ion is denoted as ion type/R, e.g., z5
.+/R and z3β’
+/R, where R is indicated 
as MSH, BN, α1, α2, β1, or β2.  When fragmentation occurs both at the peptide backbone 
and involves S-S or C-S bond cleavages (structures and abbreviations are shown in 
Scheme 3.1), the corresponding product ions are labeled as ion type–X where X is an 
abbreviation referring to types of S-S or C-S bond cleavages as shown in Scheme 3.1.  
 
 
Scheme 3.1 Structures, nomenclature, and mass increment of product ions observed in 


































3.3 Results and Discussion 
 
3.3.1 ECD and AI-ECD of TCC products from BN, MSH, and ubiquitin 
proteolytic peptides 
Panels a, c, e, and g in Figure 3.1 show ECD spectra of MSH-TCC, BN-TCC, 
α1TCCβ1, and α2TCCβ2, respectively.  The corresponding AI-ECD spectra are displayed 
in panels b, d, f, and h, respectively.  For triply protonated BN-TCC, very limited 
fragmentation was seen in both ECD and AI-ECD, consistent with the high m/z value of 
the precursor ion [27].  In both spectra, an abundant product ion peak is observed at m/z 
1680.  Zoomed-in views of this peak (insets in Figures 1a and b) show that, in ECD it 
corresponds to the charge-reduced form of the triply protonated BN-TCC precursor ion 
whereas, in AI-ECD, it corresponds to a mixture of the charge reduced species ([M + 
3H]2+.) and singly charged products from disulfide cleavage (a mixture of R-S• and R-SH, 
see Scheme 1 for nomenclature).  The occurrence of disulfide cleavage products in AI-
ECD indicates that such cleavage occurs in ECD but cannot be detected because 
noncovalent interactions between the two BN chains prevent product ions from 
separating [22, 28].  Low abundance product ions from BN backbone cleavage are seen 
in both ECD and AI-ECD.  However, the appearance of only one additional product ion 
in AI-ECD indicates that S-S bond cleavage is a preferred fragmentation pathway.  
ECD and AI-ECD spectra of quadruply protonated MSH-TCC (Figure 3.1, panels 
c and d) are clearly different from those of BN-TCC in spite of the similarity in primary 
structure, including blocked N-termini as well as the number of basic residues.  In ECD 
of MSH-TCC, prominent S-S bond cleavage as well as extensive backbone fragmentation 
is observed.  The insets in Figures 3.1c and d show zoomed-in views of the region around 
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m/z 1750-1756, clearly demonstrating singly charged ions (highlighted with solid lines) 
resulting from S-S bond cleavages. Low abundance doubly charge reduced MSH-TCC 
([M + 4H]2+..) is also present in the ECD spectrum (shown by dashed lines).  Most 
backbone fragments in the MSH-TCC ECD spectrum are z-type ions, including z3 - z5 and 
z8 - z12, with the TCC moiety and another intact MSH chain.  Among those, z3 - z5 are 
radical ions whereas z8 - z12 are even-electron species from hydrogen migration [29].  No 
c.–type ions (also from H rearrangement) were observed.  The greatly enhanced ECD 
fragmentation for MSH-TCC compared to BN-TCC may be explained by the higher 
charge state, resulting in a lower precursor ion m/z value [27].  Three significant 
differences were observed between ECD and AI-ECD of MSH-TCC.  First, the peak 
abundance corresponding to S-S bond cleavage (around m/z 1750-1755 as shown in the 
inset) was lower in AI-ECD compared to ECD alone, suggesting that disulfide bond 
cleavage is a primary fragmentation pathway subject to secondary fragmentation when 
the precursor ion is unfolded.  Second, the doubly charge reduced [M + 4H]2+.. species 
was absent in AI-ECD, indicating that this species from ECD has been subject to covalent 
bond cleavage but that complementary fragments are held together through noncovalent 
interactions that are disrupted by the pre-IR irradiation.  Several low m/z fragments, 
including (y3
+




+ - H2O, absent in ECD, 
appeared in AI-ECD of MSH-TCC.  Other peaks unique to AI-ECD include a c12’ ion 
with TCC and another MSH peptide chain as well as a low abundance peak 
corresponding to C-S bond cleavage.  Third, z3-z5/R and z8-z12/R product ion series 
detected following ECD were not observed in AI-ECD, presumably due to secondary 
fragmentation.     
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   S-S bond cleavage represents the dominant product ion peaks in both ECD and 
AI-ECD of α1TCCβ1 and α2TCCβ2 (Figure 3.1, panels e-h).  Similar to MSH-TCC, 
differences were observed in product ion patterns between ECD and AI-ECD.  First, 
neutral losses, including NH3 and its subsequent CO loss, from the charge reduced, [M + 
4H]3+., species were observed in ECD of α1TCCβ1 and α2TCCβ2 (panels e and g, Figure 
3.1) but were absent in the corresponding AI-ECD spectra.  Neutral losses of small 
molecules from charge-reduced species frequently occurs in ECD [30-32] and loss of 
NH3 and CO are considered to be specific for Ser/Thr and Asp/Glu, respectively [32] 
although the presence of these residues does not guarantee the observation of these 
neutral losses (for example, MSH-TCC studied here has two Ser and one Glu residue).  
Side chain losses are greatly enhanced in ECD of cyclic peptides compared to linear ones 
[33].  Thus, structural constraints do play a role in the appearance of neutral losses, which 
could explain why more unfolded peptides in AI-ECD do not yield these products.  
Second, backbone fragmentation of α1TCCβ1 and α2TCCβ2 was enhanced in AI-ECD 











































































































































































































































































































































































Figure 3.1 ECD and AI-ECD of TCC products from BN (panels a and b), MSH (panels c 
and d), and ubiquitin; α1TCCβ1 (panels e and f), and α2TCCβ2  (panels g and h).  For BN, 
S-S bond cleavage was observed in AI-ECD (inset in panel b) but not in ECD alone (inset 
in panel a).  * = unidentified peaks. 
 
3.3.2 Negative ion CID of BN-TCC, MSH-TCC, α1TCCβ1, and α2TCCβ2 
Singly deprotonated peptides containing cysteine disulfide bonds have been 




























































































neutral loss of H2S2 and H2S2 + CO2 [34].  Preferential S-S and C-S bond cleavages were 
also reported in negative ion CID by McLuckey and co-workers [14] and similar 
behavior was observed by Kalli et al. in EDD [10] and negative ion IRMPD [10].  
However, to our knowledge, negative ion CID of TCC products has not been explored.  
Negative ion CID spectra of BN-TCC, MSH-TCC, α1TCCβ1 and α2TCCβ2 are shown in 
Figures 3.2a to d.  Triply deprotonated TCC products of MSH and BN yielded abundant 
even electron ions corresponding to S-S and C-S bond cleavages, in agreement with 
previous reports on negative ion IRMPD [10] and CID [14] of disulfide-containing 
peptides.  The major fragmentation pathway corresponded to doubly deprotonated R-
CH2SH (R = MSH or BN) but R-CH=S and R-CH=CH2 product ions were also observed.  
For disulfide-containing peptides, it has been reported that C-S bond cleavage is followed 
by backbone fragmentation to yield c and z-S type product ions [14].  In our experiments, 
c and z-S type ions were only observed for BN which showed c5’ ion formation (c5’
--
CH=CH2 and c5’
--CH2SH) and b6 ion formation (b6
--CH2SH).  These product ions 
correspond to secondary fragmentation on the C-terminal side of the cross-linked residue 
(Lys3).  One step BN backbone cleavages, including y8
- and y9
-
 ions, were also observed.  
Neutral loss of NH3 was observed for the latter two product ions, presumably because 
amidated side chains are present in both fragments [35] (Gln7 in the y8 ion and Asn
6 + 
Gln7 in the y9 ion).  For triply deprotonated MSH-TCC, neutral losses of water from 
MSH-CH2SH and CO from MSH-CH=S, were observed.  Those losses can be 
rationalized by the presence of Glu5 [35, 36] in the sequence.   
Unlike the pronounced S-S bond cleavages and modest C-S bond cleavages 
observed for MSH-TCC and BN-TCC, only weak signals corresponding to S-S and C-S 
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bond cleavages were observed in negative ion CID of α2TCCβ2 and such fragments were 
completely absent for α1TCCβ1 (Figure 3.2, panels c and d).  Instead, a plentitude of 
neutral loss peaks, including H2O, NH3, and CH3CHO losses from precursor ions were 
observed.  These neutral losses can be rationalized due to the presence of Glu and Asp 












































































































Figure 3.2 . Negative ion CID of TCC products from BN (panel a), MSH (panel b), and 
ubiquitin; α1TCCβ1 (panel c) and α2TCCβ2 (panel d). Abundant peaks corresponding to S-
S and C-S bond cleavages are observed for BN and MSH but such cleavage is absent for 
α1TCCβ1.  For α2TCCβ2, S-S and C-S bond cleavage is observed but at low abundance.  * 
= unidentified peaks. 
 
3.3.3 EDD of BN-TCC and MSH-TCC 
Similar to ECD for positively charged ions, EDD is a radical-driven 

















































































backbone cleavages than negative ion CID [38] and retains PTMs [39] as well as higher 
order structure [40].  EDD typically cleaves Cα-C and N-Cα backbone bonds in peptides, 
generating x/a. and c/z. ions, respectively.  y-type ions are also observed in EDD [41].  
EDD of disulfide-containing peptides demonstrated preferential cleavage of S-S and C-S 
bonds as well as abundant tryptophan side chain loss [10].  EDD spectra of triply 
deprotonated MSH-TCC and BN-TCC are shown in Figure 3.3.  Unlike their 
corresponding negative ion CID spectra, fragments corresponding to S-S and C-S bond 
cleavages are observable but are not dominant.  In EDD of BN-TCC, z6
.- is the most 
abundant product ion with the exception of the charge reduced species, [M - 3H]2-..  Close 
inspection of the isotopic cluster of the charge reduced species (see inset) reveals that a 
mixture of [M - 3H]2-. and BN-C=S, with the latter corresponding to S-S bond cleavage, 
is present.  Low abundance contributions from BN-S. and BN-SH can also be assigned.  
In EDD of MSH-TCC (Figure 3.3, panel b), doubly deprotonated product ions 
corresponding to S-S bond cleavage are observed around m/z 900 and analogous singly 
deprotonated ions are observed around m/z 1780 (see inset).  Product ions resulting from 
C-S bond cleavage are also observed around m/z 1720 as is combined S-S and backbone 
bond cleavage (to yield z11
.--S.).  In addition, backbone product ions from cleavages 
between Ser1,Tyr2, and Ser3 are seen in the form of y12
- - H2O, y11
-, and y11
- - NH3.  




Figure 3.3 EDD of TCC products from BN (panel a) and MSH (panel b).  S-S and C-S 
bond cleavages are observed, along with backbone fragments, including y-, z-, and c-type 
ions.  However, the fragmentation efficiency is low.  In EDD of BN-TCC, a y9  ion with - 
17 Da (NH3) and - 129 Da mass shift is observed.  The latter shift corresponds to neutral 
loss from the tryptophan side chain, as previously reported [10]. * = unidentified peaks. 
 
3.3.4 MALDI TOF/TOF CID of BN-TCC, MSH-TCC, α1TCCβ1, and α2TCCβ2. 
Figure 3.4 shows MALDI TOF/TOF CID of BN-TCC, MSH-TCC, α1TCCβ1, and 
α2TCCβ2. In agreement with previous observations by King et al.[5], all spectra 
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differing by 66 Da.  Symmetric S-S bond cleavages of low abundance were only 
observed for MSH-TCC and α1TCCβ1.  Unlike the dominant doublet peaks from C-S 
bond cleavage shown in previous work [5], we observed a variation of signal intensities 
for the 66 Da doublets.   
For MSH-TCC, the 66 Da doublets were the dominant product ions.  Low 
abundance backbone cleavages along with some further neutral NH3 loss were observed.  
For BN-TCC, 66 Da doublets were observed but of lower abundance than a series of 
backbone cleavages.  As shown in Figure 3.1a and b, S-S and C-S bond cleavages in 
ECD of BN-TCC were not observed unless IR irradiation was applied prior to ECD.  In 
MALDI TOF/TOF CID, pre-activation is not required for observation of C-S bond 
cleavage but backbone cleavages appear more favorable. For α1TCCβ1, C-S bond 
cleavage resulted in a 66 Da doublet with the α1 peptide constituting the most abundant 
peak whereas that from β1 had a 75% lower abundance.  This observation may be due to 
the more extensive backbone fragmentation of β1 compared to α1.  A similar trend was 
observed in the TOF/TOF CID spectrum of α2TCCβ2 in which α2 yielded an abundant b10 
product ion and had lower abundance in the C-S bond cleavage doublet.  Five backbone 
cleavages also occurred on β2 but they are of rather low abundances.  The most abundant 
product ion peak for α2TCCβ2, which is accompanied by subsequent water loss, cannot be 
unambiguously identified because it represents loss of a C-terminal Arg residue, which is 
possible for both α2 and β2 to yield either b11α or b17β.   
Based on the MALDI TOF/TOF CID spectra of TCC products from BN, MSH, 
α1TCCβ1, and α2TCCβ2, it may be concluded that backbone fragmentation and C-S bond 
cleavage are two competing fragmentation channels where favoring of one channel 
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suppresses the other.  Such behavior was not observed in ECD, e.g., no S-S or C-S bond 
cleavage was observed for BN-TCC without IR irradiation but backbone cleavages were 
also insignificant.  However, it should be noticed that MALDI TOF/TOF CID requires 


































































































Figure 3.4  MALDI TOF/TOF CID of TCC products from BN (panel a), MSH (panel b), 
and ubiquitin; α1TCCβ1 (panel c) and α2TCCβ2 (panel d).  Abundant 66 Da doublets 
resulting from C-S bond cleavages are observed in all cases, along with significant 
























































































Based on the presented comparison between ECD, AI-ECD, negative ion CID, 
EDD, and MALDI TOF/TOF CID for effective and preferential cleavage of S-S and C-S 
bonds in peptides intramolecularly cross-linked with TCCs, ECD appears to be the 
superior approach, except for BN-TCC in which IR pre-irradiation, i.e., AI-ECD, was 
required.  Negative ion CID, which yields preferred S-S and C-S bond cleavages for 
disulfide-containing peptides, did not provide consistent results for S-S and C-S bond 
cleavages in peptides cross-linked by TCCs.  EDD provided S-S and C-S bond cleavages 
but with low efficiency.  Finally, MALDI TOF/TOF CID results in C-S bond cleavage to 
form a 66 Da doublet without requiring as abundant precursor ions as ECD or EDD.  
However, backbone fragmentation of ICPs can be more pronounced than C-S bond 
cleavage, rendering the identification of cross-linked peptides less straightforward.  
Therefore, we conclude that ECD is a valuable complementary tool to MALDI TOF/TOF 
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Chapter 4  
Selective C-I Bond Cleavage in ECD: Prospects for Designing 
a Novel Chemical Cross-linker and Mechanistic Implications 
 
4.1 Introduction 
In the current post-genomic era, the next challenge is to reveal the structure of 
numerous unknown proteins that are encoded in the vast genome data and understand 
their biological function and interaction networks.  Three classic techniques, X-ray 
crystallography, nuclear magnetic resonance (NMR) spectroscopy, and electron 
microscopy (EM) have been applied to reveal protein structure in crystal form (X-ray and 
EM) or in solution (NMR).  Although tremendous achievements have been made, 
bottlenecks of these techniques exit: they are time-consuming, sometimes require sample 
amounts up to gram level, and have stringent requirements for sample purity.  An 
alternative approach is to apply chemical cross-linking combined with proteolytic 
digestion and mass spectrometry (3C-PD-MS) to characterize protein structure and 
function.  This approach provides information about protein-protein interactions [1-6], 
distance constraints for protein residue pairs, solvent exposure of specific amino acids, 
and binding sites in protein complexes [7-11].  The main idea behind 3C-PD-MS is to 
link amino acid pairs covalently and therefore maintain distance constraints for 
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subsequent analysis.  Because identification of cross-linked products relies on mass 
spectrometric analysis, 3C-PD-MS is an attractive alternative to X-ray crystallography, 
NMR, and EM by demonstrating great sensitivity, high measurement accuracy, and more 
lenient requirements for sample purity and amount.  
Despite the rather straightforward implementation of 3C-PD-MS, confident 
detection of cross-linked peptides remains challenging due to the difficulty of 
differentiating cross-linked peptide signals from unmodified peptides.  In addition, 
signals for cross-linked peptides are often weak or even absent due to ion suppression 
from more abundant unmodified peptides,. Furthermore, the diversity of cross-linked 
products, including intermolecular, intramolecular, or dead-end cross-linked peptides[12], 
may also render mass spectra highly complex.  
Two main approaches have been established to enhance the detection of cross-
linked peptides in MS.  One approach is to design a cross-linker with specific enrichment 
potential [1, 2, 13-18] to isolate cross-linked peptides prior to MS analysis.  The other 
approach involves differentiation of cross-linked peptides from unmodified peptides by 
designing a cross-linker that is cleavable in either solution (e.g., by a reducing reagent 
[19, 20]), or the gas phase.  Solution-phase cleavage allows identification of cross-linked 
peptides from comparative analysis of spectra from cleaved and uncleaved samples 
whereas characteristic fragments from MS/MS, including collision-induced dissociation 
(CID) [21, 22], infrared multiphoton dissociation (IRMPD) [23], and MALDI TOF/TOF 
high-energy CID [24] allows direct identification of cross-linked peptides.  Gas-phase 
cleavable cross-linkers may be more promising than solution-phase cleavage because this 
strategy does not require multiple rounds of MS analysis and comparison of complex 
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spectra.  Therefore, the sample preparation time and required sample amount are reduced.  
Since its inception [25], electron capture dissociation (ECD) has become a 
powerful MS/MS technique for characterizing proteins and peptides.  In ECD, low 
energy electrons (<1 eV) are captured by multiply charged precursor cations, resulting in 
formation of radical species that undergo N-Cα backbone bond cleavages to generate 
even-electron c-type and radical z-type ions [25].  One of the most intriguing features of 
ECD is the preservation of post-translational modifications (PTMs) [26-30], which 
allows straightforward localization of PTMs.  Many PTMs are highly labile in the gas 
phase and are preferentially lost in slow-heating MS/MS analysis, including CID and 
IRMPD.  In addition, CID and IRMPD result in peptide backbone amide bond cleavage 
initiated by mobile protons [31] to yield b- and y-type product ions.  Thus, ECD and CID 
provide complementary structural information about proteins and peptides of particular 
importance in peptide de novo sequencing [32].  Furthermore, ECD is an ideal MS/MS 
approach for generating preferential cleavage of disulfide (S-S) bonds [33] although S-S 
bond cleavage is also observed in other MS/MS approaches, including negative ion CID 
[34], negative ion IRMPD[35], electron detachment dissociation (EDD) [35], and high-
energy CID [24, 36, 37].  Finally, ECD can be used to characterize protein interfaces due 
to retention of non-covalent interactions [38, 39].  However, to our knowledge, ECD has 
not yet been applied for differentiating cross-linked peptides from unmodified peptides 
with the exception of the experiments described in Chapter 3 of this thesis. 
Divalent metal ions, including, e.g., Ca2+, Mg2+, and Co2+, have been used to 
generate multiply charged protein and peptide cations, either stand alone or combined 
with protonation sites, for ECD analysis.  ECD of metal-adducted species may yield 
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unique fragmentation pathways compared to protonated analytes due to changes in 
electron capture behavior and gas-phase protein/peptide structure [40-42].  
The exact mechanism of ECD is still not unraveled and continues to be under 
investigation.  To date, there are two postulations: first, for peptide ECD [25, 33, 43], 
electrons are believed to be captured at protonated sites to cause neutralization and 
formation of a hypervalent radical center with subsequent energy release.  A hot hydrogen 
atom (H•) is ejected and can attach to an S-S bond (if present) or to backbone carbonyl 
groups.  This hydrogen migration results in preferential cleavage of S-S bonds or non-
selective cleavage of adjacent N-Cα backbone bonds, respectively.  This mechanism is 
referred to as the hot hydrogen model.  An alternative theory is the so-called superbase 
mechanism that was proposed by Turecek and co-workers [44] and by Simons and co-
workers [45, 46].  In that theory, electrons are captured directly by backbone amide * 
orbitals to generate a group with high basicity (superbase).  Protons are then abstracted 
from adjacent locations to yield charge neutralization and subsequent N-Cα bond 
cleavage.  In the superbase model, protons do not have to originate from protonated basic 
sites.  Therefore, it explains ECD of metal-adducted peptides.  Simons et al. [45, 46] 
concluded from computational work that 90-99% of electrons are captured at positively 
charged sites and that 1-10% are directly attached to either S-S σ* or amide π* orbitals, 
assisted by Coulomb stabilization from adjacent positively charged groups.  Such 
stabilization renders direct electron attachment exothermic.  Recently, Simons’ group 
proposed that electrons captured by positively charged groups can be released and 
transferred to S-S or N-Cα bonds for inducing subsequent dissociation [47, 48].   
Electron transfer dissociation (ETD) [49] is believed to be analogous to ECD by 
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sharing a similar mechanism and generating c- and z-type ions.  One favorable 
characteristic of ETD over ECD is its direct compatibility with radio-frequency based ion 
storage without needing a magnetic field to confine electrons [50].  Because the electron 
transfer process in ETD relies on electron donation from radical reagent anions, some 
factors that influence ECD and ETD dissociation, including cross sections for electron 
capture/transfer, recombination energies, and the time scales of the electron 
capture/transfer process, can be different [51].  For example, precursor ions absorb all 
electron energy in ECD but, in ETD, energy is partitioned between analyte ions and the 
remaining neutral reagent [48].  In addition, it has been reported that doubly protonated 
precursor ions yield less backbone fragmentation than their triply protonated counterparts 
in ECD [52].  In ETD, doubly protonated species generally generate limited 
fragmentation unless supplementary activation methods, including collisional activation 
and pre-IR irradiation, are applied [50, 51].  
Protein iodination has been widely applied in crystallographic studies as a useful 
probe with high electron density [53], and as a radio-label for monitoring metabolic 
reactions, both in vitro and in vivo [54].  Recently, carbon iodine (C-I) bonds were 
reported to demonstrate preferential cleavage under 266 nm UV laser irradiation to yield 
a radical product with unique fragmentation in subsequent CID [55].  By contrast, little is 
know about carbon-halogen bond cleavage in ECD.  Prominent carbon-bromide (C-Br) 
bond cleavage in ECD was reported by Marshall and co-workers in 2006 [56].  In that 
work, efficient C-Br cleavage was attributed to direct electron capture by the C-Br bond, 
or electron transfer from disulfide bonds, which may originally capture the electron.  
These authors also reported that disulfide bond reduction and alkylation, eliminated 
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bromide loss in ECD.  
Here, a series of standard peptides were iodinated and subjected to CID, MALDI 
TOF/TOF high-energy CID, ECD, and ETD with the aim to explore the prospect of 
designing a novel cross-linker with C-I bond that could provide unique iodine loss 
(125.89 Da) in tandem MS (MS/MS).   
 
4.2 Experimental  
4.2.1 Sample Preparation and Iodination Reaction  
Melanocyte stimulating hormone (MSH), Lys3-Bombesin (BE), and Arg-Arg-
Gastrin Fragment 22-30 (AARF) were purchased from Sigma (St. Louis, MO) and used 
in without further purification.  The sequences of these peptides are shown in Figure 4.1. 
 
Melanocyte stimulating hormone (MSH):  Ac-SYSMEHFRWGKPV-NH2
Lys3-Bombesin:   pEQKLGNQWAVGHLM-NH2
Arg-Arg-Gastrin Fragment 22-30 (AARF):  RRLEEEEEAYG  
Figure 4.1.  Sequences of peptides used in this study. 
 
Peptide iodination was carried out according to previous reports [57].  Briefly, 
peptides were dissolved in 100 mM phosphate buffered saline (PBS), pH 7.2, to a final 
concentration of 1-3 mM.  The peptide MSH was initially dissolved in PBS buffer 
followed by water (referred to as condition 1) and then water followed by PBS buffer 
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(condition 2).  In both cases, PBS buffer and water was kept at a 1:1 volume ratio.  100 
μL peptide solution was mixed with 50 μL of 75 mM NaI and 15 mM I2 solution.  This 
mixture was incubated at room temperature for ~30 minutes followed by addition of 15 
µL TFA to quench the reaction and desalting by C18 spin column.  Desalted samples were 
diluted to 5 µM for subsequent MS analysis.  
Generation of peptide gas-phase calcium adducts depends on ESI spray solvent, 
amino-acid sequence, and pH value.  In the present work, A 1 M calcium chloride (Sigma, 
St. Louis MO) stock solution was prepared in water (HPLC Grade, Fisher) and then 
added to iodinated peptide solutions to a final concentration of 30-100 µM. 
4.2.2  Mass Spectrometry 
CID (to identify the iodination site) and ECD (for iodine loss efficiency (ILE) 
calculations) were carried out with an actively shielded 7 Tesla Fourier transform ion 
cyclotron resonance (Q-FT-ICR) mass spectrometer (Apex-Q, Bruker Daltonics, Billerica, 
MA).  Target analytes were directly infused into an ESI source (Apollo II, Bruker 
Daltonics) and electrosprayed in positive ion mode for CID and ECD analysis at a flow 
rate of 70 μL/h.  A counterflow of hot (200-240°C) nitrogen gas was applied to assist 
desolvation of ESI droplets.  Potential iodinated products, determined by accurate mass, 
were selected for MS/MS experiments.  Precursor ions were accumulated in the first 
hexapole for 0.1 s, transferred through the mass-selective quadrupole (5-10 m/z isolation 
window), mass selectively accumulated in the second hexapole for up to 1-2 s, then ions 
were transferred through high-voltage ion optics, and captured in the ICR cell by 
dynamic trapping.  An indirectly heated hollow dispenser cathode was used to generate 
113 
 
an electron beam.  ECD was performed at a bias voltage of - 0.2-0.8 V and an irradiation 
time of 50-80 ms.  Argon was used as collision gas for CID.  
All Apex FT-ICR mass spectra were acquired with XMASS (version 6.1, Bruker 
Daltonics) using 512 K data points and summed over 10-66 scans.  All data were then 
analyzed with MIDAS software [58].  For accurate mass determination, external 
calibration was performed with ES tuning mix (Hewlett Packard, Waldbronn, Germany) 
or by using the calculated masses of precursor ions and charge reduced precursor ions.  
All calibrations were based on frequency-to-m/z calibration with a two-term calibration 
equation [59].  
For MALDI TOF/TOF analysis, 0.5 µL of alpha cyano-4-hydroxycinnamic acid 
(CHCA) and 2,5-dihydroxybenzoic acid (DHB) mixture (each 10 mg/mL in 50% 
acetonitrile, 0.1% TFA) was hand-spotted to 0.5 µL iodinated peptides onto a 192-well 
MALDI target and allowed to dry under atmosphere.  MALDI mass spectra were 
acquired on an Applied Biosystems 4800 Proteomics Analyzer in reflector positive ion 
mode.  Peptide masses were acquired up to 4,000 Da.  Mass spectra were obtained with 
2,000 laser (Nd-YAG laser operating at 355 nm and 200 Hz) shots.  MS/MS spectra were 
also acquired in positive ion mode.  Atmosphere, at a pressure of ~6 × 10-7 torr was used 
as collision gas with a collision energy of 2 keV.  Data analysis was performed by MS-
Expedite (version 3.0, http://www.proteomecommons.org). 
For ECD and ETD comparison, data were obtained on a Bruker SolariX 7 Tesla 
Q-FT ICR mass spectrometer.  Details of the ETD implementation have been previously 
reported [60].  Briefly, the ESI source is modified for coupling with negative ion 
chemical ionization (nCI) via a split octopole ion guide.  Fluoranthene radical anions for 
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the ETD reaction are generated in an nCI source with methane as CI reagent, and 
transferred via the split octopole to a hexapole collision cell.  ESI-generated triply- or 
doubly-protonated singly iodinated precursor ions also entered the hexapole for the ETD 
reaction.  Ion accumulation and reaction time were set as 500 and 600 ms, respectively.  
After the ETD reaction, product ions are transferred to the ICR cell for further analysis.  
ECD of the same peptides was also performed with the SolariX instrument for 
comparison.  All spectra were acquired with 256 K data points and summed over 66 scans.  
Data were analyzed with the DataAnalysis software (version 4.0, Bruker Daltonics).  In 
all ECD and ETD experiments (on both the Apex and SolariX instruments), precursor ion 
depletion was controlled to be ~90% (by comparing precursor ion peak abundance 
following ECD/ETD with a control experiment in which no MS/MS was performed).  
ILE calculations were carried out based on equation 1.  These calculations were 
performed by adding all peak abundances involving C-I bond cleavage and the resulting 
value was divided by the summed abundance of all identifiable ECD product ions.  In 
addition, all peak abundances were normalized to their charge state prior to calculation.  
For ILE analysis, experiments were performed in triplicate to obtain the average and 










4.3 Results and Discussion 
4.3.1 Selective Iodination of His6 or Tyr2 in MSH 
Following iodination reactions under both condition I and condition II described 
above, unmodified, singly-, and doubly-iodinated MSH were observed (Figure 4.2).  
Singly iodinated MSH was selected for MS/MS analysis.  Initially, we assumed that 
iodination would occur mainly on Tyr2 because tyrosine is known to be the most reactive 
amino acid residue [55].  However, because two iodinations were observed, CID was 
performed to confirm the iodination site in singly iodinated MSH from condition I and 
condition II, respectively.  Interestingly, CID spectra of singly iodinated MSH from 
condition I (Figure 4.3, panel A) and condition II (panel B) are different in appearance, 
indicating that different iodination sites were obtained following reaction condition I and 
II, respectively.  The CID spectrum of singly iodinated MSH from condition I contains a 
series of y ions (y6-y12) in which y6 and y7 ions are unmodified whereas y8-y12 ions contain 
one iodine.  These results lead us to conclude that His6, instead of Tyr2, is the iodination 
site in singly iodinated MSH from condition I, although previous reports demonstrated 
that tyrosine iodination is much faster than that of histidine [61, 62].  Similarly, the CID 
spectrum of singly iodinated MSH from condition II contained unmodified y6-y11 ions but 
one iodine addition for y12, indicating that iodination occurred on Tyr
2.  In both cases, 
iodination on His6 and Tyr2 is selective because all major fragment peaks can be 


















Figure 4.2.  Positive ion mode ESI of MSH iodination product from condition I (panel A) 
and II (panel B).  1-3: triply protonated species; 4-6: doubly protonated species; 1,4: 




























































Figure 4.3.  From the two different reaction conditions, PBS buffer followed by water 
(condition I) and the reverse order (condition II), His6 (panel A) and Tyr2 (panel B) in 






4.3.2 C-I Bond Cleavage Behavior in ECD of Doubly and Triply Protonated His6- 
and Tyr2-iodinated MSH 
Once selective iodination of His6 and Tyr2 in MSH had been identified, their triply 
protonated forms were subjected to ECD and the corresponding spectra are shown in 
Figure 4.4 (panel A for His6-iodinated MSH and panel B for Tyr2-iodinated MSH).  Peaks 
resulting from C-I bond cleavage are observed in both spectra.  However, the iodine loss 
peak for His6-iodinated MSH was much more abundant (than that for Tyr2-iodinated 
MSH, as shown in Figure 4.4 panel A and B.  In order to make a fair comparison, 
quantitative analysis was carried out by calculating the ILEs according to Equation 1. The 
ILEs from ECD of triply protonated His6 and Tyr2 iodinated MSH species are shown in 
Figure 4.5, panel A.  A clear difference is observed: 29% for His6 iodination and ~8% for 
Tyr2 iodination.  
In order to explain the discrepancy in ILEs from triply protonated His6 and Tyr2 
iodinated MSH, we note that His6 is a potential protonation site, along with Arg8 and 
Lys11 (the N-terminus of MSH is acetylated), in triply protonated MSH.  If His6 is 
protonated, the C-I bond on the same residue will be very close (a few bonds) to a 
positively charged group.  On the other hand, the C-I bond on Tyr2 is four residues away 
from the closest protonation site (His6).  ECD of doubly protonated singly iodinated MSH 
was also carried out.  Figure 4.5, panel B shows ILEs of doubly protonated His6- and 
Tyr2-iodinated MSH from ECD.  Unlike their triply protonated counterparts, ILE values 
for these two species are rather close: 22% for His6-iodinated MSH and 18% for Tyr2 
iodination.  Based on the gas-phase basicity of amino acids, Arg>>Lys>His [63, 64], Arg8 
is likely protonated in doubly protonated singly iodinated MSH.  The second protonation 
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site is likely a mixture of His6 and Lys11, thus the favorable (for C-I bond cleavage) 
proton location on His6 is less occupied than for the corresponding triply protonated 
species.  In addition, previous reports demonstrated that ECD fragmentation is influenced 
by the gas-phase conformation of precursor ions [52].  Compared with doubly protonated 
species, triply protonated species should be more unfolded in the gas phase, prior to ECD, 
due to Coulomb repulsion, thereby lowering the probability that protonated residues (His6, 
Arg8, and Lys11) are located spatially close to the C-I bond of Tyr2.  Thus, the ILE of 
Tyr2-iodinated MSH should be lower than that of His6-iodinated MSH, consistent with 
our observations.  Doubly protonated species, on the other hand, are more likely to be 
folded in the gas phase, making it possible for positively charged groups to be located 
close to the C-I bond in either His6 or Tyr2.  Based on the superbase model for ECD, 
electron attachment to the C-I bond (and thus subsequent dissociation) is stabilized by 
adjacent positively charged groups.  Thus, His6 and Tyr2-iodinated MSH may 
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Figure 4.4.  ECD of triply protonated His6-iodinated MSH (panel A) and Tyr2-iodinated 
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MSH (panel B).   In panel A, the most abundant fragment corresponds to iodine loss.  The 
ratio of this iodine loss peak to the charge reduced species is ~2:1.  Here, His6 is a likely 
protonation site, thus positive charge is very close to the C-I bond.  In panel B, the most 
abundant fragment still corresponds to iodine loss but is less abundant than for His6-
iodinated MSH. The ratio of this iodine loss peak to the charge reduced species is ~1:3.  
Series of backbone product ions are also observed.  In the case of Tyr2-iodinated MSH, 
the C-I bond is a few residues away from the closest likely positive site (His6).  
4.3.3 ECD of Ca2+-adducted Histidine- and Tyrosine-Iodinated MSH  
ECD of doubly charged Ca2+-adducted His6- and Tyr2-iodinated MSH was also 
carried out and their ILE values, ~32% for His6-iodinated MSH and ~35% for Tyr2-
iodinated MSH, respectively, are shown in panel C of Figure 4.5.  Based on the 
hypothesis above (and assuming that the Ca-peptide complex is not zwitterionic), the 
Ca2+ binding site would be crucial for C-I bond cleavage in ECD.  There is a glutamic 
acid residue (Glu5) in MSH, which likely is the preferred site for Ca2+ coordination: 
previous work showed that Ca2+ binds preferentially to side chains of acidic residues in 
the gas phase [65], particularly when acidic residues are located in the middle of the 
sequence [66].  Ca2+ binding to Glu5 may place a positively charged group close to both 
His6 and Tyr2, which may explain the similar ILE values for His6- and Tyr2-iodinated 

































































































Figure 4.5.  ILE of triply protonated His6- and Tyr2- iodinated MSH (panel A).  His6 
iodination results in much higher ILE than that of Tyr2.  ILE of doubly protonated His6-
and Tyr2-iodinated MSH are shown in panel B.  His6 iodination results in slightly higher 
ILE than that of Tyr2.  Doubly protonated peptides are likely to have more folded gas-
phase structures than triply protonated species.  Thus, positive charge can be spatially 
close to the C-I bond in the Tyr2-iodinated species.  ILE of doubly charged calcium-
adducted His6-and Tyr2-iodinated MSH is shown in panel C.  A likely calcium binding 
site is the acidic Glu5 residue between His6 and Tyr2.  Thus, positive charge may be close 
to the C-I bond in either iodinated form.  Panel D represents the ILE of doubly protonated 
and calcium-adducted Tyr10 doubly iodinated AARF.  Doubly protonated peptides may 
fold in the gas phase, placing the C-I groups on Tyr10 spatially close to the likely 
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protonation sites (Arg1-2 near the N-terminus).  The Ca2+ ion is likely to coordinate to the 
string of acidic residues N-terminal to Tyr10.  
4.3.4 ECD of Doubly Protonated and Calcium-Adducted Doubly Iodinated AAGF 
and Singly Iodinated BE  
Doubly iodinated AAGF, with both C-I bonds in Tyr10, was also subjected to ECD.  
ILEs from ECD of doubly protonated and Ca2+-adducted AAGF are shown in Fig. 5, 
panel D.  The ILEs for the two forms of AAGF are close, 27% for protonated AAGF and 
28% for Ca2+-adducted AAGF.  The three potential protonation sites in AAGF, i.e., the 
free N-terminus, and Arg 1-2, are all close to the N-terminus and seven residues away 
from the C-I bonds on Tyr10.  As discussed above, doubly charged ions may be folded in 
the gas phase, thereby placing protons spatially close to the C-I bonds in Tyr10.  In the 
case of Ca2+-adducted AAGF, the Ca2+ ion is likely to bind to the string of acidic residues 
(Glu4-8) [66].  The Ca2+ ion may also coordinate to two deprotonated Glu residues in the 
polyGlu sequence while the N-terminus or Arg1-2 is protonated, i.e., generating a gas-
phase zwitterion.  A future interesting topic would be to investigate the effect of other 
metal ions on ILE in ECD of iodinated peptides.   
ECD of singly iodinated BE was also performed for which the iodination site is 
His11.  Because the N-terminus of BE is blocked, the most likely protonation sites are 
Lys2 and His11.  Thus, based on the findings discussed above, we expected to observe 
efficient C-I bond cleavage for doubly protonated singly iodinated BE in ECD.  The 
corresponding spectrum is shown in the upper panel of Figure 4.6.  As expected, iodine 
loss corresponded to the most abundant product ion peak.  The abundance ratio between 
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the iodine loss peak and the charge reduced peak is ~4:1.  The ECD spectrum of Ca2+-
adducted BE, shown in the lower panel of Figure 4.6, also demonstrates iodine loss but 
with much lower peak abundance: the abundance ratio to the charge reduced species is 
1:3.5.  Because there are no acidic residues in BE, Ca2+ is likely to chelate to carbonyl 
oxygens [65] along the peptide backbone, which may not yield a preferential location for 


















Figure 4.6.  ECD of doubly protonated and calcium-adducted His12-iodinated bombesin. 
For the doubly protonated species (top panel), the most abundant fragment corresponds to 
iodine loss whereas iodine loss is not dominant for the calcium-adducted species (bottom 
panel).  In the doubly protonated species, His12 is likely protonated, thus placing positive 
charge close to the C-I bond. In the Ca-adducted species, there is no obvious calcium 
binding site close to His12.   
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4.3.5 C-I Bond Cleavage in ECD: Implications for the ECD Mechanism 
The results presented above regarding C-I bond cleavage in ECD provide a 
chance to refine the theory on the ECD mechanism.  Relative to the hot hydrogen model, 
the superbase mechanism seems superior for interpreting our present results: Coulomb 
stabilization from an adjacent positively charged group may allow direct electron capture 
at the C-I bond and subsequently induce C-I bond rupture.  Interestingly, the distance 
between the C-I bond and the positive charge indeed appears to influence ILE.  For 
example, protonation of His6 in singly iodinated MSH would place a positive charge only 
a few bonds away from the C-I bond and thereby yield the observed highly efficient C-I 
bond cleavage.  A similar argument can be made for doubly protonated His12-iodinated 
BE.  On the other hand, when the positively charged group is located further away from 
the C-I bond, for example in the case of triply protonated Tyr2-iodinated MSH, ILE in 
ECD is lower although still observed.  Thus, peptide gas-phase conformation plays a 
critical role for ILE in ECD because more unfolded peptides are less likely to have 
positive charge located close to a C-I bond unless the charge is a proton on an iodinated 
His residue.  The experiments involving ECD of Ca-adducted iodinated peptides 
provided additional support for this hypothesis: when the Ca2+ ion was likely to be 
localized close to a C-I bond, either through bond or through space, abundant C-I bond 
cleavage was observed.    
4.3.6 ETD and ECD Comparison of Doubly and Triply Protonated Histidine and 
Tyrosine Singly Iodinated MSH  
ETD and ECD both generate c- and z-type ions and are believed to involve similar 
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fragmentation mechanisms.  However, some reports have addressed the differences 
between ECD and ETD [48, 51].  ILEs of triply protonated His6 and Tyr2 singly iodinated 
MSH from ECD and ETD are shown in Figure 4.7.  These results demonstrate that C-I 
bond cleavage is significant in both ECD and ETD.  Similar fragmentation patterns were 
observed in ECD and ETD, including much higher ILE for His6 compared to Tyr2 
iodination, presumably due to the charge on His6.  However, ETD resulted in a much 
higher charge reduced peak abundance than ECD and less extensive backbone 
fragmentation (shown in Figures 4.8-4.11).  Although the charge reduced peak abundance 
was higher in ETD, the ILEs of His6 and Tyr2 singly iodinated MSH were higher than 
those from ECD due to the less extensive peptide backbone fragmentation.  For triply 
protonated singly iodinated MSH, His6 iodination demonstrated higher ILE value than 
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Figure 4.7.  ILEs of triply protonated His6- and Tyr2 singly-iodinated MSH from ECD 
and ETD on the SolariX FT-ICR instrument.  ILEs from ECD on the Apex instrument are 
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also shown for comparison.  Very little variation is seen between ECD on the two 
instruments.  ILEs from ETD are higher than the corresponding values from ECD 
because ETD results in more abundant charge reduced species and less peptide backbone 
fragmentation. *SI=singly iodinated 
 












































































Figure 4.9.  ETD of triply protonated His6 singly iodinated MSH on a SolariX FT-ICR 
instrument. 















































































Figure 4.11.  ETD of triply protonated Tyr2 singly iodinated MSH on a SolariX FT-ICR 
instrument.  
For doubly protonated singly iodinated MSH, as shown in Figure 4.12, no 
significant difference in ILE value was observed for His6 and Tyr2 iodination.  In addition, 
unlike the case of triply protonated singly iodinated MSH, ILE values from ECD and 
ETD of doubly protonated singly iodianted MSH only demonstrated a slight difference.  
In addition, for triply protonated species, ILEs from the Apex and SolariX instruments 
were close: 29.1±0.9% vs. 27.9±0.6% for His6 and 6.5±0.1%, 7.9%±0.05% for Tyr2, 
respectively, demonstrating interinstrument reproducibility of ECD for C-I bond cleavage.  
For doubly protonated species, on the other hand, ILEs from Apex and SolariX were 
more different: 22.8±1.2% vs. 28.7±0/2% for His6 and 18.2±0.5% vs. 27.5±0.1% for Tyr2, 
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Figure 4.12.  ILEs of doubly protonated His6- and Tyr2 singly-iodinated MSH from ECD 
and ETD on the SolariX FT-ICR instrument.  ILEs from ECD on the Apex instrument are 
also shown for comparison.  The SolariX instrument provided higher ILE values in ECD 
than the Apex instrument.  ILEs from SolariX ECD and ETD are similar. *SI=singly 
iodinated. 
 
4.3.7 MALDI TOF/TOF CID of His6 Singly Iodinated MSH    
MALDI TOF/TOF high-energy CID of His6 singly iodinated MSH was carried 
out for comparison to ECD/ETD.  The purpose of this comparison was to investigate 
whether C-I bond cleavage is analogous to C-S and S-S bond cleavage, which is known 
to preferentially occur in ECD [33], ETD [67] and MALDI TOF/TOF CID [68].  The 
corresponding spectrum is shown in Figure 4.13.  Briefly, a series of b/y ions as well as 
dehydrated internal fragments, are observed but C-I bond cleavage is absent, indicating 
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Figure 4.13.  MALDI TOF/TOF CID of His6 singly iodinated MSH.  
 
4.4 Summary 
For the peptide MSH, His6 and Tyr2 could be selectively iodinated by varying the 
initial reaction conditions.  Iodinated peptides were subjected to ECD and ETD in two 
different FT-ICR mass spectrometers in their triply- and doubly protonated and calcium-
adducted forms.  For all iodinated peptides, C-I bond cleavage was observed in both ECD 
and ETD but with various efficiencies.  It appears that proximity between the C-I bond 
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and a positive charge, either through bond or through space, is necessary for efficient C-I 
bond cleavage. ECD and ETD on the same instrument (SolariX system) both demonstrate 
prominent C-I bond cleavage and ILE values from ECD and ETD were close for triply 
protonated singly iodinated MSH.  In addition, ETD produced a more abundant charge 
reduced species but thus resulted in less backbone fragmentation.  Unlike the disulfide 
bond, which is labile in both ECD and MALDI TOF/TOF high-energy CID, the C-I bond 
is labile in ECD/ETD only.  These results provide a guide to designing a novel cross-
linker containing a C-I bond and a fixed positive charge for generation of unique reporter 
ions (iodine loss).  In addition, the C-I bond provides a new target (besides S-S and 
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Chapter 5  
Enhancing the Detection of Chemically Cross-linked Peptides 
in Mass Spectrometry: Enabling Selective Metal Dioxide-




Chemical cross-linking combined with mass spectrometry (MS) has become a 
powerful tool for characterizing protein higher order structure and identifying protein-
protein interactions.  Analysis by MS offers lenient requirements for sample purity, high 
sensitivity, and high sample throughput.   
 Detection of cross-linked peptides, however, is challenging because: 1) the cross-
linking yield is low and cross-linked products are subjected to ion suppression by the vast 
excess of unmodified peptides [1]; 2) the formation of intermolecular, intramolecular, and 
dead-end cross-linked products increases spectral complexity [2]; 3) backbone 
fragmentation of cross-linked peptides in MS/MS is either the same as for the 
corresponding unmodified peptides, or involve unknown mass shifts, making 
differentiation of MS/MS signals from cross-linked peptides and unmodified peptides, 
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respectively, difficult[3].  In order to solve these challenges, efforts have been made to 
modify chemical cross-linkers for more facile detection of cross-linked peptides in mass 
spectrometry.  
To differentiate signals from cross-linked peptides and unmodified peptides, two 
sets of spectra can be recorded for comparison.  For example, thiol-cleavable cross-
linkers (TCCs) [4] can be used for the cross-linking reaction and the product divided in 
half.  One half undergoes liquid-phase disulfide bond reduction and alkylation and the 
other half is subjected to analysis without further treatment.  Comparison of reduced and 
unreduced samples will reveal potential cross-linked products.  Second, chemical cross-
linkers can be designed to generate unique gas-phase cleavage products [5-7].  During 
MS/MS analysis, precursor ions containing gas-phase cleavable cross-linkers produce 
characteristic product ions which aid the identification of cross-linked products.  Gas-
phase cleavable cross-linkers can reduce sample preparation time, required sample 
amounts, and analysis time. 
To eliminate ion suppression by unmodified peptides, enrichment moieties can be 
incorporated into chemical cross-linkers for selective enrichment prior to MS analysis.  
One example includes incorporation of a biotin moiety into chemical cross-linkers and 
application of biotin-avidin affinity purification to separate cross-linked products from 
non-cross-linked peptides [8, 9].  However, use of biotin-avidin affinity purification 
presents several problems: 1) There must be enough distance between the biotin group 
and the two cross-linking reactive groups to minimize interference in the cross-linking 
reaction.  Therefore, a rather long chain, e.g., polyethylene glycol, is typically introduced 
to isolate the biotin group, which makes cross-linker bulky.  The length of this spacer arm 
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typically exceeds the preferred range (8-15 Å), which can impose undesired influences on 
the obtained protein structural/interaction information [1].  2) Strong detergents, 
including SDS and urea, are typically required to dissociate biotin-avidin interactions.  
Detergents are not compatible with MS analysis and their removal may be challenging 
and cause sample loss.  
Zirconium dioxide (ZrO2) and titanium dioxide (TiO2) enrichment combined with 
MS have been shown to specifically enhance the detection sensitivity of phosphopeptides 
[10-12].  Enrichment is accomplished simply by varying solvent pH.  Here, we 
demonstrate the design of a novel phosphate-containing peptide-based homobifunctional 
cross-linker with the aim of allowing metal dioxide enrichment.  Two cross-linker 
designs were explored.  First, a tripeptide with amine reactive groups at both ends and a 
phosphoserine (pS) residue in the middle was synthesized.  Second, a heptapeptide (Ac-
pSGGCGGC-NH2) with pS at the N-terminus was evaluated.  For the latter cross-linker, 
one amine reactive group was located in the middle of the peptide and the other one at the 
C-terminus. 
 
5.2 Experimental  
5.2.1 Cross-linker I 
Substance P (subP, with the sequence RPKPQQFFGLM-NH2) and melanocyte-
stimulating hormone (MSH, with the sequence Ac-SYSMEHFRWGKPV-NH2) were 
purchased from Sigma (St. Louis, MO) and Genscript (Piscataway, NJ), respectively, and 
used without further purification.  Tryptic peptide mixtures were generated by digesting 
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400 picomole apomyoglobin and 100 picomole bovine serum albumin (BSA) with 3-4 µL 
of 100 ng/µL trypsin (Promega, WI) overnight at 37 °C.  
The peptide Ac-CpSC-OH (peptide I, pS indicates phosphoserine) was purchased 
from Genescript, mixed with thiol-reactive N-[γ-maleimido butyryloxy] succinimide 
ester (GMBS, from Pierce (Rockford, IL); 4:1 molar ratio), and incubated at room 
temperature for various time periods (40, 105, and 225 minutes, respectively).  The 
product, Ac-C(GMBS)pSC(GMBS)-OH, which has two amine-reactive N-
hydroxysuccinimide (NHS) groups linked to the two cysteines, was then incubated with 
subP and MSH at room temperature (1 hour) followed by quenching with 3µL 1 M 
ammonium bicarbonate and desalting by C18 Ziptip (Millipore, Bedford, MA).  SubP and 
MSH reacted with Ac-C(GMBS)pSC(GMBS)-OH were then treated with TiO2 and ZrO2 
microtips (Glygen, Columbia, MD).  The microtips were acidified/cleaned with 3.3% 
formic acid.  Then, samples were loaded, washed with water, and eluted with 0.2% 
piperidine.  The eluates were dried down and reconstituted in ACN:H2O (1:1 volume 
ratio) for MS analysis. 
5.2.2 Cross-linker II 
The peptide Ac-pSGGCGGC-NH2 (peptide II) was purchased from Genescript 
and reacted with GMBS at 4:1 molar ratio.  Similar to the reaction for peptide I, two 
molecular equivalents of GMBS conjugate to one molecular equivalent of peptide II by 
reducing the maleimide groups in GMBS and linking them to the cysteine thiols.  Thus, a 
homobifunctional cross-linker is produced in which two NHS groups from GMBS are 
available for further cross-linking.  C18Ziptip, ZrO2, and TiO2 enrichment was performed 
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as described for cross-linker 1, except that elution was done with 0.2% piperidine and 1% 
formic acid was immediately added for pH neutralization.   
5.2.3 Mass Spectrometry Analysis 
All samples were analyzed with a 7 Tesla ESI-Q-FT ICR mass spectrometer 
(Bruker, Billerica, MA) in negative ion mode by direct infusion at 70 μL/h.  All data were 
acquired with XMASS software (version 6.1, Bruker Daltonics) in broadband mode from 
m/z = 200 to 2000 with 512k data points and summed over 10-20 scans.  Mass spectra 
were analyzed with the MIDAS analysis software [13].  When needed, external 
frequency-to-m/z calibration was performed with a two-term calibration equation [14] 
using two calibration standards (m/z = 622.02895 and 922.00979, from the calibration 
mix G2421A, Agilent Technologies, Palo Alto, CA).  Peptides and cross-linked products 
were identified based on accurate mass.  
For negative collision induced dissociation (CID), precursor ions were mass-
selectively accumulated in a hexapole with a 5-10 m/z quadrupole isolation window and 
subjected to dissociation with argon gas.  The collision voltage was 24 V.  
 
5.3 Results and Discussion 
5.3.1 Cross-linker I 
The synthesis of cross-linker I is summarized in Figure 5.1.  GMBS is a 
commercially available chemical cross-linker with one amine reactive group (NHS) and 
one sulfhydryl reactive group (maleimide).  One mole of peptide will react with two 
moles of GMBS to yield the product shown in Figure 5.1.  The resulting 
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homobifunctional cross-linker has one phosphate group (from peptide I) and two amine 




Ac-C(GMBS)pSC(GMBS)-OH      
++ 2
 
Figure 5.1.  Synthesis of cross-linker I. 
 
Cross-linker yield (at 1:4 molar ratio of peptide I and GMBS) as function of 
reaction time was investigated and the results are shown in Figure 5.2.  Reaction times 
tested for Ac-C(GMBS)pSC(GMBS)-OH formation are 40, 105 and 225 minutes for 
which the longer time provided the highest cross-linker yield (i.e., transfer of GMBS to 
both cysteine residues).  The yield of the partial cross-linker (transfer to only one cysteine 
















Figure 5.2.  Negative ion mode ESI-FT-ICR MS analysis of the yield of cross-linker I at 
different reaction times.  Peptide I and GMBS were mixed at 1:4 molar ratio.  1: 
unmodified peptide I; 2: partial reaction product with one GMBS attached to peptide I; 3: 
the cross-linker Ac-C(GMBS)pSC(GMBS)-OH.  Peaks 1-3 all correspond to singly 
charged ions. 
 
Once the cross-linker Ac-C(GMBS)pSC(GMBS)-OH was obtained, it was applied 
to react with the model peptides subP and MSH.  Results from these cross-linking 
reactions are shown in Figure 5.3.  subP contains two amine groups: one at the N-
terminus and the other at Lys3.  Intra-molecular cross-linking was the major outcome for 
this peptide (peak2, panel A in Fig. 5.3).  MSH, on the other hand, contains only one free 
amine, at Lys11, because the N-terminus is acetylated.  However, inter-molecular cross-
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linking was observed for this peptide (peak4, panel B in Fig. 5.3).  In addition, because 
free GMBS was still present (due to the excess amount added to achieve maximum yield 
of cross-linkers I and II), a product from reaction between free GMBS and MSH was also 
observed, in which one amine-reactive group from GMBS reacted with Lys11 in MSH 
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Figure 5.3.  Positive ion mode ESI-FT-ICR mass spectra following cross-linking reaction 
of subP (panel A) and MSH (panel B) with cross-linker I, Ac-C(GMBS)pSC(GMBS)-OH.  
1: singly charged un-reacted cross-linker; 2: doubly charged intramolecularly cross-
linked subP; 3: doubly charged product from cross-linking of MSH (Lys11) and an amine-
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reactive group in free excess GMBS ; 4: quadruply charged intermolecularly cross-linked 
product of two molecules of MSH; *=unidentified peak. 
The subP and MSH cross-linked product solutions were then subjected to TiO2 
and ZrO2 treatment with or without introducing a background of apomyoglobin tryptic 
peptides.  Contrary to our expectations, inter- and intramolecularly cross-linked products, 
observed without metal dioxide treatment (as shown in Figure 5.3), were not detected.  
The result for MSH is shown in Figure 5.4.  Here, all observable peaks, including those 
highlighted within the box, are singly charged and may correspond to solvent or 
contaminants from the metal dioxide surface.  The unsuccessful enrichment of cross-
linked products by TiO2 and ZrO2 may be attributed to steric effects, which prevent the 
phosphate group from interacting with the metal dioxide surface.  Based on these results, 
we focused our efforts towards redesigning the cross-linker to facilitate interaction 
between the phosphate group and the TiO2/ZrO2 surface.  This effort resulted in the 


















Figure 5.4.  ZrO2 (top) and TiO2 (bottom) treatment of Ac-C(GMBS)pSC(GMBS)-OH 
reacted with MSH.  The intermolecularly cross-linked product observed without metal 
oxide treatment (see Figure 5.3) was not detected, perhaps due to steric effects.  The 
highlighted peaks all correspond to singly-charged impurities. 
 
5.3.2 Cross-linker II 
The reaction time for maximum yield of cross-linker II was determined to be 
three hours at a 1:4 molar ratio of peptide II and GMBS at room temperature.  The 
structure of cross-linker II is shown in Figure 5.5.  In this structure, the distance between 
the phosphoserine residue and the two NHS groups is expected to be big enough to 
prevent steric interference in either intra- or inter-molecular cross-linking, and thereby 
allow selective binding of cross-linked products to TiO2/ZrO2.  However, the cross-
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linking efficiency of cross-linker II was not satisfactory.  For example, intermolecularly 
cross-linked peptides (e.g., by using MSH) were not generated, however, 
intramolecularly cross-linked subP was observed.   
 
 
   
 
Figure 5.5.  Structure of cross-linker II. 
 
SubP intramolecularly cross-linked with this novel cross-linker was spiked into an 
apomyoglobin tryptic digest and subjected to ZrO2 and TiO2 enrichment.  Initially, +36 
Da mass addition of subP cross-linked product was observed.  Further analysis 
demonstrated that this mass addition can be avoided by manipulating the pH immediately 
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following the elution process.  Therefore, eluted cross-linked product solutions from 
TiO2/ZrO2 enrichment were promptly neutralized.  A comparison of C18 Ziptip, ZrO2, and 
TiO2 treatment of intramolecularly cross-linked subP in an apomyoglobin tryptic digest 
background is shown in Figure 5.6.  Most apomyoglobin tryptic peptides, highlighted in 
the top panel of Fig. 5.6, were removed by TiO2 and ZrO2 treatment, particularly in the 
case of TiO2.  By contrast, subP cross-linked product, both in triply- and doubly-
deprotonated form (peak 1 and 3, respectively), was detected following TiO2 and ZrO2 
treatment.  A deactivated form of the cross-linker (due to addition of amine groups from 
ammonium bicarbonate) was also observed and the corresponding structure is shown in 






















Figure 5.6.  Comparison of Ziptip (top), TiO2 (middle), and ZrO2 (bottom) treatment of 
intramolecularly cross-linked product from subP with cross-linker II. 1: triply-
deprotonated subP cross-linked product; 2: product (see Fig. 5.7) of reaction between the 
cross-linker and ammonium bicarbonate; 3: doubly-deprotonated cross-linked subP 






Figure 5.7.  Deactivated cross-linker II from reaction with ammonium bicarbonate. 
 
In CID of intramolecularly cross-linked subP (Figure 5.8), C-S bond cleavages on 
the reduced maleimide moiety were observed whereas neutral loss (- 98 Da) from 
phosphoserine, ubiquitous in low-energy (positive [15] and negative [16] ion mode) and 
high-energy CID [17, 18], was absent.  Efficient C-S bond cleavage in negative ion CID, 
along with prominent disulfide bond cleavage, has been previously reported [19].  In CID 
of subP intramolecularly cross-linked with cross-linker II, heterolytic C-S bond cleavage 
at both maleimide groups generated the free peptide II (peak 2, Figure 5.8).  A peak 34 
Da lower can be generated by subsequent C-S bond cleavage, resulting in SH2 loss, as 
shown in the scheme in Figure 5.8, to yield a vinyl group on one of the cysteine residues 
(peak 4 in Fig. 5.8).  Alternatively, this species can be generated by direct C-S bond 
cleavage on the other side of the sulfur.  These data reveal that the C-S bond of the 
reduced maleimide group, at least under certain circumstances, is more labile than the 
phosphodiester bond in negative ion CID, a phenomenon that, to our knowledge, has not 
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Figure 5.8.  Negative ion CID of doubly deprotonated subP cross-linked with cross-
linker II (peak 1).  C-S bond cleavage on the reduced maleimide group is observed to 




In this Chapter, two peptide-based cross-linkers were designed to include a 
phosphate group and two amine reactive (NHS) groups.  The purpose of adding the 
phosphate group was to allow cross-linked product enrichment with metal dioxides.  
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Results show that the distance between the phosphate group and NHS groups is crucial 
for enrichment.  For the smaller cross-linker I, TiO2/ZrO2 enrichment was unsuccessful, 
presumably due to steric effects in which phosphoserine in cross-linked peptides was 
hindered from interacting with the metal oxide surface.  For the large cross-linker II, in 
which phosphoserine is located further from the two NHS groups, TiO2/ZrO2 enrichment 
for intramolecularly cross-linked subP was demonstrated.  However, cross-linker II did 
not demonstrate intermolecular cross-linking (e.g., for MSH).  Future work would focus 
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Chapter 6  
Improved Detection of Ions below m/z 700 with Quadrupole 
Fractionation (QF) in Hybrid Q-FT-ICR Mass Spectrometry   
 
6.1 Introduction 
6.1.1 Linear Quadrupole 
The development of the linear quadrupole for mass spectrometric analysis can be 
traced back to the late 1950s [1].  Since then, the linear quadrupole has also been 
established as a key component in hybrid mass spectrometers to serve as mass selector 
[2], ion guide [3], and ion storage device [4].  In addition, the theory concerning ion 
motion and stability in a linear quadrupole lead to the development of the three-
dimensional quadrupole ion trap, which is used in a wide range of applications [5]. 
Both DC voltage (U) and alternating voltage (with amplitude VRF) are applied to 
the four rods of a linear quadrupole in a pair wise manner: two opposing quadrupole rods 
bear the potential (U + VRFcosɷt) and the other pair has the potential - (U + VRFcosɷt).  





























t   
in which u represents the Cartesian coordinates x or y, z is an integer, e is the elementary 
charge, r0 is the radius inscribed by the quadrupole rods, and m is the ion mass. 
 At specific values of U and VRF, ions of particular m/z values can follow either 
stable or unstable trajectories within the quadrupole [6].  When the amplitude of an ion 
trajectory is continuously confined between the quadrupole rods in both the x- and y-
direction, the ion can travel through the quadrupole.  If U and VRF are such that the ion 
motion is unstable, ions will collide with the quadrupole rods or exit between them and 
thus do not make it through the quadrupole [7].   
 The concept of stable and unstable ion trajectories as function of ion m/z value 
can be utilized to achieve several goals in mass spectrometry.  First, by ramping U and 
VRF, ions with increasing m/z values can reach the other end of the quadrupole and be 
detected in an m/z-dependent manner to generate a mass spectrum with a specific m/z 
range (depending on the initial and final U/VRF values).  Here, the quadrupole performs 
as a mass analyzer [8].  Second, if U and VRF are fixed, only ions within a specific m/z 
region will undergo stable motion and thus the quadrupole serves as a mass selector, e.g., 
for subsequent tandem mass spectrometry (MS/MS) experiments.  The linear quadrupole 
can also function in radio frequency (RF)-only mode to serve as an ion guide for a wide 
m/z range of ions, or, in combination with axial electrodes, as an “ion bottle” for trapping 
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of ions prior to subsequent MS analysis [9, 10].  The RF-only quadrupole can also be 
used as a collision cell for confining product ions in MS/MS experiments based on 
collision induced dissociation (CID) [10] although higher order multipoles are typically 
preferred for ion storage due to their higher storage capacity and better focusing abilities 
[11]. 
6.1.2 Linear Quadrupole and FT-ICR MS 
Since the first introduction in 1974 [12], FT-ICR mass spectrometry has become a 
powerful tool for the detection and characterization of biomolecules by providing sub-
ppm mass measurement accuracy [13] and resolving power exceeding 106 [14].  The 
success of FT-ICR MS relies on tremendous advances in various related areas, including 
the development of the ICR cell [15-18], refining the methods for ion excitation and 
detection [19-21], the coupling of “soft-ionization” sources including electrospray 
ionization ESI [22] and matrix-assisted laser desorption/ionization MALDI [23], and the 
introduction of external ion accumulation in a multipole [24].  The latter development 
serves three main functions: 1) it alleviates the conflict between the pulsed nature of FT-
ICR mass analysis and the continuous ion generation from an ESI source, 2) it allows a 
high duty cycle to be maintained despite the time requirement for high resolution FT-ICR 
MS, and 3) it allows efficient transfer and injection of ions from atmospheric pressure 
into high vacuum.   
Interfacing of a linear quadrupole mass filter with an FT-ICR mass analyzer 
equipped with multipole external ion accumulation extends the latter concept to mass-
selective external ion accumulation, which provides further improvements in sensitivity 
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and dynamic range for ion detection [25].  In addition, the quadrupole can provide 
external, rapid selection of precursor ions with a specific m/z value for subsequent 
MS/MS analysis in the ICR cell, e.g., sustained off-resonance irradiation (SORI) CID 
[26], electron capture dissociation [27], or infrared multiphoton dissociation [28].  
Hendrickson et al. [29] demonstrated that more compounds can be detected from crude 
oil by quadrupole fractionation (QF) of an FT-ICR mass spectrum into 30-40 m/z slices 
by use of an external quadrupole-octopole interface.  Similarly, QF has been applied to 
improve protein detection with signal-to-noise (S/N) ratio increasing from 4 to >200-fold 
and ~24-fold on average [30].  Further, QF-based FT-ICR analysis has been applied to 
metabolite detection and shown to increase peak abundances up to five fold [31].  When 
using external ion accumulation in a multipole, it is important to ensure that ions are 
accumulated and transferred to the ICR cell without m/z bias.  Efforts to understand m/z-
related discrimination during external multipole accumulation have been made both 
experimentally and theoretically [32-34].  
    In this chapter, we investigated the detection of proteolytic peptides as well as 
cross-linked peptides by applying the QF approach.  Improved detection was observed in 
both cases, particularly in the low m/z region (350-600).  These discoveries are helpful 
for understanding ion motion in a quadrupole-hexapole interface and provide an option 
for improving detection of ions with low m/z value.  
 
6.2 Experimental 
Horse heart myoglobin, apo-myoglobin, and bovine serum albumin (BSA) were 
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purchased from Sigma (St. Louis, MO) and used without further purification.  Trypsin 
was purchased from Promega (Madison, WI) and chymotrypsin, and GluC were from 
Sigma. Enzymes were used at either 100 ng/µL (trypsin and GluC) or 50 ng/µL 
(chymotrypsin).  The temperature for trypsin and GluC digestion was 37 °C and RT was 
used for chymotrypsin digestion.  The time for all digestions was 12-15 h.  All 
proteolysis experiments were quenched by adding 0.1% (v/v) formic acid. 
Approximately 300 pmol of BSA was analyzed both with and without incubated 
with 10 µL 10mM dithiothreitol (DTT) at 56°C for 1h to achieve disulfide bond reduction. 
After cooling down to room temperature (RT), the mixture was incubated with 10 µL 100 
mM iodoacetamide (IAA) 1h in the dark at RT for alkylation.  Both variants of the 
protein were digested with 4 µL 100 ng/µL trypsin.  apo-myoglobin was digested with 
three different enzymes, including trypsin, chymotrypsin, and GluC.  Peptides from the 
three different types of proteolysis were mixed together.  Horse heart myoglobin was 
chemically cross-linked with bis(sulfosuccinimidyl)suberate (BS3) by mixing 
protein:cross-linker at a 1:100 molar ratio and reacting at RT for 30 minutes.  The 
reaction was quenched by adding 1M NH4HCO3, the protein was then denatured by 
heating at 100 °C for ~10 minutes and digested with trypsin for cross-linked peptide 
detection.  Sample concentrations were adjusted to ~0.3 µM by adding 
CH3CN:H2O:HCOOH (49.95:49.95:0.1 volume ratio) for positive ESI mode and 
CH3CN:H2O (1:1 volume ratio) or MeOH:H2O:NH4OH (49.9:49.9:0.2 volume ratio) for 
negative ESI mode.  Samples were analyzed on a 7 Tesla ESI-Q-FT-ICR mass 
spectrometer (Bruker Daltonics, Billerica, MA) at a flow rate of 70 μL/h.  Quadrupole 
fractionation was performed by collecting spectra from m/z 300 to 1250 at 50 m/z 
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intervals.  Direct infusion (DI) was carried out by maintaining all parameters the same as 
with QF except for omitting the isolation windows (here, the quadrupole operated in RF-
only mode).  The number of scans for acquiring spectra was either the same in QF and 
RF-only analysis, or a larger number was used in DI to proportionally compensate for the 
extra time needed for QF analysis.  For data analysis, only peptides with a monoisotopic 
peak S/N ratio greater than three were considered.  CID was applied, if necessary, to 
ensure the identity of cross-linked peptides and tryptic peptides.  LC/MS of tryptic 
peptides was performed with an Agilent 1100 HPLC interfaced to the FT-ICR instrument 
and equipped with a 1 mm×15 cm C18 column.   
 
6.3 Results and Discussion 
6.3.1 Improved Detection of Non-cross-linked Peptides by QF 
In DI of BSA tryptic peptides without DTT/IAA treatment, 14 peptides were 
observed after summing three FT-ICR transients.  These peptides were identified by 
accurate mass and confirmed by CID to correspond to a sequence coverage of 22%.  
Following QF of the same sample with 50 m/z slices and three scans per spectrum (as in 
DI above), 31 peptides were identified and confirmed by CID, corresponding to a 
sequence coverage of 41%.  The identities of peptides observed in DI and QF analysis are 
summarized in Table 6.1.  18 more peptides were found with quadrupole fractionation of 
which 14, as indicated by parentheses in Table 6.1, were detected with a mass less than 












































 For BSA treated with DTT/IAA prior to trypsin digestion, 25 peptides were 
identified and confirmed by CID in direct infusion analysis whereas 31 peptides were 
observed with QF.  Similar to untreated BSA, DI and QF spectra were both obtained with 
three scans per spectrum.  LC/MS was also carried out for peptide identification.  
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Identified peptides in DI, QF, and LC/MS are shown in Table 6.2.  Example spectra are 
shown in Figure 6.1, which displays the m/z region of two tryptic peptides with m/z 
values lower than 450, including Y434TR436 (panel a) and  L483CVLHEK489 (panel b).  
Both these peptides are undetectable in DI but show observable signals with QF.  Two 
other peptides, K548QTALVELLK557 (panel c) and A236WSVAR241 (panel d), are observed 
in both DI and QF modes but with enhanced S/N ratio in the latter case.  Among the eight 
additional peptides identified with quadrupole fractionation, only two were singly 
protonated ions.  The lack of small peptides may be due to losses in the C18 Ziptip 
desalting treatment, which was necessary for the DTT/IAA treated sample.  The sequence 
coverage with DI and QF were 59% and 72%, respectively.  The sequence coverage in 
LC/MS of BSA tryptic peptides following DTT/IAA treatment was 60% (peptides were 
identified by accurate mass only).  The results for DTT/IAA-treated BSA are summarized 
in Figure 6.2.  The sequence coverage obtained from LC/MS is unexpectedly low.  This 
behavior may be due to a non-optimized LC method, including sample amount, column 
size, elution procedure, and detection parameters.  Nevertheless, QF demonstrated an 
advantage over DI, particularly in the low m/z region. 
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Table 6.2. BSA (with DTT/IAA treatment) tryptic peptides that identified in QF 
and DI analysis 
Peptides Identified in QF Peptides Identified in DI 





89‐100 (Cys_CAM99)*  89‐100 (Cys_CAM99) 89‐100 (Cys_CAM99)
106‐138 (Cys_CAM125)   
118‐138 (Cys_CAM125)  118‐138 (Cys_CAM125)  
139‐155 (Cys_CAM147)  139‐155 (Cys_CAM147) 139‐155 (Cys_CAM147)
161‐167   161‐167  
168‐183 




286‐297 (Cys_CAM288)  286‐297 (Cys_CAM288) 286‐297 (Cys_CAM288)
298‐309 (Cys_CAM301,302)  298‐309 (Cys_CAM301,302)  





















*: The reduction and alkylation of given cysteine residue is indicated (e.g. Cys_CAM99: the 




















Figure 6.1.  Improved BSA tryptic peptide detection by QF (top spectra in each panel) 
over DI (bottom spectra in each panel).  Peptide sequences and charge states are: a) 
[Y434TR436 + H]+ ; b) [L483CVLHEK489 + 2H]2+ ; c) [K548QTALVELLK557 + 2H]2+ ; d) 
[A236WSVAR241 + H]+ .  Modified cysteine residue (from carbamidomethylation) in b) is 


































Figure 6.2.  Sequence coverage of BSA obtained by DI, LC/MS, and by QF FT-ICR MS 
analysis. 
 
6.3.2 Improved Detection of Cross-linked Peptides by QF 
Cross-linked peptides obtained from reacting BS3 with myoglobin were subjected 
to DI and QF analysis, respectively. Two intramolecularly cross-linked peptides, 
SEDLK62K63HGTVVLTALGGILK and NDIAAK145YK147ELGFQG, were identified with 
DI and confirmed by CID.  With QF, three more cross-linked species, 
FK47HLK50TEAEMK, LFTGHPETLEK42FDK45FK, and TEAEMK56ASEDLK62K were 
found based on accurate mass.  The two former ones were confirmed by CID but the S/N 
ratio for the latter one was too low for CID.  The corresponding mass spectra are shown 





























Figure 6.3.  Three intramolecularly cross-linked peptides that were observed with QF 
(top spectra in column a-c) but not in DI (bottom spectra). 
 
Based on the results above, QF can effectively increase S/N ratio and improve ion 
detection, particularly in the low m/z region (<700).  However, it should be pointed out 
that these spectra were acquired with the same number of scans for QF and DI analysis.  
Because QF requires more time (n-fold longer than DI where n = the number of m/z 
regions) than DI, this comparison may not be fair.  Allowing additional time for signal 
averaging in DI analysis (to yield n-fold more scans) may compensate for the difference 
reported above in terms of S/N ratio between QF and DI.  On the other hand, because QF 
seemed particularly useful in the low m/z region, further analysis of that area was 
performed, adjusting for the discrepancy in time between QF and DI.   
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6.3.3 Comparison of QF and DI after Compensating for the Extra Time Needed 
for QF  
In the work presented in this section, QF spectra (in 50 m/z segments) were 
obtained by averaging three scans whereas DI spectra were acquired with 21 scans over 
the 350-700 m/z region, which seemed to benefit the most from QF based on the results 
presented above.  Thus, the time taken to perform both experiments was the same.  QF 
and DI spectral acquisition were compared by calculating the ratios of absolute peak 
abundances between QF and DI spectra.  When three scans were used in both QF and DI, 
the ratio was scaled to compensate for the extra time required for QF.  Although S/N ratio 
is known to increase as the square root of the number of scans [35], our data (see Figure 
6.4 for an example) suggest that the absolute peak abundance achieved in DI is 
proportional to the number of scans (e.g., 2×106 for three scans and ~4×106 for six scans).  
A summary for BSA tryptic peptides is shown in Fig. 6.4, in which most of the peak 






































Figure 6.4.  Ratios of peak abundances for BSA tryptic peptides from DI spectral 
acquisition with thirty vs. three scans, respectively.   
  
We first compared QF and DI in positive ESI mode by using a mixture of 
apomyoglobin peptides from trypsin, chymotrypsin, and Glu C digestion, respectively.  
These results are shown in Figure 6.5 in which the ratios of peptide peak abundances 
between QF (three scans) and DI (21 scans) are plotted as function of m/z value.  
Significant signal enhancements by QF, ranging from 2-9 folds, are shown in the 350-500 
m/z region, even when the extra time required for QF was compensated for.  The five 
peptides that benefited the most from QF all have m/z values below 400, confirming that 



































Figure 6.5.  Ratio of peak abundances between QF (3 scans) and DI (21 scans)  analysis 
of a peptide mixture in positive ESI mode.  The mixture was obtained by digesting 
apomyoglobin with three enzymes (trypsin, chymotrypsin, and Glu C), respectively, and 
mixing the resulting peptides.  Three replicates were carried out to obtain average and 
standard deviation. 
 
  QF and DI were also compared in negative ESI mode by analyzing the same 
peptide mixture generated from trypsin, chymotrypsin, and GluC digestion of 
apomyoglobin (panel A, Figure 6.6) and BSA digested with trypsin after DTT/IAA 
treatment (panel B, Figure 6.6).  Both DI and QF spectra for negative ion mode analysis 
were obtained with three scans.  Similar to positive mode ESI, signal enhancements in 
QF are observed in the low m/z area (350-600) but the enhancement ratios are lower than 
those in positive ESI, considering that the extra time required for QF was not 
compensated for in the negative ion mode experiments.  Without compensation (which 
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biases towards QF, the enhancement ranged from 7-9 fold (for apo-myoglobin) and 5-11 
fold (for BSA).  If absolute peak abundance in negative ion mode is assumed to scale 
proportionally to the number of scans (as was observed in positive ion mode, Fig. 6.4), 
the enhancement after compensating for the extra time required for QF (a five-fold 
difference for the m/z region 350-600) would be 1.4-1.8 fold for myoglobin and 1-2.2 
fold for BSA.  Based on these calculations, we conclude that QF in negative mode ESI 
































































Figure 6.6.  Ratio of peak abundances between negative ion mode QF and DI analysis of 
peptide mixtures obtained from three enzyme (trypsin, chymotrypsin, and Glu C) 
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digestion of apo-myoglobin (panel A) and  reduced and alkylated BSA (panel B).  Three 
replicates were carried out to obtain average and standard deviation.  
 
Based on computer simulations and theoretical calculations of ion motion in RF-
only multipole ion guides, ion distributions are “onion-like” with multiple cylindrical 
layers [32, 36].  Ions with higher charge at a specific mass are more radially confined 
than ions of lower charge.  Likewise, at a specific charge, ions of lower mass are more 
radially confined than ions of higher mass.  Thus low charge and high mass ions are more 
likely to be radially lost [32].  However, the comparison of QF and DI presented here 
demonstrates that ions with lower m/z values appear to be preferentially lost in DI 
analysis.  This behavior may be explained by axial rather than radial ejection of such 
species during hexapole storage due to their higher axial kinetic energy.  An alternative 
explanation may be that low m/z ions are radially lost during RF-only quadrupole 
transmission because they are closer to the low mass cut-off value than higher m/z ions. 
 
6.4 Summary 
In this chapter, comparisons between QF and DI detection of proteolytic peptides 
as well as cross-linked peptides were carried out.  Signal enhancements were observed in 
QF analysis in the low m/z (350-600) region in both positive and negative ESI mode.  In 
positive ion mode, 2-9 fold signal enhancements were obtained with QF after 
compensating for the 7-fold longer time required for QF (21 scans were used for DI and 
three scans for each QF slice).  In negative ESI mode, lower enhancement, 1-2.2 fold, 
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was estimated after compensating for the longer time require for DI.  These results cannot 
be explained based on previous computational experiments, which modeled radial 
oscillations of ions in RF-only multipoles as function of mass and charge.  However, low 
m/z ions may still be axially lost due to their higher axial kinetic energy: in DI analysis, 
space charge repulsion from trailing higher m/z ions may cause this axial ejection.  In QF 
analysis, space charge repulsion from higher m/z ions can be removed, thus providing a 
benefit for the detection of low m/z ions.  Further studies of ion motion in RF-only and 
mass-selective quadrupole modes, including computer simulations, would be necessary to 
explaining the results in this Chapter.  Nevertheless, QF is shown to improve ion 
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Chapter 7  
Characterization of Enzyme Function and Functional 
Differentiation in Curacin A and Jamaicamide Biosynthesis by 
FTICR MS and IRMPD 
 
7.1  Introduction 
Non-ribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs) are 
two enzyme families that catalyze the biosynthesis of a large number of natural products 
with great diversity in chemical structure and pharmacological potential, including 
antitumor [1], antimicrobial, and immunosuppressant properties [2].  Curacin A (Cur) is a 
mixed polyketide-nonribosomal peptide (PK-NRP) natural product isolated from the 
marine cyanobacterium Lyngbya majuscula with potential anti-tumor activity [3].  
Biosynthesis of Cur relies on the catalysis of PKSs and NRPSs, in which substrates are 
covalently linked to a serine residue in a carrier protein through a phosphopantetheine 
(PPant) arm (Figure 7.1).  Substrates in NRPS/PKS catalysis are subjected to various 
chemical reactions (e.g. dehydration and decarboxylation) and undergo chain elongation 





Figure 7.1.  Chemical structure of PPant. 
 
Like Cur, jamaicamide (Jam) is a mixed polyketide-nonribosomal peptide (PK-
NRP) natural product isolated from the marine cyanobacterium Lyngbya majuscula.  The 
structures of Cur and Jam, however, are rather different, as shown in Figure 7.2.  
Nevertheless, the Cur and Jam biosynthetic pathways have high homology, including 
dehydratases (ECH1s), decarboxylases (ECH2s), and enoyl reductases (ERs).  Therefore, 
functional determination of enzymes in the Cur and Jam biosynthetic pathways provides 
key insight into the mechanism of natural product biodiversity.  In addition, comparison 
of analogous enzyme components from the Cur and Jam biosynthetic pathways can 
provide insights into the evolution and environmentally driven adaptation of these 
biosynthetic enzymes at the biochemical rather than the genetic level.   
In this Chapter, top-down and bottom-up FT-ICR MS and IRMPD experiments 
were performed to elucidate the functions of a GCN5-related N-acetyltransferase (GNAT) 
in the initiation module of Cur biosynthesis, Cur halogenase (Hal), ECH1s, ECH2s, and 
ERs from both the Cur and Jam biosynthetic pathways, and a sulfotransferase (ST) and 
thioesterase (TE) involved in release of mature Cur with a terminal double bond.  The 
presence of Hal is not surprising in the Jam pathway because Jam contains a vinyl 
chloride group.  Halogenation reactions have previously been studied in natural product 
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biosynthesis [4-7].  However, Cur does not contain a halogen group but intermediate 
cholorination may be involved in cyclopropane ring formation [4, 8].  Previous work 
from our group in collaboration with the Sherman lab revealed that Cur ECH1 and ECH2 
catalyze dehydration and decarboxylation, respectively [9].  ER belongs to the acetyl-
CoA NADPH-dependent reductase family and typically reduces α,β C=C bonds [10].  In 





Figure 7.2.  Chemical structures of Cur (top) and Jam (bottom). 
 
Furthermore, with the aim to understand the Cur Hal catalytic mechanism based 
on crystal structures from different ligand binding states, IRMPD was applied to monitor 
the catalytic efficiency of wild type (WT) Cur Hal as well as a series of site-specific 





7.2 Experimental  
7.2.1.  Protein Expression 
Reactions with Cur Hal, ECH1, ECH2, and Cur/Jam ER were performed with 
intermediates linked to acetyl carrier protein encoded by the CurE gene cluster (ACPII) 
whereas the ACP encoded by CurA was used for functional analysis of GNAT.  For ST 
and TE reactions, the ACP encoded by CurM (denoted as ACPIII) was used.  Details are 
shown in Figure 7.3. All protein samples analyzed by MS and IRMPD in this Chapter 
were prepared by Dr. Liangcai Gu from the Sherman lab (AR-GNAT-ACP, (AR is an N-
terminal adaptor domain with unknown function), ACP, Cur Hal, ECH1, ECH2, ER, ACPII, 
ST, TE, and ACPIII for functional and functional differentiation studies of the Cur and 
Jam pathways) and Dr. Dheeraj Khare from Prof. Janet Smith’s lab (wt and mutants of 
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Figure 7.3. Enzymes (except KS and AT) that investigated in this thesis. The gene 





7.2.2 FT-ICR MS for Functional Analysis of Proteins from the Cur and Jam 
Pathways 
Trypsin digestion for bottom-up analysis of the AR-GNAT-ACP tridomain was 
carried out by Dr. Gu.  Mass spectrometric analysis was performed with an actively 
shielded 7 Tesla quadrupole-Fourier transform ion cyclotron resonance (FT-ICR) mass 
spectrometer (APEX-Q, Bruker Daltonics, Billerica, MA). Target analytes (peptides for 
the AR-GNAT-ACP tridomain) and intact ACPs for top-down analysis) were diluted with 
an electrospray solution (1:1 CH3CN:H2O with 0.1% HCOOH) and directly infused into 
an electrospray ionization (ESI) [11] source (Apollo II, Bruker Daltonics) at a flow rate of 
70 µL/h and a voltage of - 3.8 kV.  A counterflow of hot (240 C) nitrogen gas was 
applied to assist desolvation of ESI droplets.  For accurate mass determination in top-
down analyses, up to 10 picomoles of apomyoglobin (Sigma, St. Louis, MO) was spiked 
into the ESI solution as internal calibrant. Multiply protonated ions generated from ESI 
were externally accumulated in a hexapole for 1 s and transferred via high voltage ion 
optics to the ICR cell for analysis.  All data were acquired with XMASS software 
(version 6.1, Bruker Daltonics) in broadband mode from m/z = 200 to 2000 with 512k 
data points and summed over 20-30 scans.  Mass spectra were analyzed with the MIDAS 
analysis software [12].  When needed, external frequency-to-m/z calibration was 
performed with a two-term calibration equation [13] using two calibration standards (m/z 
= 622.02895 and 922.00979, from the calibration mix G2421A, Agilent Technologies, 
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Palo Alto, CA).  For infrared multiphoton dissociation (IRMPD), precursor ions were 
mass-selectively accumulated in a hexapole with a 3-5 m/z quadrupole isolation window, 
transferred to the ICR cell, and irradiated for 100-300 ms by 10.6 μm photons at 10 W 
laser power (25 W CO2 laser, Synrad, Mukilteo, WA) for 30-50 scans.  Unless 
specifically mentioned, top-down and IRMPD analyses of ACPs incubated with Cur AR-
GNAT-ACP, ECH1s, ECH2s, and ERs from Cur and Jam, Cur Hal, and Cur ST and TE 
were all carried out in a similar manner. 
7.2.3.  IRMPD-based Quantification of Cur ER, Jam ER, and Cur Hal Catalytic 
Efficiency 
The nomenclature and chemical structures of substrates and products from Hal, 
ECH1, ECH2, and ER catalysis are shown in Figure 7.4. 
 
1‐ACPII Cl‐1‐ACPII 2‐ACPII   Cl‐2‐ACPII   3‐ACPII  
Cl‐3‐ACPII   4‐ACPII   5‐ACPII  Cl‐4‐ACPII   Cl‐6‐ACPII   6‐ACPII    
Figure 7.4.  Nomenclature and chemical structures for substrates and products for Hal, 




For ER analysis, the +12 charge state of ACPII-bound intermediates was selected 
for IRMPD (mixture of substrate and product for saturation reactions and mixture of 
internal standard and product for cyclopropanation, as described below).  Peak 
abundances of PPant ejection products generated by IRMPD [14] were measured to 
quantify the yields of Cur/Jam ER catalyzed , C=C saturation and cyclopropanation as 
function of reaction time.  In a similar but time-independent approach, IRMPD peak 
abundances were measured to determine the catalytic efficiencies of wild type and mutant 
Cur Hal.  However, for Hal, the entire charge state distribution was used for IRMPD. 
For ER analysis, the ratio of PPant ejection products with a two Dalton mass 
difference (i.e., corresponding to unsaturated substrate and reduced product) was 
calculated from the abundance of n and n + 2 peaks with the n + 2 peak abundance 
adjusted by subtracting the calculated abundance for the second isotopic peak of the 
substrate.  For the cyclopropanation reaction, an internal standard (4-ACPII) was added to 
ensure unbiased precursor ion isolation of both ACP-bound product and the species used 
for relative quantification (4-ACPII is only two Da heavier than the product from 
cyclopropanation (5-ACPII), i.e., these two ions are only 0.2 m/z units apart in the +12 
charge state (similar to substrate and product in saturation reactions) whereas the ACPII-
bound substrate, Cl-3-ACP, is 34 Da heavier than its cyclopropanation product and thus 
separated by 2.8 m/z units in the +12 charge state).  An isolation window of 5 m/z units 
was used.  IRMPD-based quantification methods were validated by mixing ACPII-bound 
substrate and product at known ratios and performing IRMPD.   
For Cur Hal analysis, IRMPD PPant ejection ions for the product and substrate 
181 
 
are observed at m/z 439.12 and 405.16, respectively. The peak abundance ratio of these 
two ejection products was used to estimate substrate (1-ACPII) to product (Cl-1-ACPII) 
conversion efficiency in Cur Hal catalysis.  Here, a single chlorine atom addition to the 
substrate is unlikely to influence ESI efficiency of the ACP-bound intermediate.  Time 
course experiments were also carried out with WT Cur Hal as well as with single amino 
acid mutants, monitoring the IRMPD product ions at m/z 405 and 439. 
 
7.3 Results and Discussion 
7.3.1 Functional analysis of GNAT in the initiation module of CurA biosynthesis  
Trypsin digested AR-GNAT-holo-ACP was characterized by FT-ICR and IRMPD.  
Here, AR refers to an N-terminal adaptor domain of unknown function.  As shown in 
Figure 7.5, the PPant-modified 469-484 tryptic peptide (row B in Fig. 7.5) with the 
sequence ALMEMGIESLELLELR (containing Ser477, the known PPant loading site) was 
observed.  By contrast, only the apo-peptide was observed for AR-GNAT-apo-ACP (row 
A in Fig. 7.5).  PPant ejection from the AR-GNAT-holo-ACP active site peptide was 
observed in IRMPD (spectrum not shown).  The observed and calculated masses of these 
tryptic peptides and their PPant ejection ions are listed in Table 7.1, bottom.  































Figure 7.5. Partial FT-ICR mass spectra of trypsin digested AR-GNAT-ACP in apo- (row 
A) and holo form (row B) and after incubation with malonyl-CoA (row C).  An 
unmodified doubly protonated peptide (469-484) and its modified counterpart (PPant 
loaded) were observed at position 1 and 2, respectively.  Acetyl transfer product was 












Table 7.1. Precursor and PPant ejection ions observed in FT-ICR MS and IRMPD of apo- 
and holo-ACP before and after incubation with AR-GNAT-apo-ACP and acetyl- or 
malonyl-CoA, and of NH2-ACP after incubation with AR-GNAT-apo-ACP and acetyl-
CoA (top), and of the trypsin digested AR-GNAT-apo/holo-ACP tridomain before and 




Obs. avg. mass Calc. avg. mass Obs. [M+H]+ Calc. [M+H]+ 
apo‐ACP  10820.7  10821.1  
holo‐ACP  11160.9  11160.7 261.128 261.127 
acetyl‐S‐ACP  11202.5  11202.7 303.138 303.137 
NH2‐ACP  11144.5  11144.7 244.166 244.166 





Obs. mass  Calc. mass Obs. [M+H]+ Calc. [M+H]+ 
apo‐ACP  1845.97  1845.95
holo‐ACP  2186.05  2186.04 261.128 261.127 




The GNAT enzyme superfamily performs diverse functions in prokaryotes and 
eukaryotes by transferring an acetyl group to a primary amine at a specific step in diverse 
biosynthetic pathways [15].  In this Chapter, GNAT was revealed to transfer an acetyl 
group to a thiol group.  This unprecedented function of GNAT was revealed by FT-ICR 
MS.  As shown in Figure 7.6, acetyl transfer to holo-ACP-SH (PPant has free terminal 
thiol group) occurs following incubation with acetyl-CoA and AR-GNAT-apo-ACP: a 
product ion peak can be clearly observed at the + 42 Da position (acetyl transfer) relative 
to the substrate peak.  AR-GNAT-apo-ACP can also perform its classical function, i.e., 
184 
 
transferring an acetyl group to holo-ACP-NH2 (in which the terminal SH group in PPant 
is replaced by an NH2 group) but at low efficiency: in the right column of Figure 7.6, 
only trace amount of acetyl-NH-ACP is observed in the m/z area of + 42 Da.  Acetyl-S-
ACP, observed after incubation with AR-GNAT-apo-ACP (left column in Fig. 7.6) was 
subjected to IRMPD and the corresponding PPant ejection ion is shown in Figure 7.7.  
For acetyl-NH-ACP, the precursor ion signal was too weak for IRMPD.  The observed 
and calculated masses of apo- holo- and acetyl-loaded ACPs and their PPant ejection ions 


















+ 42 Da + 42 Da
m/z
1115 1120 1125 1115 1120 1125
 
Figure 7.6.  Partial FT-ICR mass spectra of holo-ACP-SH (left) and holo-ACP-NH2 
(right) incubated with the AR-GNAT-apo-ACP tridomain in the presence of malonyl-CoA.  
Acetyl transfer to holo-ACP-SH can be readily observed whereas no significant signal is 









Figure 7.7.  IRMPD of the acetyl transfer product of holo-ACP-SH.  The indicated PPant 
ejection ion was observed. 
 
FT-ICR MS and IRMPD also revealed that the Cur GNAT has decarboxylation 
function: after incubating holo-ACP with either acetyl-CoA or malonyl-CoA and AR-
GNAT-apo-ACP, the same product, acetyl-holo-ACP, was observed (as shown in Figure 
7.8.).  Because acetyl-CoA and malonyl-CoA differ by one carboxyl group in their 
chemical structures, AR-GNAT-apo-ACP must catalyze decarboxylation along with 
acetyl transfer.  Similar results were observed on the peptide level, as shown in row C, 
Figure 7.5.  Here, acetyl addition was observed in the AR-GNAT-holo-ACP tridomain 
after incubation with malonyl-CoA, demonstrating the occurrence of decarboxylation.  In 
addition, the AR domain is important for effective acetyl transfer.  As shown in Figure 7.8, 
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Figure 7.8.  FT-ICR MS comparison of the acetyl transfer efficiency of GNAT-apo-ACP 
didomain and GNAT monodomain from acetyl- and malonyl-CoA, respectively.  The 
substrate and product are holo-ACP (1) and acetyl-holo-ACP (2), respectively. 
 
7.3.2 Fuctional determination of Cur Hal, ECH1s, ECH2s, and ERs from Cur and 
Jam  
Top-down FT-ICR MS analysis of reaction products from Cur Hal, ECH1, ECH2, 
and ER catalysis is shown in Figure 7.9.  Incubation of 1-ACPII with Cur ECH1 and Cur 
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ECH2 resulted in dehydration and decarboxylation, respectively.  When Cur ER and 
NADPH were added, a +2 Da shift relative to the decarboxylation product (3-ACPII) was 
observed to yield 4-ACPII.  This reaction represents the canonical ER function of 
reducing α,β C=C bonds.  Reduction was confirmed by IRMPD (Table 7.2, PPant 
ejection ion from 4-ACPII).   
Cur Hal was confirmed to catalyze mono-chlorination (1-ACPII to Cl-1-ACPII), as 
shown in Figure 7.9.  The chlorinated product (Cl-1-ACPII) was incubated with Cur 
ECH1, ECH2 and ER in a similar manner as described for 1-ACPII above.  As expected, 
successive dehydration and decarboxylation was observed when ECH1 and ECH2 were 
present.  However, when Cur ER and NADPH were added along with ECH1 and ECH2, 
the expected saturation product was absent and a peak with the same m/z value as 4-
ACPII was observed, indicating elimination of chlorine and possible formation of 5-ACPII, 
containing the cyclopropyl ring.  The structures of 4-ACPII and 5-ACPII were confirmed 
by the Sherman and Wipf groups based on synthesis of authentic standards and GC-MS.  
This discovery reveals that Cur ER not only keeps the canonical function of reducing α,β 
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Figure 7.9.  FT-ICR MS analysis of 1-ACPII and Cl-1-ACPII after incubation with 





























apo‐ACPII  11300.8  11300.7     
1‐ACPII  11785.9  11785.9  405.170  405.174 
2‐ACPII  11767.9  11767.9  387.159  387.164 
3‐ACPII  11723.9  11723.9  343.169  343.174 
4‐ACPII  11725.9  11725.9  345.185  345.190 
5‐ACPII  11723.9  11723.9  343.169  343.169 
6‐ACPII  11723.9  11723.9  343.169  343.163 
Cl‐1‐ACPII  11819.9  11819.8  439.131  439.128 
Cl‐2‐ACPII  11801.9  11802.0  421.120  421.110 
Cl‐3‐ACPII  11757.9  11757.9  377.130  377.140 
Cl‐4‐ACPII  11759.9  11759.8  379.146  379.156 







Subsequent experiments were carried out to investigate the function of ECH1, 
ECH2 and ER from Jam, as shown in Figure 7.10.  Compared to Cur ER, incubation of 
Cl-3-ACPII (from reaction with Cur ECH1 and ECH2) with Jam ER and NADPH did not 
produce 5-ACPII but Cl-4-ACPII (with a +2 Da shift relative to Cl-3-ACPII), indicating 
that Jam ER has the canonical α,β C=C reduction function and does not catalyze 
cyclopropanation. Furthermore, the function of Jam ER seems redundant in the Jam 
pathway.  As shown in Figure 7.11, the product from incubation of Cl-1-ACPII with Jam 
ECH1 and ECH2 has different behavior than the product from incubation of Cl-1-ACPII 
with Cur ECH1 and ECH2: the former product does not undergo further reaction (i.e., 
reduction of cyclopropyl formation) when incubated with either Cur or Jam ER.  IRMPD 
of products from incubation of Cl-1-ACPII or 1-ACPII with Jam ECH1 and ECH2 also 
showed that addition of Jam ER and NADPH did not change the peak abundance at the n 
+ 2 position of the PPant ejection ion (corresponding to C=C bond reduction) relative to 
the monoisotopic peak (n) (Figure 7.11).  The structure of the product from incubation of 
1-ACPII with Jam ECH1 and ECH2 was confirmed by GC-MS involving synthesized 
authentic standards [16] to have β,γ C=C bond (6-ACPII), thus Cl-6-ACPII has a vinyl 
chloride moiety which cannot be introduced by Cur or Jam ER.  Therefore, the function 
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Figure 7.10. FT-ICR MS analysis of Cl-1-ACPII incubated with ECH1, ECH2, and ER 




















Figure 7.11.  IRMPD of products from 1-ACPII (panels A and B) and Cl-1-ACPII (panels 
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C and D) incubated with Jam ECH1 and ECH2 (panels A and C) and Jam ECH1, ECH2, 
and ER (panels B and D).  No significant change in peak abundance at the n + 2 position 
relative to the corresponding unsaturated PPant ejection ion was seen for Cl-1-ACPII.  
 
7.3.3 Functional differentiation of ERs from Cur and Jam  
As mentioned above, Cur ER shows the unprecedented function of catalyzing a 
cyclopropanation reaction.  At the same time, Cur ER and Jam ER have both 
demonstrated the canonical function of saturating , C=C bond.  Thus, we explored the 
interesting comparison of Cur ER and Jam ER catalytic efficiencies for cyclopropanation 
and saturation, respectively, by FT-ICR MS. 
The , C=C saturation, (e.g., by converting Cl-3-ACPII to Cl-4-ACPII) does not 
affect ESI efficiency and the products and substrates have similar charge states 
distributions.  Therefore, a single protein charge state can be selected for analysis [17].  
In this Chapter, quantification based on a single charge state (+12) selected for 
fragmentation is shown (see below) to yield identical results as subjecting the entire 
charge state distribution to IRMPD.  Thus, we focused on the +12 charge state for 
IRMPD analysis.  For Cur ER cyclopropanation, quantification of 5-ACPII was achieved 
by using 4-ACPII as an internal standard.  No desaturation product of 4-ACPII was 
detected to interfere with the 5-ACPII measurement.  Relative catalytic yield can be 
obtained by measuring the ratio of the PPant ejection ions from ACPII-related species 
with a two Dalton mass difference, i.e., peaks n and n+2, respectively.  
Before comparing the catalytic efficiencies of ERs from Cur and Jam, the 
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IRMPD-based quantification method was validated by analyzing a series of known 
mixtures of ER-related substrates/products or internal standard/product pairs, including 3-
ACPII/4-ACPII, Cl-3-ACPII/Cl-4-ACPII, and 4-ACPII (used as internal standard)/5-ACPII.  
As shown in Figure 7.11, all three pairs show good agreement (linearity) between the 
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Figure 7.12.  3-ACPII/4-ACPII (panel A), Cl-3-ACPII/Cl-4-ACPII (panel B), and 4-
ACPII/5-ACPII (panel C) were mixed at known ratios and quantified by IRMPD.  Each 
measurement was performed in triplicate to obtain a standard deviation.  
 
After validating the IRMPD-based quantification method, time-course studies of 
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catalytic efficiencies were performed, as shown in Figure 7.13.  These data demonstrate 
that Jam ER saturation of α,β C=C is much faster (by ~240-fold) than that of Cur ER 
saturation under identical experimental conditions.  Jam ER has retained a canonical α,β 
C=C reduction function and so has Cur ER but with lower efficiency.  In addition, Cur 
ER has gained the unprecedented ability for cyclopropanation of a chlorinated substrate 
(by the upstream Cur Hal).  These results provide unique insights into functional group 
























Figure 7.13.  Catalytic efficiencies for cyclopropanation and saturation of Cur and Jam 
ERs.  All time-course studies were performed in triplicate under the same reaction 
conditions.  
 
7.3.4 Application of IRMPD to reveal crucial residues for Cur Hal catalysis 
Chlorination assay (from 1-ACPII to Cl-1-ACPII) was developed by Dr. Gu from 
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Sherman’s lab. Briefly, the chlorination reaction was carried out in a 110 µL mixture 
containing 5 µM Hal, 10 mM Tris-HCl (pH 7.8), 100 µM fresh Fe(NH4)2(SO4)2, 25 µM 
1-ACPII, and 1 mM α-ketoglutarate.  The mixture was incubated at 24 °C for 10 min and 
the reaction was quenched by adding 20 µL formic acid.  HPLC (Source 15RPC column 
from GE Healthcare with linear gradient from 30% to 70% CH3CN) was then applied to 
purify the product for subsequent MS analysis.  Based on the crystal structure of Cur Hal 
obtained by the Smith group, selected residues were mutated to elucidate substrate 
recognition and binding of chloride and αKG.  IRMPD was applied to monitor PPant 
ejection ions from the substrate (1-ACPII, m/z 405) and product (Cl-1-ACPII, m/z 439) of 
the Hal reaction and thereby evaluate the Cur Hal catalytic efficiency.  The corresponding 
results are shown in Figure 7.14.  Wild type Cur Hal showed ~82% relative yield.  A 
conservative substitution, Leu112 to Ile, provided a similar value, 72%.  Replacement of 
Arg241 and Arg247, which are basic residues and believed to anchor αKG to the Cur Hal 
active site,[18], with Ala rendered Cl-1-ACPII almost undetectable, indicating nearly 
complete functional loss of Cur Hal.  Substituting Ser 120, which was believed to bind 
Cl- via hydrogen bonding, and Ser132, which connects to the Cur Hal active site through 
a hydrogen bond, with Ala had similar effects as the arginine mutations.  Mutation of 
residues in the active site lid resulted in loss of Cur Hal function to various extents.  
Among these mutations, the largest functional loss, up to 20 fold, was observed for K50, 
K54, and Y68.  Ala substitution of Ser44 and K48 resulted in 4-6 fold functional loss, 






































































Figure 7.14.  Catalytic efficiencies of WT Cur Hal and site-specific Hal mutants from 
IRMPD-based quantification. 
       
7.3.5 Characterization of products from ST and TE catalysis in the termination 
module of CurA biosynthesis  
The Cur chain termination, which involves formation of an unusual terminal 
olefin (Figure 7.2), was also studied, as shown in Figure 7.15.  After treating holo-ACPIII 
(1-ACPIII, see Fig. 7.14) with ST in the presence of adenosine 3’-phosphate 5’-
phosphosulfate (row C), a product with +80 Da shift was observed, indicating addition of 
an SO3
- group to form 2-ACPIII.  When 1-ACPIII was treated with ST and TE, a product 
with a – 256 Da shift (ACPIII tethered to PPant with a free SH group, denoted as 3-ACPIII) 
was observed.  Combined with other data from the Sherman lab, addition of an SO3
- 
group is believed to occur on 1-ACPIII (catalyzed by ST) to form 2-ACPIII followed by 
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product release (by the TE) involving decarboxylative chain termination to form 3-ACPIII 
[19].  Because sulfate groups are highly labile in the gas phase, IRMPD was unable to 























Figure 7.15.  FT-ICR MS analysis of apo-ACPIII (A), holo-ACPIII (B), and holo-ACPIII 
incubated with ST (C), and ST + TE (D).  Peaks labeled with diamonds in A-D 




In this Chapter, FT-ICR MS was successfully applied to characterize enzymatic 
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reactions in the Cur and Jam biosynthetic pathways.  There are two main approaches to 
reach that goal.  First, top-down analysis can provide accurate mass of substrate and 
product and enzyme function can be revealed from observed mass shifts.  For example, -
18 Da shift indicates dehydration and + 80 Da shift may correspond to SO3
- group 
addition. Second, IRMPD can be applied to investigate and confirm reaction mechanisms 
due to generation of specific PPant ejection ions.  In addition, substrate and product 
structural information generally remains on PPant ejection ions and, therefore, simplifies 
characterization of substrates and products.  For example, C=C saturation, which only 
causes a 2 Da mass difference, can be successfully characterized and differentiated by 
IRMPD whereas it is difficult to decipher in a top-down approach..   
FT-ICR MS and IRMPD revealed that Cur GNAT has the unprecedented function 
of transferring an acetyl group to a free thiol group, instead of the canonical amine group.  
The N-terminal AR domain is important for this novel function of GNAT.  In addition, 
the Cur GNAT displays bifunctional activity by also catalyzing decarboxylation. 
ECH1 and ECH2 from Cur and Jam appear at first glance to both catalyze 
dehydration (ECH1s) and decarboxylation (ECH2s) based on accurate mass shifts.  
However, further analysis involving both FT-ICR MS and other approaches, such as GC-
MS and organic synthesis, revealed that ECH1 and ECH2 from Cur generate a product 
with α,β C=C moiety whereas Jam ECH1 and ECH2 yield β,γ C=C.  The function of Cur 
Hal was revealed to involve formation of mono-chlorinated product.  Coupled with Cur 
Hal, ECH1, and ECH2, Cur ER was revealed to have the unprecedented function of 
catalyzing cyclopropanation.  At the same time, Cur ER still retains the canonical 
function of the ER enzyme family to reduce α,β C=C bond.  The saturation function of 
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Jam ER is redundant in Jam biosynthesis because the formation of β,γ C=C and vinyl 
chlorination are catalyzed by upstream enzymes (Hal, ECH1 and ECH2).  
 The catalytic efficiencies of Cur ER cyclopropanation and Cur and Jam ER 
saturation were also evaluated. IRMPD results showed that Cur ER catalyzes 
cyclopropanation much faster, ~240 fold, than saturation.  Jam ER can still efficiently 
catalyze a saturation reaction.  We applied a similar strategy to explore the catalytic 
efficiency of Hal following a series of site-specific mutations.  Finally, FT-ICR MS was 
applied to investigate the sequential addition and release of SO3
- on ACPIII, catalyzed by 
ST and TE, respectively, thereby providing insight into the decarboxylative chain 
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Chapter 8  
Summary and Prospects for Future Studies 
 
8.1 Summary and Conclusion  
8.1.1 The Goals of the Dissertation 
Mass spectrometry (MS) combined with chemical cross-linking has become a 
promising technique to characterize protein structure at low resolution and protein-
protein interactions.  Advantages provided by MS include high sample throughput, high 
sensitivity, and lenient requirements for sample purity.  Coupled with proteolysis and 
liquid chromatography (LC), large protein complexes with molecular weights up to 670 
kDa have been characterized [1]. 
However, efficient identification of cross-linked peptides remains challenging.  
Difficulties include: 1) how to generate MS signals for cross-linked peptides; and 2) how 
to differentiate such signals from peaks corresponding to unmodified peptides.  For the 
first challenge, cross-linked peptides suffer from low cross-linking yield and ion 
suppression by the large excess of unmodified peptides.  The chemical cross-linking yield 
can be improved by controlling reaction conditions, including the molar ratio of sample 
and cross-linker, pH value, and modification of reactive groups [2].  LC/MS can be 
applied to alleviate the ion suppression effect but is unable to completely solve this 
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problem because a number of unmodified peptides may still co-elute with cross-linked 
peptides and thereby influence their ionization efficiencies.  In addition, optimizing the 
separation of cross-linked peptides from unmodified peptides in LC is time and sample 
consuming.  For the second challenge, cross-linked peptide signals are difficult to 
differentiate from those of unmodified peptides in MS/MS because product ions from 
cross-linked peptides can be either the same as for the corresponding non-cross-linked 
peptides, or carry “mystery” mass shifts.  Such mass shifts are difficult to identify 
because all possible combinations of proteolytic peptides need to be considered, 
representing a significant computational problem [3].  
To solve the first problem, affinity tags can be incorporated into cross-linkers to 
allow selective enrichment.  To date, biotin is the most commonly used and commercially 
available affinity tag, however, biotin must be sufficiently distant from the reactive 
groups to minimize interferences.  Therefore, long chain, e.g., polyethylene glycol, chains 
[4], are typically introduced to isolate the biotin group, which makes the cross-linker 
bulky.  In addition, the length of this spacer arm normally exceeds the preferred range of 
8-15 Å [2, 5], which may influence the acquisition of meaningful information on protein 
structure and interactions [2].  In addition, detergents are typically required to dissociate 
biotin-avidin interactions and removal of detergents prior to MS analysis may be 
challenging and cause sample loss.  For the second problem, gas-phase cleavable cross-
linkers, which display unique fragmentation patterns in MS/MS analysis, can be utilized.  
This strategy has been implemented with IR irradiation [6, 7], UV irradiation [8], or CID 
[9-13] to produce characteristic so called “reporter ions” [9], which provide identification 
of cross-linked products.  
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One of main purposes of this thesis is to explore efficient detection of cross-
linked peptides in MS analysis, which includes: 1) designing cross-linker with novel 
enrichment potential, 2) investigating optimal MS/MS approaches to induce efficient gas-
phase fragmentation of cross-linked peptides with disulfide bond linkage, and 3) study 
the C-I bond cleavage under ECD with the aim to design the cross-linker with unique 
mass loss in MS/MS analysis.  The other goal for this thesis is to apply chemical cross-
linking, MS and MS/MS techniques to reveal protein-protein interaction, enzyme 
function, and enzyme function differentiation.    
8.1.2 Summary of Experimental Results 
In this thesis, interactions between gene transcriptional activators and co-activator 
(mediator) 15 were characterized.  In some cases, the binding site could be localized to a 
single amino acid residue.  The successful mapping of such in vitro protein-protein 
interactions relied on the complementary use of multiplexed MS and MS/MS techniques. 
Incorporation of a redox-sensitive biotin tag into transcriptional activators containing a 
photo-cross-linking group was also important.  Notably, C-C and C-S bond cleavages in 
the photo-cross-linker moiety were observed in MALDI TOF/TOF CID.  In some cases, 
such cleavages resulted in free mediator tryptic peptides.  To our knowledge, this unique 
fragmentation behavior in MALDI TOF/TOF CID has not previously been reported.  
A novel peptide-based cross-linker was synthesized by incorporating an N-
terminal phosphate group and two amine reactive groups in the middle and at the C-
terminus, respectively.  This cross-linker demonstrated amine reactivity and an 
intramolecularly cross-linked product could be selectively enriched by TiO2 and ZrO2.  
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Compared with biotin-based enrichment, which typically involves MS-unfriendly salts 
and detergents, selective enrichment of phosphate-containing cross-linked product by 
metal dioxides can be achieved simply by changing the pH.  
Fragmentation patterns of peptides chemically cross-linked with disulfide bond-
containing cross-linkers were investigated in ECD, EDD, negative ion CID, and MALDI 
TOF/TOF CID.  The purpose of this project was to find an optimal gas-phase cleavage 
approach to facilitate selective identification of cross-linked peptides.  Results 
demonstrated that combined use of ECD and MALDI TOF/TOF CID would provide 
efficient S-S and C-S bond cleavages in the cross-linker.  
Highly selective C-I bond cleavage in ECD and ETD was observed.  Data also 
demonstrated that a through-bond or through-space proximate positively charged group 
can facilitate and enhance C-I bond cleavage.  These results provide a guide to designing 
novel cross-linkers, for which the unique mass of iodine loss (125.9 Da) would be helpful 
to differentiate cross-linked peptide signals in MS/MS analysis.  In addition, these 
discoveries provide an additional model to understand the ECD/ETD mechanisms. 
Quadrupole fractionation (QF) was revealed to achieve better detection of 
proteolytic peptides, particularly in the low m/z region (<700) than direct infusion (DI) 
mode.  These results cannot be explained based on previous computational experiment, in 
which ions with higher m/z value were believed to have larger radius for radial 
stratification in RF-only multipoles and are more likely to lose [14]. Results in this thesis 
demonstrated that low m/z ions may still be axially lost due to the space charge repulsion 
from trailing higher m/z ions in DI analysis. Space charge repulsion can be removed in 
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QF analysis and therefore the detection of low m/z ions is improved. Further studies of 
ion motion in RF-only and mass-selective quadrupole would be necessary to explain the 
results in this Chapter. 
Finally, FT-ICR MS and IRMPD were applied to characterize the function of 
enzymes from the curacin A and Jamaicamide biosynthetic pathways.  Furthermore, 
IRMPD was applied to estimate catalytic efficiencies for several enzymes in both 
pathways. These results provide insights into the evolution and environmentally driven 
adaptation of these enzymes at the biochemical rather than genetic level.   
 
8.2 Prospects for Future Studies 
8.2.1 Photo-cross-linking and Mass Spectrometry 
As discussed in Chapter 2, in vitro photo-cross-linking combined with 
multiplexed MS, MS/MS analyses, and avidin purification was successfully applied to 
characterize protein-protein interactions in vitro.  Ideally, these methods should be 
extendable to in vivo analysis of protein complexes in their native environment.  
Incorporation of the photo-cross-linker p-benzoyl phenyl alanine (pBpa) into target 
protein in vivo by substituting endogenous residues can be achieved by genetic 
engineering [15, 16].  However, addition of an enrichment moiety to such cross-linkers 
would be highly challenging.  Incorporation of single or tandem enrichment tags, 
including polyhistidine and biotin, has been reported [17, 18] but it will only enrich the 
undigested complex and not proteolytic cross-linked products.  Formaldehyde-mediated 
protein cross-linking can also be applied in vivo [19] .  However, this method is limited to 
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the identification of protein subunits in a protein complex and does not provide precise 
binding sites [20].  In addition, formaldehyde has a very short spacer arm (~about 2 Å) 
and will only cross-link residues that are in very close proximity [21].  Future directions 
in this area should focus on the design of specific unnatural amino acids that contain both 
cross-linking and enrichment moieties.  For example, pBpa may be modified to introduce 
an alkyne group, which can be used for alkyne-azido “click” purification [22].  Once such 
unnatural amino acids are incorporated into target protein complexes, they could undergo 
cross-linking reaction and be subsequently enriched, particularly following proteolysis.  
In addition, such a method could be combined with other tags (e.g., histidine or biotin) to 
achieve purification of target protein complexes prior to proteolysis.  Thus, the chance of 
observing cross-linked peptides should be enhanced.     
8.2.2 Fragmentation Patterns of Cross-linked Peptides with Disulfide Bond 
Linkage 
In Chapter 3, fragmentation patterns of cross-linked peptides with disulfide bond 
(S-S) linkage were investigated.  S-S and C-S bond cleavages in various MS/MS 
approaches were the main focus of that study.  Based on the results from ECD, EDD, 
negative ion CID, and MALDI TOF/TOF CID, the first and last of these MS/MS 
approaches were considered to be the optimal combination for inducing efficient S-S/C-S 
bond rupture and thereby aid the identification of S-S cross-linked peptides.  
One remaining question is the preference of C-S cleavage vs. S-S cleavage.  For 
example, in that work, efficient C-S bond cleavages were observed in MALDI TOF/TOF 
high energy CAD.  On the other hand, efficient S-S bond cleavage is observed in ECD.  
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Because S-S and C-S bonds have similar dissociation energies [23], it would be 
interesting to further examine this phenomenon.  
8.2.3  Design of a Novel Cross-linker with Metal Dioxide Enrichment Potential or 
Unique Fragmentation Pattern 
In Chapter 5, efforts were discussed to design a peptide-based cross-linker with 
TiO2/ZrO2 enrichment potential.  A phosphate group was positioned at the peptide N-
terminus whereas two amine-reactive (N-hydroxysuccinimide (NHS)) groups were 
placed in the middle and at the C-terminus, respectively.  The spatial distance between 
the phosphate group and the two NHS groups should be long enough to allow selective 
binding of the phosphate to TiO2/ZrO2.  However, the observed enrichment efficiency 
was not ideal, which may be attributed to the branched nature of the cross-linker.  In 
addition, only intramolecularly cross-linked peptides were observed for this cross-linker 
and efforts to obtain intermolecularly cross-linked species from model peptides and 
standard proteins were unsuccessful.  To solve these problems, two amine-reactive groups 
need to be placed at both ends of a linear molecule with fixed length.  A phosphate group 
could be incorporated by extending a branch at the middle of such a linear molecule.  The 
length of that branch should be long enough to allow metal dioxide enrichment.  Based 
on this idea, a potential design was developed by Prof. Larsen at the University of 
Michigan.  The proposed structure, in which the phosphate group is incorporated via a 
PEG chain, is shown in Figure 8.1.  The length of the PEG chain can be easily varied.  In 




Figure 8.1.  A novel cross-linker design suggested by Prof. Larsen.  
 
In Chapter 4, C-I bond cleavage in ECD was examined.  It was concluded that an 
adjacent positive charge, either through bond or through space, is required to obtain 
efficient C-I bond cleavage.  This conclusion is very important for designing a novel 
cross-linker with a gas-phase labile C-I bond.  The release of an iodine atom in MS/MS 
analysis yield a unique mass loss (125.9), which can facilitate differentiation of cross-
linked peptide signals from those of unmodified peptides.  Similar to the design of a 
phosphate-containing cross-linker, the iodine-based cross-linker can be designed as a 
linear molecule with amine-reactive groups at both ends.  In addition, a fixed charged 
group and a C-I moiety can be placed in the middle of the backbone.  Numerous reports 
have demonstrated the design and synthesis of such linear cross-linkers with reactive 
groups at both ends [10, 12, 24].  Further, incorporation of a fixed charge group into a 
cross-linker has also been reported [12].  Comparison of C-I bond cleavage in ECD and 
266 nm UV laser irradiation would also be interesting.  As mentioned in Chapter 4, the 
charge-directed C-I bond cleavage observed in ECD appears to be best explained by the 
“Utah-Washington” model for ECD [25, 26].  Such effects, however, should be absent 
under 266 nm UV irradiation.  Therefore, C-I photodissociation may be more reliable 
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than that from ECD. 
8.2.4 Study of Quadrupole Fractionation Mechanisms 
As shown in Chapter 6, signal enhancements were observed in quadrupole 
fractionation (QF) analysis in the low m/z (i.e., 350-600) region in both positive and 
negative ESI mode.  These results contradict previous computational analysis, which 
modeled radial oscillations of ions in RF-only multipoles as functions of mass and charge 
[14].  Higher m/z ions have higher radial oscillation radii and are therefore more likely to 
be radially lost.  We concluded that space charge repulsion from trailing higher m/z ions 
may cause axial ejection of lower m/z ions.  In QF analysis, space charge repulsion from 
higher m/z ions is removed, thus providing a benefit for the detection of low m/z ions.  
Further studies of ion motion in RF-only and mass-selective quadrupole modes, including 
computer simulations and analysis of different sample types (e.g., metabolites with m/z 
values below 700), would be necessary to explain the results in this Chapter.   
8.2.5 MS/MS-based Approach to Study Enzyme Catalytic Efficiency  
Results in Chapter 7 demonstrate that IRMPD can be applied to reveal enzyme 
catalytic efficiency.  Spectral complexity is greatly reduced by selective cleavage of the 
reactive group off a carrier protein (PPant ejection).  This method can be generalized as 
an MS/MS-based approach to estimate the relative ratio between substrate and product if: 
1) the reaction occurs at a specific site in a protein (e.g., the PPant arm discussed in 
Chapter 7) and that region can be selectively cleaved in MS/MS; 2) the reaction does not 
result in big changes in ionization efficiency; and 3) the product can be purified for 
subsequent analysis.  This MS/MS-based approach can be applied for time-course studies, 
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